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Progress Toward the Total Synthesis of Lomaiviticins 
Abstract 
A synthetic plan for the dimeric diazobenzofluorene natural product lomaiviticin 
A and lomaiviticin B is presented. The route features a late-stage oxidative enolate 
dimerization of a monomeric oxanorbornanone, as well as a cyanophthalide-based 
anionic annulation. 
In chapter 2, a synthetic route to enone 2.42 is described. Starting from the readily 
prepared intermediate 1.101, enone 2.42 was prepared in seven steps. A key 
cyanophthalide annulation utilizing enone 2.42, where the C1 and C5 ketones are 
differentiated, was successfully applied. 
Chapter 3 describes an optimization study of the oxanorbornanone enolate 
dimerization. By using simple ketone 3.3 as a model, reaction conditions minimizing 
undesired side reactions were identified. These conditions were effectively applied to the 
dimerization of the fully elaborated tetracyclic precursor. 
A synthesis of the full carbon skeleton of the lomaiviticin aglycone is illustrated 
in chapter 4. A tetracyclic intermediate 4.13, prepared from enone 2.42, underwent 
stereoselective dimerization under the optimized conditions to provide C2-symmetric 
dimer 4.12. During the dimerization study, a critical remote steric effect of C11 
substituent was observed. A crystal structure of a dimeric intermediate helps lend support 
to our hypothesis regarding the remote steric effect. 
!! iv 
Finally, synthetic efforts to accomplish a synthesis of the lomaiviticin aglycone 
ent-1.3 is described in chapter 5. Although the C4 sulfone of dimer 4.12 was efficiently 
substituted with an oxygen atom, the key C11b-O bond cleavage was not realized under a 
variety of strategies. 
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Chapter 1 
Lomaiviticins: New Diazobenzofluorene Natural Products 
 
1. 1. Isolation and Structure Determination 
In 2001, two new diazobenzofluorene glycosides were identified by He and 
coworkers during the investigation of the real producer of namenamicin related endieyne 
natural products. A potent antitumore agent, namenamicin was originally isolated from a 
marine ascidian Polysyncraton lithostrotum (Figure 1.1).1 
 
Early on it was suspected that one of the microbial symbionts was responsible for 
the production of the natural product, therefore several actinomycetes were isolated from 
the host and tested. The fermentation broth of micromonospora lomaivitiensis, one of the 
actinomycetes found in Polysyncraton lithostrotum, exhibited potent DNA-damaging 
activity and was found to be highly cytotoxic against a panel of cancer cell lines. Inspired 
by these observations, He and coworkers isolated two new compounds, lomaiviticin A !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
(1) McDonald, L. A.; Capson, T. L.; Krishnamurthy, G.; Ding, W.-D.; Ellestad, G. A.; 
Bernan, V. S.; Maiese, W. M.; Lassota, P.; Kramer, R. A.; Ireland, C. M., J. Am. 
Chem. Soc. 1996, 118, 10898-10899. 
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Figure 1.1 Structure of namenamicin.
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(1.1) and lomaiviticin B (1.2) by reverse phase HPLC purification of the acidic 
acetonitrile extract of micromonospora lomaivitiensis fermentation broth (Figure 1.2).2 
 
Lomaiviticin A and B were isolated as amorphous powders, precluding X-ray 
diffraction analysis. Their structural proposal was made primarily on extensive 1D and 
2D NMR experiments together with high resolution mass spectroscopy. One of the 
striking features of their structures was found by comparing the number of 13C signals 
from the NMR and the number of carbon atoms derived from the molecular formula. 
Since 13C NMR spectra only accounted for half the number of carbon atoms determined 
by the mass spectroscopy, it was hypothesized that the lomaiviticins were symmetric 
dimers. The dimeric nature of the natural product is also revealed in the cross peak of H2 
and C2’(or H2’ and C2) in the HMBC spectrum. Since only the multiple bond correlation 
is displayed in HMBC, a linkage between C2 and C2’ is suggested (Figure 1.3a). Other !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
(2) He, H.; Ding, W.-D.; Bernan, V. S.; Richardson, A. D.; Ireland, C. M.; Greenstein, 
M.; Ellestad, G. A.; Carter, G. T., J. Am. Chem. Soc. 2001, 123, 5362-5363. 
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Figure 1.2 Structure of lomaiviticin A, lomaiviticin B, and lomaiviticin aglycone.
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substructures of the lomaiviticins were revealed by analysis of NMR spectral data. The 
presence of 5,8-dihydroxy-1,4-naphthoquinone and diazobenzofluorene unit, which were 
also detected by UV and IR absorption spectra, defines the tetracyclic backbone skeleton 
of the natural product (Figure 1.3b).3 The two separate spin systems of the aliphatic 
region of the lomaiviticin A spectra were assigned to be originating from !-N,N-
dimethylpyrrolosamine and "-oleandrose, which are attached at the C4 and C3 positions, 
respectively (Figure 1.3c). Lomaiviticin B, on the other hand, was decorated only with "-
oleandrose at the C3 position. The orientation of the anomeric protons were determined 
by coupling constant analysis. 
 
The relative stereochemistry of the cyclohexene D-ring region was determined 
based on the assumption that both natural products have the same relative configuration 
at C2, C3, and C4. First, the configuration of protons at the C2 and C4 positions were 
assigned to be identical in both natural products based on the w-coupling in the gCOSY 
spectrum (Figure 1.4a). Second, since lomaiviticin B exists as a bis-hemiketal, forming 
two furanol rings, the C2–C2’ linkage and the C–O bond at the C2 position were thought 
to be placed on the identicall face of the cyclohexene ring (Figure 1.4b). This !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
(3) (a) Nawrat, C. C.; Moody, C. J., Nat. Prod. Rep. 2011, 28, 1426-1444. (b) Herzon, 
S. B.; Woo, C. M., Nat. Prod. Rep. 2012, 29, 87-118. 
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stereochemical assignment is reflected on the stereochemical assignment of lomaiviticin 
A, thereby suggesting the stereochemistry of the cyclohexene D-ring is as shown in 
Figure 1.2. 
 
The absolute stereochemistry of the lomaiviticins, as well as the stereochemical 
correlation between the appended carbohydrate moieties and the aglycone were not 
elucidated. Given the structural similarities with the related diazobenzofluorene natural 
product kinamycins, however, it was deduced that both classes of the natural product 
have identical absolute configuration at the C3 and C4 positions (Figure 1.5).4 
 
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
(4) Gould, S. J., Chem. Rev. 1997, 97, 2499-2510. 
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On the other hand, the absolute stereochemistry of N,N-dimethylpyrrolosamine 
and oleandrose remain elusive, although they are found in other natural products such as 
!-pyrrolosporin5 and avermectins6 (Figure 1.6). 
 
Given the limitations of spectroscopic methods described above, a complete 
structural elucidation of the natural products would be made possible only by a chemical 
synthesis of both the aglycone and the carbohydrate counterparts. 
 
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
(5) Schroeder, D. R.; Colson, K. L.; Klohr, S. E.; Lee, M. S.; Matson, J. A.; Brinen, L. 
S.; Clardy, J., J. Antibiot. 1996, 49, 865-872. 
(6) Davies, H. G.; Green, R. H., Chem. Soc. Rev. 1991, 20, 211-269. 
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1.2. Biosynthetic Hypothesis and Mechanism of Action 
The exact biosynthetic pathway of the lomaiviticins has not been elucidated to 
date. However, the biosynthesis of the related natural product kinamycins has been 
comprehensively studied and reviewed in 1997." In this section a brief survey of the 
kinamycin biosynthesis as well as possible dimerization pathways of the lomaiviticins are 
presented. In addition, proposed mechanisms of bioaction of the diazobenzofluorene 
compounds are discussed. 
The kinamycin biosynthesis research was conducted by extensive feeding studies 
with isotopically labeled building blocks, such as sodium [1-13C] acetate or [2-13C] 
acetate, and isolation of biosynthetic intermediates which in turn were resubjected to the 
biosynthetic conditions (Figure 1.7).7 The pathway commences with condensation of ten 
molecules of S-acetylcoenzyme A 1.4 to form a polyketide derived carbon skeleton of the 
natural product 1.5, which in turn is converted to dehydrorabelomycin 1.6.8 
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
(7) Sato, Y.; Gould, S. J. Tetrahedron Lett. 1985, 26, 4023-6. 
(8) (a) Seaton, P. J.; Gould, S. J., J. Am. Chem. Soc. 1987, 109, 5282-5284. (b) Seaton, 
P. J.; Gould, S. J. J. Antibiot. 1989, 42, 189-97. 
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Dehydrorabelomycin, the first co-metabolite of the kinamycin biosynthesis, undergoes an 
oxidative rearrangement to form the 5-membered C-ring over a three step sequence. First 
an oxidative C–C bond cleavage is believed to take place to provide intermediate 1.7. 
Second, reduction of the B-ring triggers an intramolecular alkylation to form the five- 
membered C-ring of the natural product (1.8). Final decarboxylation concludes 
biosynthesis of kinobscurinone 1.9, the earliest proven biosynthetic precursor possessing 
the five-membered C-ring.9 
The next stage of the biosynthesis is the introduction of the diazo group, which is 
believed to take place in two separate events each providing one of the two nitrogens of 
the diazo moiety (Figure 1.8). The first nitrogen atom of kinamycin is introduced at the 
kinobscurinone stage by a reductive enamine formation to give another co-metabolite 
stealthin C 1.10. This pathway was shown to be mediated by glutamine- or ammonia-
dependent aminotransferase.10 Oxidative introduction of the second nitrogen atom takes 
place with an unknown mechanism, which results in the formation of prekinamycin 1.11. 
 
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
(9) Gould, S. J.; Melville, C. R., Bioor. Med. Chem. Lett. 1995, 5, 51-54. 
(10) Gould, S. J.; Melville, C. R.; Cone, M. C.; Chen, J.; Carney, J. R., J. Org. Chem. 
1997, 62, 320-324. 
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Figure 1.8 Biosynthetic introduction of the diazo group in the kinamycins.
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Final decoration of the D-ring was proposed to involve multistep events 
consisting of oxidative transformations and acylations (Figure 1.9). First an oxidative 
dearomatization of the prekinamycin D-ring generates ketoanhydrokinamycin 1.12.8b 
Then the D-ring oxidation state is adjusted through reduction of the carbonyl group 
together with epoxide opening to give kinamycin F 1.13, a precursor to the other 
members of the natural product family. A multifunctional enzyme, kinamycin 
acetylstransferase I (KAT I), has been isolated, and it was shown that the acylation of 
kinamycin F takes place through the action of KAT I.11 To date, only kinamycin D and E 
were isolated from the KAT I mediated acylation experiment, suggesting other KATs are 
yet to be identified. 
 
Based on the structural similarity, it is believed that the biosynthesis of the 
lomaiviticins follows a biosynthetic pathway similar to that of the kinamycins. One 
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
(11) Gould, S. J.; O'Hare, T.; Seaton, P.; Soodsma, J.; Tang, Z., Bioorg. Med. Chem. 
1996, 4, 987-994. 
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unanswered question is how and at which stage the dimeric structure is formed. The 
important step that forms the central C–C bond at the axis of symmetry is believed to 
occur through an oxidative phenolic coupling of 1.14, an intermediate that resembles 
prekinamycin 1.11 of the kinamycin biosynthesis (Figure 1.10a). Oxidative phenolic 
coupling is a commonly observed reaction in the biosynthesis of other natural products.12 
After formation of the C2–C2’ bond the intermediate may undergo a similar pathway as 
the kinamycins, except for the glycosylations. Another possibility is dimerization of an 
enolate species such as 1.16, which could be generated from the corresponding epoxide 
1.15 by two electron reduction. Epoxide 1.15 is an analogous intermediate to 
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
(12) (a) Hüttel, W.; Müller, M., ChemBioChem 2007, 8, 521-529. (b) Zhao, B.; 
Guengerich, F. P.; Bellamine, A.; Lamb, D. C.; Izumikawa, M.; Lei, L.; Podust, L. 
M.; Sundaramoorthy, M.; Kalaitzis, J. A.; Reddy, L. M.; Kelly, S. L.; Moore, B. S.; 
Stec, D.; Voehler, M.; Falck, J. R.; Shimada, T.; Waterman, M. R. J. Biol. Chem. 
2005, 280, 11599-11607. 
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ketoanhydrokinamycin 1.12 in the kinamycin biosynthesis. This hypothesis was 
suggested in 2011 by Porco and coworkers in their synthetic work on FL-120B’ 1.17.13 
The lomaiviticins are potent anticancer and antibacterial agents.2 Lomaiviticin A 
is cytotoxic toward 24 cancer cell lines with IC50 values ranging from 0.007 to 72 nM. 
The lomaiviticins also inhibit the growth of gram positive bacteria Staphylococcus aureus 
and Enterococcus faecium, with MIC’s ranging from 6 to 25 ng/spot in a plate assay.  It 
is believed that these bioactivities stem from the ability of lomaiviticin A and B to cleave 
DNA in vitro under reducing conditions; however, no detailed mechanistic studies under 
physiologically relevant conditions havs been reported to date. It is only suggested that 
they possess a unique mode of action based on their unusual cytotoxicity profile. 
Although little is known about the mechanism of action of the lomaiviticins, the 
related natural product kinamycins have been extensively studied with particular focus on 
the triggering pathway both in vitro and in vivo.3 Findings made over the last three 
decades are summarized below. 
The first experimental model system used to test a bioreactivity proposal on the 
kinamycin family was a simple diazofluorene ring system (Figure 1.11). In 1995 
Jebaratnam and coworkers found that diazofluorene 1.18 in the presence of Cu(OAc)2 or 
light cleaves single-stranded pBR322 DNA.14 It was suggested that 1.18 is converted to a 
carbene (1.19) or a radical species (1.20), which is responsible for DNA cleaving activity. 
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
(13) Scully, S. S.; Porco, J. A., Angew. Chem. Int. Ed. 2011, 50, 9722-9726. 
(14) Arya, D. P.; Jebaratnam, D. J., J. Org. Chem. 1995, 60, 3268-3269. 
  Chapter 1 
 
! 11 
 
In 1977 Moore proposed a quinone methide intermediate as a reactive 
intermediate for the action of diazobenzofluorene natural products (Figure 1.12).15 
Reduction of the kinamycin B-ring to a hydroquinone such as 1.22 initiates expulsion of 
two acetates leading to a quinone methide species such as 1.23 or 1.24. High nucleophilic 
susceptibility of these species was thought to be responsible for cell death via the attack 
of biological nucleophiles. 
Moore’s hypothesis was partially supported by the experimental work of Feldman 
and coworkers in 2006 (Figure 1.13).16 Feldman showed that synthetic dimethyl 
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
(15) Moore, H. W., Science 1977, 197, 527-532. 
(16) Feldman, K. S.; Eastman, K. J., J. Am. Chem. Soc. 2006, 128, 12562-12573. 
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Figure 1.11 Jebaratnam's proposed formation of reactive species.
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prekinamycin 1.25 undergoes quinone methide formation under reductive conditions and 
eventually leads to formation of thioether 1.26–a thiol adduct to the quinone methide. It 
was proposed that the quinone methide is generated via the intermediacy of a vinyl 
radical species 1.29, which upon reduction to quinone methide 1.30, can trap a solvent 
molecule to form compound 1.26. It was postulated that a DNA molecule may act as a 
bionucleophile to the quinone methide, providing an adduct such as 1.26. Feldman’s 
experiment not only validates the suggestion of a quinone methide or a vinyl radical as a 
reactive species, but also stresses the importance of the reductive conditions to initiate the 
pathway. One drawback of the experiment is that the employed condition is not mild 
enough to be extrapolated to biologically relevant circumstances. 
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An orthogonal biological mechanism of action was proposed by Dmitrienko and 
coworkers in 2002 (Figure 1.14).17 The authors proposed that direct attack of a protic 
nucleophile to the diazo group of 1.31 can lead to the formation of an azo compound such 
as 1.32, which eventually decomposes to an aryl radical species 1.34 via loss of nitrogen. 
The hydrogen atom abstracted product of the aryl radical 1.35 was isolated as well as 
compound 1.36–a direct adduct of the naphthol to intermediate 1.33. The authors 
suggested that the kinamycins and the lomaiviticins may exhibit their cytotoxic activities 
by addition of biological nucleophiles to the diazo group or aryl vinyl radical formation 
via loss of nitrogen. 
 
A biologically more relevant initiation condition was investigated by Melander 
and coworkers (Figure 1.15).18 They found out that naturally occurring reducing agents 
such as dithiothreitol (DTT) or glutathione (GSH) with intracellularly relevant !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
(17) Laufer, R. S.; Dmitrienko, G. I., J. Am. Chem. Soc. 2002, 124, 1854-1855. 
(18) (a) Ballard, T. E.; Melander, C., Tetrahedron Lett. 2008, 49, 3157-3161. (b) C. L. 
Heinecke, C. L.; Melander, C., Tetrahedron Lett. 2010, 51, 1455-1458. 
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concentrations are sufficient enough to trigger the decomposition of kinamycin D (1.37), 
eventually leading to double-stranded DNA cleavage. They speculated that this process is 
taking place through the intermediacy of quinone methide species 1.39 or radical species 
1.41. Formation of these intermediates are in accordance with the observations made by 
Feldman and Dmitrienko. 
 
Given the structural similarities of the kinamycins and the lomaiviticins, it is 
believed that they share a common mechanism of action in the biosystem. However, it 
remains to be investigated why nature requires a dimeric structure for the lomaiviticins 
and what the roles of the carbohydrate moieties are. These questions offer further 
motivation for discovery of a totally synthetic approach to the supply of these potentially 
valuable natural products. 
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1.3. Other Synthesis Efforts 
In the previous sections we discussed two reasons to synthesize the lomaiviticins: 
structure confirmation and biomedical research. As synthetic targets, lomaiviticins 
impose the highest level of complexity in several aspects (Figure 1.16). 
 
First and foremost, the axis of symmetry at the C2–C2’ bond imparts the greatest 
challenge. Generally, C2-symmetric molecules are prepared either by two directional 
synthesis or late stage dimerization.19 When the central bond exists between two sp3 
carbons, very few choices exist other than early stage formation of the bond and two 
directional expansion of the core. However, double processing of such a complex 
molecule might suffer from low yield and undesired reactivity. What makes the bond 
formation between C2 and C2’ more challenging is the fact that the bond formation, 
which is next to a quaternary center at C3, needs to be diastereoselective. Second, the 
highly reactive diazobenzofluorene ring should be prepared with the proper oxidation 
state of neighboring groups.# As is well documented in the literature, a diazo group is !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
(19) Vrettou, M.; Gray, A. A.; Brewer, A. R. E.; Barrett, A. G. M., Tetrahedron 2007, 
63, 1487-1536. 
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highly reactive under acidic and nucleophilic conditions.20 In order to prevent loss of the 
functionality, the diazo group at C5 has to be stabilized by neighboring electron-
withdrawing groups such as the B-ring quinone or C1 ketone in the lomaiviticins. 
Although introduction of diazo groups in other molecules have been widely explored,21 
carrying this sensitive functional group through the synthesis can be problematic. Third, 
the D-ring of the natural product, with a net hydroquinone oxidation state, is highly 
oxidized. Furthermore, the oxygen substituents need to be introduced with proper 
stereochemistry and they cannot not be lost throughout the synthesis, since they are 
highly prone to aromatize by elimination of hydroxide or alkoxide. 
As of April 2012, several efforts to overcome these challenges have been reported 
and reviewed.# Although a total synthesis of the lomaiviticins has not been accomplished 
to date, partial structures of the natural product, including the aglycone and the 
carbohydrate moieties of the natural product, have been prepared. In this section the 
published attempts to prepare the lomaiviticin natural products are presented. Synthesis 
and glycosylation studies of lomaiviticin carbohydrates are not discussed.22 
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
(20) Regitz, M.; Maas, G., Diazo Compounds-Properties and Synthesis, Academic Press, 
Orlando, 1986. 
(21) For review, see: Maas, G., Angew. Chem. Int. Ed. 2009, 48, 8186-8195. 
(22) (a) Morris, W. J.; Shair M. D., Org. Lett. 2008, 11, 9-12. (b) Gholap, S. L.; Woo, C. 
M.; Ravikumar, P. C.; Herzon S. B., Org. Lett. 2009, 11, 4322-4325. (c) Morris, W. 
J.; Shair M. D., Tetrahedron Lett. 2010, 51, 4310-4312. 
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In 2006, Nicolaou and coworkers have disclosed their synthesis of the D-D’ 
dimeric core of lomaiviticin B (1.42) and lomaiviticin A (1.43 or 1.44).23 The synthesis 
highlights two directional functionalization of simple symmetric dimer 1.47, as is 
outlined in Figure 1.17. 
 
Starting from bisenone 1.47, the C1 and C1’ positions were masked with a C–C 
bond by double conjugate addition of dimethyl malonate to provide an unsymmetric 
dimer 1.48 (Scheme 1.1). The C3 ethyl group was introduced in a streoselective manner 
by addition to the carbonyl group at C3 to give diol 1.49. Interestingly, one of the methyl 
esters was lost during the introduction of the ethyl group, presumably via a retro-aldol 
reaction. After protection of the resulting tertiary carbinol as BOM ether 1.50, the central 
methine with a methyl ester was converted to ketone functionality (1.52) in six 
straightforward functional group manipulations through the intermediacy of olefin 1.51. 
At this stage the oxidation state of C1 was increased to that of an alcohol by " oxidation 
of the ketone to provide a symmetric diol 1.53. LAH reduction of the central carbonyl 
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
(23) Nicolaou, K. C.; Denton, R. M.; Lenzen, A.; Edmonds, D. J.; Li, A.; Milburn, R. R.; 
Harrison, S. T., Angew. Chem. Int. Ed. 2006, 45, 2076-2081. 
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Figure 1.17 Nicolaou's synthetic plan for the D-D' core of lomaiviticin A and B.
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group of 1.53 gave triol 1.54 and set the stage for the exposure of the C1 ketone 
functionality. 
 
At this point the synthetic route has diverged to form either the core of 
lomaiviticin A or lomaiviticin B. For the synthesis of lomaiviticin A core, triol 1.54 was 
treated with Pb(OAc)4 to induce oxidative C–C bond cleavage (Scheme 1.2). 
Interestingly, the initially formed "-hydroxy aldehyde 1.55 cyclizes on the C1 ketone of 
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the other ring to give a cyclic hemiacetal 1.56.24 After reduction of the hemiacetal, the 
core was subjected to another round of oxidative C–C bond cleavage to give a cyclic 
ketal 1.57. Upon exposure to Ley oxidation conditions, cyclic ketal 1.57 was converted 
to, through the intermediacy of hydroxy ketone 1.58, the lomaiviticin A core, 1.44. 
Synthesis of the lomaiviticin B core commenced with the removal of the BOM 
protecting group at C3 of 1.54 to give intermediate 1.59 (Scheme 1.3). Under the 
oxidative C–C bond cleaving conditions, a mono formate 1.62 was isolated as the major 
product, presumably through formation of 1.60 and 1.61. Deformylation in methanolic 
ammonia proceeded smoothly to give the core structure of lomaiviticin B 1.42 in a 
bishemiketal form. 
 
The Nicolaou group has also reported a synthesis of the monomeric half 
lomaiviticin aglycone 1.63 by adapting the route previously developed for the synthesis 
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
(24) Similar phenomena have also been observed in our own research program. See 
section 1.4, 3.1, and 5.1 for details. 
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of kinamycin C, F, and J.25 Retrosynthetically, they joined of building blocks of similar 
complexity, 1.64 and 1.65, by a transition metal catalyzed coupling reaction and the 
benzoin condensation (Figure 1.18).26 
 
Naphthyl bromide 1.64 and iodoenone 1.65 were joined to give 1.66 in the 
presence of Pd catalyst and Cu (Scheme 1.4). The resulting keto aldehyde 1.66 was 
treated with catalyst 1.67,27 developed in the research group of Rovis, to form the five 
membered C-ring of the natural product (1.68). A novel allylic transposition reaction 
sequence installed the oxygen atom at C1 to give alcohol 1.69. After introduction of the 
C5 hydrazone, Dess-Martin periodinane was used to oxidize both the C5 hydrazone and 
the C1 hydroxyl group to give the stabilized diazo compound 1.70. All that separated 
them from the desired monomeric unit was a four-step sequence of oxidation state 
adjustment and removal of protecting groups. 
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
(25) Nicolaou, K. C.; Li, H.; Nold, A. L.; Pappo, D.; Lenzen, A., J. Am. Chem. Soc. 
2007, 129, 10356-10357. 
(26) Nicolaou, K. C.; Nold, A. L.; Li, H., Angew. Chem. Int. Ed. 2009, 48, 5860-5863. 
(27) (a) Kerr, M. S.; Read de Alaniz, J.; Rovis, T., J. Am. Chem. Soc. 2002, 124, 10298–
10299. (b) Kerr, M. S.; Read de Alaniz, J.; Rovis, T., J. Org. Chem., 2005, 70, 
5725–5728. 
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The Sulikowski group has also demonstrated the synthesis of the central D-D’ 
core system, albeit in a form devoid of the C3 hydroxyl group.28 As in Nicolaou’s 
approach, it was prepared by two directional expansion (Scheme 1.5). Nickel-catalyzed 
reductive dimerization of iodoenone 1.72 provided bisenone 1.73. Double conjugate 
addition of vinyl cuprate, followed by stereoselective protic quenching, established the 
desired stereochemistry at the C2 and C2’ positions to give ketone 1.74. Elimination of 
the acetonide functionality took place uneventfully in the presence of DBU; however, an 
epimerization of one of the C2 stereocenter occurred under these conditions to provide 
unsymmetric bisenone 1.75 in 56% yield. Interestingly, DBU mediated elimination of 
reduced product 1.76, generated by catalytic hydrogenation of 1.74, produced an entirely 
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
(28) Zhang, W.; Baranczak, A.; Sulikowski, G. A., Org. Lett. 2008, 10, 1939-1941. 
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different product 1.77. It is suspected that 1.77 is formed by base-mediated acetonide 
cleavage followed by capture of the carbonyl group on the other side by the diol. 
 
To circumvent this unexpected reactivity, the Sulikowski group pursued an 
alternative strategy (Scheme 1.6). Enolsilane 1.78 was prepared by treating 1.73 with 
allyltributyltin in the presence of TBSOTf. In six straightforward functional group 
manipulations, the C3 ally group of 1.78 was converted to an ethyl group (1.79). 
Treatment of 1.79 with TBAF resulted in removal of the TBS groups as well as cleavage 
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of the acetonide protecting groups to give an intermediate bisenone (not shown). The 
enone was acetylated and iodinated to give bis("-iodoenone) 1.80, which constitutes the 
C3/C3’ dideoxy core of the lomaiviticins. 
In 2011 a synthesis of the lomaiviticin aglycone was reported by the Herzon 
group.29 Their synthesis closely resembles their own synthesis of kinamycin F, with the 
addition of the final dimerization strategy.30 A highly functionalized intermediate such as 
1.82 allowed rapid entry to the lomaiviticin aglycone after dimerization (Figure 1.19). 
 
Preparation of the dimerization precursor is described in Scheme 1.7. The 
synthesis commences with Birch reduction of TIPS protected 3-ethylphenol, followed by 
Sharpless asymmetric dihydroxylation to install two hydroxyl groups at C3 and C4 
(1.84). Diol 1.84 was subjected to a Saegusa oxidation to provide enone 1.85, which was 
subsequently converted to a diastereomeric mixture of mesityl acetals 1.86. Conjugate 
addition of (trimethylsilyl)methylmagnesium chloride, trapping of the resultant enolate as 
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
(29) Herzon, S. B.; Lu, L.; Woo, C. M.; Gholap, S. L., J. Am. Chem. Soc. 2011, 133, 
7260-7263. 
(30) Woo, C. M.; Lu, L.; Gholap, S. L.; Smith, D. R., J. Am. Chem. Soc. 2010, 132, 
2540-2541. 
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a TMS enol ether, followed by another round of Saegusa oxidation provided enone 1.87. 
Enone 1.87 underwent addition-elimination reaction with dibromoquinone 1.88 in the 
presence of an anhydrous fluoride source to give coupling product 1.89. Palladium-
mediated cyclization reaction of 1.89 furnished hydroxyfulvene 1.90, which contained 
the five-membered C-ring of the natural product. Compound 1.90 underwent Regitz 
diazo transfer reaction31 in the presence of TfN3 and DMAP, to establish the 
diazofluorene unit of the natural product. At this point, the two diastereomeric mesityl 
acetals were separated by silica gel chromatography to provide two different dimerization 
precursors, 1.91 and 1.92. 
 !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
(31) Regitz, M., Angew. Chem. Int. Ed. 1967, 6, 733. 
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While the precursor 1.91 was not effective towards the desired dimerization, 
compound 1.92 was successfully elaborated to the lomaiviticin aglycone (Scheme 1.8). 
The TMS enol ether of ketone 1.82 was treated with manganese 
tris(hexafluoroacetylacetonate) to mediate oxidative dimerization. It should be noted that 
a judicious choice of oxidant, which is non-Lewis acidic and does not have coordinating 
ligands, was crucial to the success of the reaction. Under the optimized conditions, the 
desired (2R, 2’R)-diastereomer 1.93, along with the minor undesired (2S, 2’S)-
diastereomer 1.94, was isolated. The authors attributed the stereochemical outcome to the 
long distance steric influence of the C3, C4 mesityl acetal (see the figure in the box). It 
was proposed that the methyl group of the mesityl group gears the ethyl group at the C3 
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position toward the Si face of the enolsilane, effectively blocking the undesirable face to 
dimerization. One step global deprotection of 1.94 provided the aglycone of the natural 
product. As was expected, the initially formed 1,4-diketone product spontaneously 
cyclized to the bisketal form of the product 1.3 upon standing in chloroform or upon 
chromatographic purification. 
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1.4. Shair Group Strategy 
In the previous section, synthetic efforts towards the lomaiviticin natural products 
were reviewed. Parallel to these attempts, the Shair group has also been tackling the 
problem with our own strategies since 2004. In this section the synthetic strategies 
devised in the Shair group, as well as the plans to accomplish a synthesis of the 
lomaiviticins are presented. 
As was discussed in Section 1.3, the biggest challenge of the synthesis is the 
formation of the central C2–C2’ bond which connects two identical halves of the natural 
product. Due to convergency and efficiency issues, the best way to make a C2-symmetric 
molecule is to unify two pieces of advanced intermediates at the latest stage possible.$% 
To this end oxidative dimerization of the enolate of the cyclohexenone D-ring to form the 
C2–C2’ bond was the pathway of choice (Figure 1.20).32 It was envisioned that a 
dimerization precursor such as ketone 1.95 would undergo dimerization in the presence 
of base and oxidant. 
 
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
(32) Ito, Y.; Konoike, T.; Saegusa, T., J. Am. Chem. Soc. 1975, 97, 2912-2914. 
PO
PO PO
O
O
O
PO
Et
OH
OP
OPOP
O
O
O
OP
Et
HO
OH
HO
Problems
1. !-elimination
2. diastereoselectivity
oxidative
enolate
coupling
lomaiviticin aglycone,
1.3
Figure 1.20 Oxidative enolate coupling strategy for the synthesis of lomaiviticin aglycone
1.95
HO
HO O
O
N
N
H
H
N
O
O OH
OH
N
OH
HO
O
O
Et
OH
HO
Et
  Chapter 1 
 
! 28 
This strategy, however, has two potential problems (Figure 1.21). First, the 
intermediate enolate is highly prone to expel oxygen substituent at the C3 position 
through !-elimination, thereby forming an aromatized compound such as 1.96 (path I). 
Second, there is no straightforward way to control the stereoselectivity of the 
dimerization event (path II). The size of the neighboring substituents at the C3 position, 
ethyl and hydroxyl groups, do not differ significantly. In addition, the orientation of the 
C4 substituent disfavors the desired dimerization, since it is directing the face of desired 
dimerization. In Herzon’s synthesis of the lomaiviticin aglycone, the dimerization had 
low levels of stereocontrol due to the same reason. 
 
To circumvent these problems, Dr. Evan Krygowski formulated an ingenious 
solution (Figure 1.22).33 By using a connective transform, cyclohexenol D-ring was 
retrosynthetically converted to an oxanorbornanone, which can be converted back to the 
cyclohexenol by base mediated elimination (Figure 1.22a). In the oxanorbornane system, 
the #* orbital of C–O bond is not efficiently aligned with the $ orbiral of the enolate 
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
(33) Krygowski, E. S., Ph. D. Thesis, Harvard University, Cambridge, MA, 2008. 
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thereby obstructing efficient !-elimination of the C3 hydroxide (Figure 1.22b).34 Use of 
the oxanorbornane solves the diastereoselectivity problem as well. As is well documented 
in the literature, the favored face of approach is the exo face–the same face of the oxygen 
bridge (Figure 1.22c).35 Therefore by using a dimerization precursor such as 1.97, it was 
anticipated that the !-elimination and diastereoselectivity problems would be resolved 
(Figure 1.22d). 
 
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
(34) (a) Jackson, S. R.; Johnson, M. G.; Mikami, M.; Shiokawa, S.; Carreira, E. M. 
Angew. Chem., Int. Ed. 2001, 40, 2694-2697. (b) Tojo, S.; Isobe, M. Synthesis 2005, 
1237-1244. 
(35) (a) Marchionni, C.; Vogel, P.; Roversi, P., Tetrahedron Lett. 1996, 37, 4149-4152. 
(b) Mosimann, H.; Vogel, P.; Pinkerton, A. A.; Kirschbaum, K., J. Org. Chem. 
1997, 62, 3002-3007. (c) Arjona, O.; Menchaca, R.; Plumet, J., Org. Lett. 2001, 3, 
107-109. 
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In order to test the idea, a model study was initiated and the result was published 
in 2008 (Scheme 1.9).36 The desired oxanorbornanone model D-ring was constructed 
from three simple building blocks, furanone 1.98,37 acrylate 1.99,38 and aldehyde 1.100,39 
in six straightforward steps. The highlight of the synthesis includes conjugate addition of 
the furanone enolate to acrylate 1.99, Evans’ anti-selective aldol reaction,40 and a 
diastereoselective furan Diels-Alder reaction.41 It should be noted that this sequence of 
reactions was highly scalable, hence over 50 g of 1.101 could be easily prepared from a 
single batch in enantiopure form. Oxanorbornanone 1.101 was converted to the 
dimerization precursor 1.102 in four steps, which involves acid mediated removal of the 
oxazolidinone chiral auxiliary and Barton decarboxylation.42 The model CD-ring system 
1.102 was successfully dimerized. In the presence of an amide base, the corresponding 
enolate was formed without undergoing significant !-elimination and, by using an non-
coordinating Fe(III) oxidant [Cp2Fe]PF6,43 the enolate was dimerized in a !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
(36) Krygowski, E. S.; Murphy-Benenato, K.; Shair, M. D., Angew. Chem. Int. Ed. 2008, 
47, 1680-1684. 
(37) Stuart, J. G.; Nicholas, K. M. Heterocycles 1991, 32, 949-963. 
(38) Ho, G.-J.; Mathre, D. J. J. Org. Chem. 1995, 60, 2271-2273. 
(39) Danda, H.; Hansen, M. M.; Heathcock, C. H., J. Org. Chem. 1990, 55, 173-181. 
(40) Evans, D. A.; Tedrow, J. S.; Shaw, J. T.; Downey, C. W., J. Am. Chem. Soc. 2001, 
124, 392-393. 
(41) For review see: Oliver Kappe, C.; Shaun Murphree, S.; Padwa, A., Tetrahedron 
1997, 53, 14179-14233. 
(42) Barton, D. H. R.; Crich, D.; Motherwell, W. B., J. Chem. Soc. Chem. 
Commun. 1983, 17, 939. 
(43) (a) Jahn, U. J. Org. Chem. 1998, 63, 7130-7131. (b) Jahn, U.; Hartmann, P. Chem. 
Commun. 1998, 209-210. 
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diastereoselective manner in 45% isolated yield. C2-symmetric dimer 1.103 was isolated 
as a single diastereomer. 
 
After a successful dimerization, model core 1.103 was moved forward to an 
intermediate that more closely resembles the natural product (Scheme 1.10). In two steps, 
C5 ketone was revealed by desilylation of the C5 TBS ether and oxidation. Interestingly, 
the central 1,4-diketone moiety of the dimer incorporated one molecule of water to form 
bishemiketal 1.104 as soon as a ketone oxidation state was set at the C5 position. This 
would become a universal observation made several other times in future investigations. 
With the C5 ketone in hand, the stage was set for the conversion of oxanorbornane to a 
cyclohexenol. By treating ketone 1.104 with K2CO3 in methanol, the desired 
cyclohexenol unit was obtained in high yield to provide cyclohexenol 1.105. Under 
harsher conditions, the resulting allylic sulfone of 1.105 underwent displacement with 
methoxide, completing the CDD’C’ system of the lomaiviticins in a hydrate form 
(1.106). 
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Based on these preliminary results, a strategy to prepare the entire carbon skeleton 
of the lomaiviticin aglycone was formulated (Figure 1.23). Due to the availability issue of 
the oxazolidinone chiral auxiliary, the enantiomeric form of lomaiviticin aglycone 1.3 
was targeted. First, indeneone 1.107 was chosen to be the direct precursor to the 
lomaiviticin aglycone. Well-precedented diazo group introduction (vide infra) and B-ring 
oxidation, together with global deprotection, would generate the target compound. 
Indenone 1.107 would be generated from the oxanorbornanone 1.109 by the cascade 
fragmentation/displacement reaction discovered in the Krygowski’s model study. The 
cascade is believed to take place with the intermediacy of allylic sulfone 1.108. Metal 
hydroxide would be the choice of base to install protecting group free C4 hydroxyl group. 
1,4-Diketone 1.109 is the dimerization product of ketone 1.110. It was anticipated that 
the dimerization would occur in a diastreoselective manner if the result of the model 
dimerization was reflected in the real system. Dimerization precursor 1.110, which has 
two extra rings compared to the model CD ring system 1.102, would be prepared from an 
enone 1.111 and a phthalide derivative 1.112 by an anionic annulation reaction (vide 
infra). Finally it was anticipated that enone 1.105 could be accessed from previously 
prepared intermediate 1.101. 
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Scheme 1.10 Model synthesis of lomaiviticin CDD'C' core.
  Chapter 1 
 
! 33 
 
In addition to the global strategy, two specific transformations deserve further 
comment. First, the challenging diazo group introduction would be attempted on the C5 
ketone of dimer 1.107. Related conversions of ketones to the corresponding diazo groups 
through the intermediacy of hydrazones have been investigated by other groups (Figure 
1.24). Porco and coworkers used a two-step sequence to introduce the diazo group of 
kinamycin C (Figure 1.24a).44 Indenone 1.113 was converted to the corresponding TBS 
hydrazone (not shown) by a protocol previously reported by Myers and coworkers.45 The 
resulting hydrazone was oxidized to afford kinamycin C 1.114 by the action of a 
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
(44) Lei, X.; Porco, J. A., J. Am. Chem. Soc. 2006, 128, 14790-14791. 
(45) Furrow, M. E.; Myers, A. G., J. Am. Chem. Soc. 2004, 126, 12222-12223. 
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hypervalent iodine oxidant. The Nicolaou group also used an analogous strategy in their 
synthesis of the kinamycins (Figure 1.24b).&' Indenone 1.115 was converted to diazo 
compound 1.116 with the intermediacy of a tosyl hydrazone (not shown). In this case, the 
oxidation of the hydrazone was accompanied with the oxdation of the B-ring 
hydroquinone, to give stabilized diazo compound 1.116. 
 
The other key reaction of the strategy is the anioninc annulation of phthalide 
derivatives (Figure 1.25).46 In the annulation donor 1.117, X is usually an electron 
withdrawing group which can be eliminated, such as a cyanide or a sulfone. It is 
generally believed that the reaction takes place through a Michael/Dieckmann reaction 
cascade of the anion of phthalide derivative 1.117 onto an enone (path I). However, a 
concerted cycloaddition mechanism cannot be completely excluded (path II). In both 
cases, elimination of substituent X, followed by aromatization, is operational to provide 
hydroquinone product 1.118. 
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
(46) For review see: (a) Mal, D.; Pahari, P., Chem. Rev. 2007, 107, 1892-1918. (b) 
Rathwell, K.; Brimble, M. A., Synthesis 2007, 643-662. 
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In addition to the original synthetic plan, a more conservative strategy was also 
conceived (Figure 1.26). Due to the anionic nature of the annulation and dimerization, C1 
and C5 ketones may have to be protected in a base resistant form, as in dimerization 
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Figure 1.25 Mechanism of phthalide derivative anion annulation.
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precursor 1.120 or annulation precursor 1.122. This obviously is a secondary strategy of 
choice, since additional protection/deprotection manipulations are required at compound 
1.119 or 1.121 stage. 
In this chapter, background information of the diazobenzofluorene natural 
products lomaiviticin A and B has been described. For structure elucidation and further 
biomedical research, a completely synthetic supply of the natural product is required. 
Synthetic efforts to access these natural products, including our own approach, has been 
reviewed. 
  Chapter 2 
 
! 37 
Chapter 2 
Key Intermediate Synthesis and AB-Ring Annulation 
 
2.1. First Generation Enone Synthesis 
As was discussed in the previous section, enone 1.111 was chosen as the primary 
target to investigate the possibility of avoiding protective groups of the C1 or C5 
carbonyl groups during the dimerization or annulation steps (Figure 2.1).1 Intermediate 
1.101 was chosen as a rational position to begin investigations on this possibility, since 
1.101 is easily accessible in large quantities and in enantiopure form.!
!
The synthetic strategy to transform 1.101 to 1.111 is outlined in Figure 2.2. The 
immediate precursor to enone 1.111 was expected to be TBS ether 2.1. It was envisioned 
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
(1) For review of protecting group free synthesis: Young, I. S.; Baran, P. S., Nature 
Chem. 2009, 1, 193-205. 
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that the C5a–C11a double bond could be installed through an oxidative decarboxylation 
reaction of acid 2.2. Consequently, the synthetic problem of 1.111 was reduced to an 
efficient preparation of carboxylic acid 2.2 from oxanorbornanone 1.101, a compound 
previously prepared by Dr. Evan Krygowski.2 
Scheme 2.1 describes the forward synthesis of compound 1.111. A global 
reduction of oxanorbornanone intermediate 1.101 provided diol 2.3 in 79% yield, with 
concomitant removal of oxazolidinone chiral auxiliary. It should be noted that the 
strength of the reducing agent had to be attenuated by forming a mixed boronate to 
maximize the yield.3 Addition of 1.0 equiv of methanol to LiBH4, prior to addition of the 
substrate, formed LiBH3OMe. After a two-step oxidation sequence, carboxylic acid 2.2 
was obtained. Oxidative decarboxylation of carboxylic acid 2.2, upon treatment with 
Pb(OAc)4 and Cu(OAc)2 in refluxing benzene, provided the desired allylic TBS ether 2.1 
in 19% yield.4 
 !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
(2) Krygowski, E. S.; Murphy-Benenato, K.; Shair, M. D., Angew. Chem. Int. Ed. 2008, 
47, 1680-1684. 
(3) Beshore, D. C.; Smith, A. B., III, J. Am. Chem. Soc. 2007, 129, 4148-4149. 
(4) Bird, C. W.; Butler, H. I.; Coffee, E. C. J.; James, L. M.; Schmidl, B. W. C., 
Tetrahedron 1989, 45, 5655-5666. 
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In an effort to improve the oxidative decarboxylation reaction, the mechanism of 
the reaction was analyzed. Figure 2.3 describes the generally accepted reaction. It is 
believed that the homolytic cleavage of Pb–O bond in intermediate 2.4 is the rate-limiting 
step. Accordingly, we tried to enhance the facility of this process by rendering the metal 
center more electropositive. We suspected that Pb(OCOCF3)4, which is in equilibrium 
with Pb(OAc)4 in the presence of TFA, would participate preferentially in the reaction 
cycle to form an intermediate 2.7, which might undergo a faster Pb–O bond cleavage than 
intermediate 2.4. 
 
Simple exchange of the acetate ligand for trifluoroacetate improved the yield 
significantly to 42% yield, 63% yield based on recovered starting material (Scheme 2.2). 
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Although this was not a satisfactory result, a sufficient amount of material was prepared 
to test the key annulation. TBS deprotection and DMP oxidation5 of 2.1 took place 
uneventfully to provide enone 1.111 with 85% yield over two steps. 
Enone 1.111 contains handles for two key reactions: the C1 ketone for enolate 
dimerization and the C5 enone for phthalide derivative annulation. First, enone 1.111 was 
treated with the anion of well-documented phthalide annulation donors such as 
cyanophthalide 2.106 or sulfonylphthalide 2.117 (Scheme 2.3a). To our disappointment, 
enone 1.111 underwent rapid decomposition even at !78 °C. A nonanionic annulation 
donor 2.128 was also applied to the reaction, yet the starting material still decomposed. 
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
(5) Dess, D. B.; Martin, J. C., J. Org. Chem. 1983, 48, 4155-4156. 
(6) Okazaki, K.; Nomura, K.; Yoshii, E., Synth. Commun. 1987, 17, 1021-1027. 
(7) Hauser, F. M.; Rhee, R. P., J. Org. Chem. 1980, 45, 3061-3068. 
(8) Myers, A. G.; Tom, N. J.; Fraley, M. E.; Cohen, S. B.; Madar, D. J., J. Am. Chem. 
Soc. 1997, 119, 6072-6094. 
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Dimerization of enone 1.111 was also attempted under Dr. Krygowski’s optimized 
conditions, but gave only decomposed starting material (Scheme 2.3b). No dimeric 
product 2.13 was detected. 
Based on these observations, it is evident that the ketone at C1 and the enone at 
C5 are not compatible under anionic annulation or dimerization conditions (Figure 2.4). 
This led us to devise an orthogonal protecting group strategy so that we can mask the C1 
or C5 ketone selectively. According to the original plan, it was decided to protect the C1 
ketone before attempting annulations on the C5 enone. 
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Figure 2.4 Incompatibility of C1 and C5 ketones.
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2.2. Second Generation Enone Synthesis 
The next goal of the project was the preparation of a C5 enone annulation 
precursor, where the C1 carbonyl group is masked in a base insensitive form. 
Differentiation of the C1 and C5 carbonyl groups was realized after the oxidative 
decarboxylation described in section 2.1 (Scheme 2.4). The C1 ketone of allylic alcohol 
2.8 was protected as a 5,5-dimethyl-1,3-dioxane by treatment of 2.8 with 2,2-dimethyl-
1,3-propanediol in the presence of a catalytic amount of acid to give compound 2.14.9 
The C5 ketone was generated in a two-step protocol described in the previous section. In 
this way, the desired annulation precursor 2.15, where C1 the ketone is protected as its 
corresponding ketal, was prepared. 
 
Since this sequence of reactions is still hampered by the low yield of the Pb 
mediated oxidative decarboxylation described earlier, another more efficient and benign 
decarboxylation condition was sought. A protocol developed by Tsuji using catalytic Pd 
was determined to be the condition of choice (Figure 2.5).10 In the proposed catalytic 
cycle of the reaction, Pd(0) first associates with the allyl ester 2.16, followed by oxidative 
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
(9) Williams, D. R.; McGill, J. M., J. Org. Chem. 1990, 55, 3457. 
(10) Shimizu, I.; Tsuji, J., J. Am. Chem. Soc. 1982, 104, 5844-5846. 
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addition to give intermediate 2.17. This Pd carboxylate readily undergoes 
decarboxylation to give a Pd " allyl complex 2.18. 2.18 undergoes #-hydride elimination 
to form the desired enone 2.15. 
  
To prepare the requisite #-keto allyl ester 2.16, carboxylic acid 2.2 was alkylated 
with allyl bromide to give allyl ester 2.20 in 91% yield (Scheme 2.5). At this stage, the 
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C5 ketone was protected in its corresponding ketal form in 97% yield (2.21). In two 
straightforward transformations involving TBS removal and oxidation, the desired #-keto 
allyl ester 2.16 was prepared, setting the stage to test the desired Pd catalyzed 
transformation discussed in Figure 2.5. The desired catalytic cycle, however, was 
severely impeded by undesired side reactions, such as proto depalladation, C–O reductive 
elimination, or C–C reductive elimination to give ketone 2.22, allyl vinyl ether 2.23, or 
allyl ketone 2.24, respectively. Use of various Pd sources, such as Pd(OAc)2, Pd(PPh3)4, 
PdCl2(PPh3)3, or Pd2(dba)3, did not improve the selectivity. 
The undesired reaction pathways are depicted in Figure 2.6. It was suspected that 
the " allyl complex 2.18 did not undergo competitive #-hydride elimination, due to the 
lack of an extra alkyl group at the $ position, which sterically enforces #-hydride 
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elimination. Thus, the Pd " allyl complex allows other side reactions to occur before the 
desired #-hydride elimination. Additionally, the side products were hard to separate from 
the desired product by silica gel chromatography. 
Although we were not able to access the desired enone in one step, the reaction 
served as a reliable method to remove the ester functionality. We focused our attention on 
the selective formation of ketone 2.22 by using an alternative Tsuji’s protocol,11 and 
decided to oxidize the ketone at C5 to the corresponding enone in a separate step. The 
alternative reductive deallylation/decarboxylation protocol is described in Figure 2.7. The 
" allyl complex 2.18 undergoes transmetallation with a metal hydride such as Bu3SnH, to 
give a metal carboxylate such as 2.25. Upon heating, 2.25 loses one molecule of CO2, to 
provide a metal enolate, which is protonated to yield ketone 2.22. 
 
By adding Bu3SnH as an external hydride source, ketone 2.22 was isolated as a 
single product in 89% yield (Scheme 2.6). Subsequent oxidation of 2.22 was achieved by 
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
(11) Tsuji, J.; Nisar, M.; Shimizu, I., J. Org. Chem. 1985, 50, 3416-3417. 
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treatment with Barton’s benzeneseleninic anhydride.12 This oxidation reaction suffered a 
conversion issue, due to the lack of complete conversion to the desired enone 2.15. 
Additionally, a small amount of unreacted starting material 2.22 remaining in the reaction 
was hard to separate from the product enone 2.15. This protocol, however, provided a 
sufficient amount of desired enone 2.15 to study the key annulation reaction until a better 
method was discovered. 
 
With the protected enone 2.15 in hand, the key annulation was attempted (Scheme 
2.7). Treatment of enone 2.15 with the anion of Kraus annulation donor 2.106 provided 
tetracyclic hydroquinone 2.26 in 41% yield.13 To avoid isolating side product 2.28, which 
is formed after initial conjugate addition, the reaction had to be stirred at an elevated 
temperature, a condition that drives the reaction to completion. The hydroxyl groups of 
the hydoquinone was protected as the corresponding allyl ether to give tetracyclic 
intermediate 2.27. 
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
(12) Barton, D. H. R.; Lester, D. J.; Ley, S. V., J. Chem. Soc., Perkin Trans. 1 1980, 
2209. 
(13) Kraus, G. A.; Sugimoto, H., Tetrahedron Lett. 1978, 19, 2263-2266. 
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In order to investigate the oxidative enolate dimerization, we attempted to 
deprotect the ketal at the C1 position of 2.27 (Scheme 2.8). However, under a variety of 
Lewis and Bronsted acidic conditions, a clean deprotection was not realized (Scheme 
2.8a). Under these conditions loss of the MOM ether was the first event to take place. 
Even after MOM deprotection, ketal deprotection did not occur before other undesired 
side reactions. A control experiment using 2.22 suggests that the hindered CD-ring 
system is problematic (Scheme 2.8b). 
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In summary, the desired oxidative enolate dimerization could not be attempted at 
this stage since the revelation of the C1 ketone was problematic. However, we have 
acquired useful knowledge regarding: 1) protection of the C1 ketone; 2) preparation of 
the enone functionality; and 3) execution of the cyanophthalide annulation, which 
provided the tetracyclic intermediate 2.26. 
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2.3. Third Generation Enone Synthesis 
After unsuccessful deprotection of the C1 ketal, a decision was made to change 
the protecting group strategy (Figure 2.7). Instead of protecting the C1 carbonyl group as 
the corresponding ketal, it was reduced and protected. To ultimately regenerate the C1 
ketone, an additional oxidation step would be required. 
 
The first protecting group chosen was the MEM ether, which is known to be 
cleaved significantly faster than the MOM ether.14 Fortunately, the C1 ketone of 1.102 
could be stereoselectively reduced and the resulting hydroxyl group was protected as a 
MEM ether in 89% yield over two steps (2.30). After three identical transformations, 
enone 2.31, with the C1 ketone protected as a MEM ether, was prepared. As expected, 
cyanophthalide annulation, as well as allyl ether formation, was realized uneventfully to 
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
(14) Corey, E. J.; Gras, J.-L.; Ulrich, P., Tetrahedron Lett. 1976, 17, 809-812. 
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provide tetracycle 2.32. 
The MEM ether, however, was resistant to removal (Scheme 2.10). Under 
standard Lewis acidic conditions, MOM ether deprotection occurred first. It is suspected 
that the coordinative assistance of the allyl ether oxygen is responsible for the inverted 
deprotection selectivity (2.34). This finding led us to use another protecting group, that 
could be removed under non-acidic conditions. 
 
The next protecting group utilized was a pivalate ester, a functionality which can 
be deprotected under reductive conditions. Instead of using the reduction product of 
1.102 (not shown) as a pivalate precursor, a slightly different class of intermediate was 
ultimately used. The route could be established due to a serendipitous finding that 
enabled both removal of oxazolidinone auxiliary and differentiation of the C1 and C5 
carbonyls at the same time (vide infra). 
During our continued effort to devise a more efficient route to the annulation 
acceptor, an interesting and potentially useful transesterification reaction was discovered 
(Scheme 2.11). Under a standard NaBH4 reduction condition, global reduction of 1.101 
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took place to give diol 2.3 as the major product (Scheme 2.11a). Interestingly, when the 
reaction mixture was quenched at a low temperature with acetone as a hydride scavenger, 
the oxazolidinone was exchanged with a solvent molecule to give methyl ester 2.35 
(Scheme 2.11b). Inspired by this result, the solvent was changed to allyl alcohol and the 
identical reactivity was observed with similar efficiency (Scheme 2.11c). It is believed 
that a boronate species such as the structure in the box is responsible for the observed 
reactivity. This finding established an easy and efficient route to allyl ester 2.36, where 
the C1 and the C5 hydroxyl groups are differentiated. 
 
The newly discovered reactivity was applied to the prepration of a new annulation 
precursor 2.42 (Scheme 2.12). The C1 hydroxyl group of allyl ester 2.36 was protected as 
a pivalate ester. We anticipated that this ester could be selectively cleaved under 
reductive conditions, that do not affect other parts of the molecule during the preparation 
of the tetracyclic intermediate. Then the C5 TBS ether was exposed to TBAF to give 
hydroxy ester 2.37 in 91% yield over two steps. Subsequent Swern oxidation of 2.37 not 
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only oxidized the C5 hydroxyl group, but also oxidized the C5a carbon to give $-chloro 
#-keto ester 2.39 as the sole product. Similar reactivity has been witnessed by Smith and 
coworkers and is attributed to electrophilic chlorination of the enol tautomer of the first 
oxidation product 2.38.15 The $-chloride 2.39 was readily reduced in the presence of 
zinc, 16  then the resulting #-keto allyl ester 2.40 was subjected to the optimized 
decarboxylation reaction, discussed in the previous section, to provide ketone 2.41 in 
82% yield over two steps. Finally ketone 2.41 was converted to enone 2.42 through a 
standard $-selenation/oxidation sequence in 73% yield.17 The seven-step sequence from 
1.101 to 2.42 was highly scalable and reproducibly provided over 10 g of enone 2.42 in a 
single batch. Therefore, this sequence has been utilized throughout the research program 
without further modifications. 
 !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
(15) Smith, A. B., III; Leenay, T. L.; Liu, H.-J.; Lloyd, A. K. N.; Ball, R. G., 
Tetrahedron Lett. 1988, 29, 49-52. 
(16) Snider, B. B.; Patricia, J. J., J. Org. Chem. 1989, 54, 38-46. 
(17) Reich, H. J.; Renga, J. M.; Reich, I. L., J. Am. Chem. Soc. 1975, 97, 5434-5447. 
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As anticipated, enone 2.42 underwent efficient Kraus annulation in 85% yield 
(Scheme 2.13). The allyl protecting group of the B-ring hydroquinone was introduced 
through a Mitsunobu reaction to give fully protected tetracyclic intermediate 2.44.18 
 
The C1 hydroxyl group deprotection was tested under reductive conditions 
(Scheme 2.14). Exposure of 2.44 to DIBAL-H led to pivalate cleavage with concomitant 
nonstereoselective reduction of the C5 ketone. 
 
In summary, a highly reliable procedure for the preparation of an annulation 
acceptor 2.42 was discovered. Enone 2.42 could be successfully advanced to a tetracyclic 
intermediate by cyanophthalide annulation. The C1 and C5 ketones could be strictly 
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
(18) For review see: Kumara Swamy, K. C.; Bhuvan Kumar, N. N.; Balaraman, E.; 
Pavan Kumar, K. V. P., Chem. Rev. 2009, 109, 2551-2651. 
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differentiated by protecting the C1 hydroxyl group as a pivalate ester. Finally, the 
protecting group could be cleanly removed at a post-annulation stage under reductive 
conditions, albeit with undesired reduction of the C5 ketone. 
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2.4. Synthesis of Tetracyclic Dimerization Precursor 
With scalable access to the tetracycle 2.44 available, we turned our focus to the 
preparation of an appropriate dimerization precursor. Initially, we attempted to remove 
the pivalate protecting group under nucleophilic conditions without affecting the C5 
ketone (Scheme 2.15). However, a variety of nucleophilic conditions resulted in 
extensive decomposition of the starting material before removal of the pivalate protecting 
group at C1 was observed. This result was in accordance with the problems incurred 
during the ketal deprotection at the C1 position due to the steric hindrance around the D-
ring oxanorbornane. The pivalate protecting group could only be cleaved by a hydride 
nucleophile. DIBAL-H reduction of 2.44 provided diol 2.45 in approximately 1:1 
diastereoselectivity at C5. Global Swern oxidation of 2.45 generated a potential 
dimerization precursor 2.47 in 59% yield over two steps. 
 Reagents and conditions: (a) DIBAL-H, CH2Cl2, !78 °C; (b) (COCl)2, DMSO, CH2Cl2; then Et3N,  !78 to 0 °C.
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However, ketone 1.110 does not tolerate the basic enolization conditions required 
for the oxidative dimerization reaction just like compound 1.111 (Scheme 2.16). As soon 
as an amide base, either LDA or LiHMDS, was added to 1.110, the starting material 
disappeared and multiple unidentified compounds were formed. We hypothesized that the 
C5 ketone is responsible for the decomposition pathway, hence it was decided that the C5 
ketone should be protected in a base tolerant form. 
 
The investigation of a suitable C5 carbonyl group began with its reduction and 
protection as its corresponding TBS ether. (Scheme 2.17). A chemoselective C5 carbonyl 
group reduction was realized by exposing 2.44 to NaBH4 at low temperature. As was 
observed in the global reduction to form 2.45 in Scheme 2.15, the diastereoselectivity of 
was low, ranging from 1:1 to 2:1. The mixture of diastereomers was treated with TBSOTf 
in the presence of Hunig’s base to give TBS ether 2.47 in 31% yield over two steps. Two 
straightforward subsequent manipulations provided the C1 ketone in 71% yield over two 
steps. Although a dimerization precursor could be prepared through this method, the low 
yield and low stereoselectivity in the first step prevented us from preparing a sufficient 
amount of dimerization precursor to attempt oxidative dimerization. 
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Scheme 2.16 Attempted dimerization of oxanorbornanone 1.110.
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Additionally, protection strategies for the C5 ketone of 2.44 in a variety of forms were 
pursued (Figure 2.8). Targeted compounds included, but were not limited to, ketals (2.50, 
2.51 or 2.52), thioketal (2.53), olefin (2.54), hydrazones (2.55), silyl enol ethers (2.56), or 
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cyanohydrins (2.57). In all cases, sufficient conversion was not realized or the starting 
material did not react. 
A breakthrough was made when the protecting group of the A-ring hydroquinone 
was changed from a MOM ether to a methyl ether, a functional group which is more 
stable under acidic conditions. Methyl protected cyanophthalide 2.586 and enone 2.42 
underwent efficient annulation to give tetracycle 2.59 in 85% yield. This compound was 
highly stable towards Lewis acidic conditions, thus tolerating the forcing reaction 
conditions required to install a C5 protecting group. In addition, the sequence of 
protecting group introduction had to be switched. Exposure of the annulated product 2.59 
to Noyori’s ketalization conditions provided dioxolane 2.60 in 76% yield.19 When the 
allylated version of tetracycle 2.59 (not shown) was exposed to identical conditions, no 
ketalization was observed, suggesting the steric bulk of the allyl ether retarded 
ketalization of the C5 ketone. 
 
After the C5 ketone was successfully masked, the B-ring hydroquinone was 
protected as a bisallyl ether under nucleophilic alkylation conditions to provide bisallyl 
ether 2.61 in 87% yield (Scheme 2.19). When Mitsunobu conditions were employed, a !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
(19) Tsunoda, T.; Suzuki, M.; Noyori, R., Tetrahedron Lett. 1980, 21, 1357-1358. 
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quinone 2.64 was isolated as a major product presumably through the assistance of DIAD 
(2.63). Finally, the C1 ketone was exposed under the optimized protocol, which involves 
NaBHEt3 reduction and Ley oxidation to provide ketone 2.62. 
 
In summary, a route to the targeted dimerization precursor 2.62 was established. 
Annulation precursor enone 2.42 was prepared in seven steps from the readily accessible 
compound 1.101. Enone 2.42 was protected at the C1 position to avoid decomposition 
during the anionic annulation. It was elaborated to the dimerization precursor 2.62 in five 
additional steps. During the course of the investigation, judicious choice of protecting 
groups as well as appropriate stage of application of those protecting groups were crucial 
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for the successful preparation of 2.62. 
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Chapter 3 
 Two Directional Synthesis 
 
Although the initial plan was to dimerize an advanced tetracyclic intermediate to 
minimize double processing, a strategy involving an early stage dimerization and 
expansion of the core was also investigated (Figure 3.1).1 In this strategy, dimeric 
intermediate 1.109 would be generated from a dimeric enone such as 3.1 through the 
bidirectional annulation method discussed in chapter 2. Therefore, the first goal was the 
preparation of enone 3.1 from well established intermediate 2.41 by using an oxidative 
enolate dimerization. This strategy didn’t successfully culminate with the formation of 
the advanced intermediate. However, a very important piece of information regarding 
dimerization of the oxanorbornanone enolate was discovered during the investigation. In 
                                                
(1) Vrettou, M.; Gray, A. A.; Brewer, A. R. E.; Barrett, A. G. M., Tetrahedron 2007, 
63, 1487-1536. 
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this chapter, the finding is described. 
The starting point of this approach was intermediate 2.41 where the C1 and C5 
ketones are fully differentiated. As a prelude to the dimerization, the C5 ketone was 
protected as a TIPS enol ether, a functionality which can be converted to an enone at a 
later stage to provide compound 3.1 (Scheme 3.1). The removal of the pivalate protecting 
group and subsequent oxidation to a ketone took place uneventfully to give ketone 3.3 in 
94% yield over two steps. At this point, conversion of the TIPS enol ether to the 
corresponding enone was assured in the monomeric setting. Saegusa oxidation condition 
provided enone 1.111, a compound previously prepared from a different route, in 71% 
yield.2 
 
In the previous model study, the yield of the dimerization was never greater than 
51%.3 To improve the conversion of the reaction, an optimization study was initiated. 
The primary goal was to minimize undesired !-elimination, which was often observed 
upon warming the reaction from "78 °C to "20 °C, a condition utilized in the model 
                                                
(2) Ito, Y.; Hirao, T.; Saegusa, T., J. Org. Chem. 1978, 43, 1011-1013. 
(3) Krygowski, E. S.; Murphy-Benenato, K.; Shair, M. D., Angew. Chem. Int. Ed. 2008, 
47, 1680-1684. 
Reagents and conditions: (a) NaHMDS, TIPSOTf, THF, !78 to 23 °C; (b) NaBHEt3, THF, 0 °C; (c) TPAP, NMO, 4 
Å MS, CH2Cl2, 23 °C; (d) Pd(OAc)2, O2, DMSO, 100 °C.
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study (Figure 3.2). By suppressing the side reaction at a low temperature, it was 
anticipated that the conversion to the desired product, dimer 3.5, would be maximized. 
 
In order to find the optimal reaction temperature, ketone 3.3 was treated with an 
amide base for 1 hour at "78 °C to initiate enolate formation, then the mixture was 
warmed to a desired temperature and maintained for 3 hours. At the end of the reaction, 
the reaction mixture was quenched with TMSCl to trap the lithium enolate as a TMS enol 
ether. Usually, the enol ether product 3.6 was isolated together with the !-elimination 
product 3.4 as well as the unreacted starting material 3.3. The ratio of these products are 
summarized in Scheme 3.2. 
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At "20 °C, only starting material and the !-elimination byproduct were detected 
(entry 1). By lowering the temperature to "40 °C, the formation of byproduct was 
suppressed (entry 2). Eventually, the desired TMS enol ether was formed and detected at 
"60 °C, suggesting the enolate had a certain lifetime to be trapped after 3 hours of 
enolization (entry 3). At "78 °C, no product, other than the starting material was 
observed, suggesting that the enolization of hindered ketone 3.3 is slow at this 
temperature (entry 4). 
Based on these observations, a scenario regarding the enolization of ketone 3.3 
was made (Figure 3.3): 1) the enolate formation of the oxanorbornanone 3.3 is slow at or 
below "78 °C; 2) the undesired !-elimination is predominant at or above "40 °C; 3) at 
"60 °C both enolate formation and !-elimination take place. Since the oxidation of an 
enolate species to form enoxy radical 3.7, an electron transfer reaction, should be fast 
enough to take place before undergoing undesired !-elimination, it was hypothesized that 
the lithium enolate, formed at "60 °C, would undergo oxidation to dimerize before 
forming 3.4. 
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By utilizing the optimized temperature, the desired dimerization took place in 
57% yield to provide symmetric dimer 3.5 (Scheme 3.3).4 The reaction was highly 
reproducible up to 300 mg scale, and the only byproduct was unreacted starting material 
3.3. Dimer 3.5 was further advanced to attempt double annulation by introducing the 
enone functionality from the TIPS enol ether. Under Saegusa oxidation conditions, 
bisenone 3.8 was isolated in 59% yield in a cyclic hydrate form instead of a 1,4-diketone. 
As was observed in the model study of Dr. Krygowski, the initially formed bisenone 3.1 
has gained one molecule of water to form a bishemiketal. 
 
With the dimeric enone in hand, the well-investigated Kraus annulation was 
applied to expand the core (Scheme 3.4).5 To our disappointment, however, enone 3.8 
                                                
(4) Later in the investigation, it was found that longer reaction time was required to 
maximize the yield. See chapter 4. 
(5) Kraus, G. A.; Sugimoto, H., Tetrahedron Lett. 1978, 19, 2263-2266. 
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underwent rapid decomposition upon treatment with the anion of cyanophthalide 2.106 or 
silyloxyisobenzofuran 2.12,7 derived from 2.10. It was suspected that the acidic protons 
of the central bishemiketal were responsible for the observed decomposition. Therefore, 
it was decided that the bishemiketal should be protected. 
 
The protection of the hemiketal turned out to be highly challenging presumably 
due to the sterically hindered nature of the core structure. Standard silylating agents such 
as TMSCl or TMSOTf did not provide any silylated product. It was not until Corey’s 
silylation condition was applied to the system that the bistrimethylsilyl ether of the 
                                                
(6) Okazaki, K.; Nomura, K.; Yoshii, E., Synth. Commun. 1987, 17, 1021-1027. 
(7) Myers, A. G.; Tom, N. J.; Fraley, M. E.; Cohen, S. B.; Madar, D. J., J. Am. Chem. 
Soc. 1997, 119, 6072-6094. 
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bishemiketal was isolated (Scheme 3.5).8 In neat TMSCN at elevated temperatures, enone 
3.8 underwent a smooth silylation to provided fully protected bisenone 3.10 in 58% yield, 
setting the stage for the anionic annulation. 
The attempted annulations are summarized in Scheme 3.6. Unlike bisenone 3.8, 
3.10 turned out to be highly unreactive towards various annulation conditions. Under 
standard Kraus’ conditions only conjugate adduct 3.11 was formed, suggesting that the 
final Dieckmann reaction did not occur (equation a). A more reactive annulation donor 
3.12 increased the reactivity of conjugate addition. However, the desired Dieckmann 
condensation still did not occur until the end of the reaction (equation b). A less reactive 
annulation donor such as 2.12 or 3.14 did not react at all with enone 3.10 even at an 
elevated temperature (equation c). 
                                                
(8) Corey, E. J.; Wu, Y. J., J. Am. Chem. Soc. 1993, 115, 8871-8872. 
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Since the stereochemical outcome of the Michael addition is not clear, it is hard to 
analyze the transition state of the Dieckmann condensation. However, such a hampered 
Dieckmann condensation in Kraus annulations under crowded settings are documented 
(Figure 3.4). Danishefsky9 and Myers7 have independently reported similar conjugate 
additions of a cyanophthalide anion in their synthesis of dynemicin A. In both cases a 
hindered electrophile did not allow for the final Dieckmann condensation. 
                                                
(9) Shair, M. D.; Yoon, T. Y.; Mosny, K. K.; Chou, T. C.; Danishefsky, S. J., J. Am. 
Chem. Soc. 1996, 118, 9509-9525. 
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In conclusion, optimized dimerization conditions were found by utilizing ketone 
3.3 as a model oxanorbornanone (Figure 3.5). The control of enolization temperature was 
critical for minimizing formation of !-elimination byproduct. This optimal temperature 
found in the model study was universally applicable to other dimerization precursors 
containing oxanorbornanone substructure (vide infra). The dimer thus formed was 
advanced to the annulation stage, which did not culminate into the desired product due to 
the steric congestion of the core structure. The dimerization condition used in the route 
was eventually used to prepared advanced intermediates in the future to prepare the entire 
carbon skeleton of the natural product. 
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Chapter 4 
 Synthesis of the Full Carbon Skeleton of the Lomaiviticins 
 
4.1. Remote Steric Effect of the C11 Substituent 
In chapter 2 and 3, the synthesis of the dimerization precursor and optimization of 
the dimerization conditions were discussed, respectively. In the real dimerization event, 
however, additional insights were required than were disclosed in the previous chapters. 
The dimerization precursor 2.62, the synthesis of which was discussed in chapter 
2, was subjected to the optimized dimerization conditions; LiHMDS, HMPA, and 
[Cp2Fe]PF6 in THF at !60 °C. To our disappointment, the compound did not undergo 
desired dimerization under these conditions (Scheme 4.1). Only starting material 2.62 
was recovered with greater than 80% yield and none of dimer 4.1 was detected. At this 
point a variety of solvent/oxidant combinations was reexamined, still without yielding 
any dimeric product. 
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Compound 2.62 showed a similar enolization profile to the oxanorbornanone 3.3, 
a compound used in the model study in chapter 3. LiHMDS-mediated enolization at !60 
°C, followed by TMSCl quenching provided both desired silyl enol ether 4.2 and "-
elimination product 4.3 (Scheme 4.2). The experimental result suggests that a post-
enolization event, either oxidation to the enoxy radical or union of enoxy radical and 
enolate, is responsible for the unsuccessful dimerization of 2.62. 
 
Later, critical insight was gained when a modified approach was attempted. In 
2008, Thomson and coworkers reported a successful dimerization of simple cyclic 
ketones via the intermediacy of a silyl bis-enol ether such as 4.5 (Figure 4.1).1 Since a 
similar enolization/silylation pathway was successfully applied to our own tetracyclic 
ketone system 2.62 (Scheme 4.2), it was anticipated that a similar oxidative condition 
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
(1) Avetta, C. T.; Konkol, L. C.; Taylor, C. N.; Dugan, K. C.; Stern, C. L.; Thomson, R. 
J., Org. Lett. 2008, 10, 5621-5624. 
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could provide the desired dimeric structure, as in Thomson’s approach. 
However, ketone 2.62 did not undergo any silyl bis-enol ether formation under a 
variety of conditions attempted (Scheme 4.3). No dimeric enol ether 4.7 was detected 
under the reaction conditions employed. Instead, starting material was isolated 
presumably through the intermediacy of silyl mono-enol ether such as 4.8, which 
undergoes hydrolytic regeneration of 2.62. This hypothesis is supported by isolation of a 
small amount of amino silane 4.9, which presumably was formed by reaction of 4.8 with 
the amide base. From this observation, it was speculated that certain steric interactions 
exist in the dimeric structure of ketone 2.62, although their exact nature was elusive. The 
postulated interaction may be obstructing the approach of two molecules of 2.62, even in 
the presence of a silicon linker. 
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Since little is known about the exact mechanism of the dimerization, the 
destabilizing interactions developing during the dimerization cannot be analyzed. Instead, 
we tried to extrapolate the interactions in the potential products to the transition state 
(Figure 4.2). 
 
Potentially, three products, with one antiperiplanar and two gauche conformations 
regarding the H2C2C2’H2’ dihedral angle, can be formed depending on the trajectory of 
the approaching reaction partners (Figure 4.3). In all cases unfavorable steric congestions 
were found.2 The examined interactions are depicted as red arrows. In the case when the 
dihedral angle is 180 ° (antiperiplanar), a non-bonded interaction between the C3 ethyl 
group and the C3’ ethyl group was observed (Entry 1). When the dihedral angle is 60 ° 
(gauche-), interactions between the C11 allyloxy group and the C3’ ethyl group, or 
between the C11’ allyloxy and the C3 ethyl group, were observed (Entry 2). Finally the 
conformer with a !60 ° dihedral angle (gauche+) suffered from severe steric repulsion 
between the C11 allyloxy group and the C11’ allyloxy group (Entry 3). !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
(2) The analysis was made by simple hand-held plastic models. 
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Based on these observations, it was concluded that the steric repulsion between 
the C3 ethyl group or the C11 allyloxy group with some other part of the other reaction 
partner is responsible for the unfavorable dimerization (Figure 4.4). Therefore, by 
reducing the size of the C11 substituent, the energy barrier to the dimerization would be 
lowered. Removing the C3 ethyl group was not a strategy of choice, since it is extremely 
hard to reintroduce at a later stage. 
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The hypothesis was quickly tested simply by changing the protecting group of the 
C11 hydroxyl group (Scheme 4.4). Previously prepared compound 2.60 was treated with 
NaHMDS in the presence of MeOTf to methylate both hydroxyl groups of the B-ring 
hydroquinone. Then the C1 ketone functionality was exposed by an established two-step 
sequence to give new dimerization precursor 4.10. Ketone 4.10 was subjected to identical 
dimerization conditions. In contrast to the dimerization attempt of 2.62, a small amount 
of quasi-stable product was isolated. Although clean magnetic resonance spectroscopic 
data was not acquirable due to rapid decomposition at room temperature, the compound 
had the correct molecular weight of the dimeric structure 4.11 based on high resolution 
mass spectroscopy.3 The stark difference between the dimerization result of 2.62 
(Scheme 4.1) and 4.10 (Scheme 4.4) suggested that the size of the C11 substituent indeed 
is related to the dimerization result, even though they are located remotely from the 
reacting center. 
 
Although the desired dimerization was not realized with the previously 
established strategy, a new prerequisite for the reaction was suggested. Based on the !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
(3) Exact mass calculated for C62H62NaO20S2 [(M+Na)+]: 1213.3168; found 1213.3160. 
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structural analysis of the potential products, non-bonded interactions of the C11 
substituent were suspected to be the reason for inefficient dimerization. It was anticipated 
that by further reducing the size of the C11 substituent, we would be able to prepare the 
dimeric intermediate through oxidative enolate coupling. 
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4.2. Dimerization of Tetracyclic Precursor 
Based on the findings discussed in the previous section, we decided to revise the 
synthetic plan (Figure 4.5). Most notably, it was decided to use tetracycle 4.13 as the new 
dimerization precursor. Compound 4.13 has a hydrogen atom, the smallest substituent 
possible, at the C11 position. Since the oxidation state of the B-ring is a phenol, an extra 
oxidation step would be required after dimerization in dimer 4.12. Now the synthetic 
challenge is reduced to the preparation of the new dimerization precursor 4.13 from 
enone 2.42. 
 
Among the various strategies available for this type of annulation, a protocol 
developed by Hauser was chosen (Figure 4.6).4 In this reaction, the anion of sulfoxide 
4.14 first undergoes conjugate addition to enone 4.15, followed by Dieckmann 
condensation. After cyclization to form intermediate 4.17, the cyclized product is heated 
to eliminate the sulfoxide and the newly formed ring tautomerizes to provide phenol 4.19. 
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
(4) Hauser, F. M.; Rhee, R. P., J. Org. Chem. 1978, 43, 178-180. 
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As a major modification to this strategy, we decided to use a phenyl ester instead 
of the conventionally used methyl or ethyl esters.5 As is documented in the literature, the 
use of a phenyl ester greatly facilitates the Dieckmann condensation in a similar 
Michael/Dieckmann sequence (Figure 4.7).6 The lower basicity of the phenoxide would 
make it a better leaving group. It was also expected that the phenoxide generated would 
not cause side reactions due to the lower nucleophilicity. 
 
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
(5) White, J. D.; Nolen, E. G.; Miller, C. H., J. Org. Chem. 1986, 51, 1150-1152. 
(6) For use of phenyl esters in related annulations, see: (a) Charest, M. G.; Lerner, C. 
D.; Brubaker, J. D.; Siegel, D. R.; Myers, A. G., Science 2005, 308, 395-398. (b) 
Sun, C.; Wang, Q.; Brubaker, J. D.; Wright, P. M.; Lerner, C. D.; Noson, K.; 
Charest, M.; Siegel, D. R.; Wang, Y.-M.; Myers, A. G., J. Am. Chem. Soc. 2008, 
130, 17913-17927. 
O
OEt
S(O)Ph
O
OEt
S(O)Ph
O
OEt
S(O)Ph
Me
Me
O
Me
Me
O O
H
S
OPh
Me
O
Me
Me
Me
O O
Me
Me
OOH
+ Me
O
Me
LDA
THF
!78 °C
66 °C
2h70%
conjugate
addition
Dieckmann
condensation
eliminationtautomerization
Figure 4.6 Hauser's sulfoxide annulation.
4.14 4.15 4.16
4.17
4.184.19
N
O
O O OBn
H
OTBS
NMe2O
O OBn
O
OPh
Me
BocO
N
O
O OBn
H
OTBS
NMe2O
O OBn
BocO
Me
H
O HO
LDA,
TMEDA
THF
!78 to 0 °C
+
79%
Figure 4.7 Myers' Michael/Dieckmann annulation using a phenyl ester.
4.20 4.21 4.22
  Chapter 4 
 
 79!
The desired sulfoxide annulation donor was prepared from commercially 
available 2,3-dimethyl hydroquinone (Scheme 4.5).7 After protection of the acidic 
hydroxyl groups of the hydroquinone, one of the methyl groups was brominated under 
radical conditions. The resulting benzylic bromide was treated with Ca(OH)2 in aqueous 
media to provide benzylic alcohol 4.24 in 61% yield over three steps. Alcohol 4.24 was 
oxidized to the corresponding acid 4.25 in a standard two-step protocol, then acid 4.25 
was converted to the phenyl ester 4.26 through the intermediacy of an acid chloride. 
Another round of radical bromination provided another benzylic bromide. The bromide 
underwent a substitution reaction with NaSPh to provide a sulfide, which in turn was 
oxidized to the corresponding sulfoxide 4.27. All procedures were amenable to scale, and 
up to 10 g of sulfoxide 4.27 was easily prepared from a single batch. 
 
The use of this annulation donor established a synthetic route to the desired 
tetracyclic intermediate 4.28, which has the desired oxidation state in the B-ring (Scheme 
4.6). Deprotonation of sulfoxide 4.27 with LiHMDS, followed by addtion of enone 2.42, 
provided compound 4.28 in 90% yield. !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
(7) Mal, D.; Bandhyopadhyay, M.; Datta, K.; Murty, K. V. S. N., Tetrahedron 1998, 
54, 7525-7538. 
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Scheme 4.5 Synthesis of sulfoxide 4.27.
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The optimization of the annulation reaction deserves further comment. First, full 
deprotonation of sulfoxide 4.27 was slow. Based on a deuterium quenching experiment, it 
takes no less than 6 hours at !60 °C to achieve greater than 95% deprotonation. Second, 
use of three equivalents of amide base was critical for the success of the annulation. As is 
described in Figure 4.8, the annulation occurs via different stages: 1) a condensation to 
form the ring, which generates a phenoxide; 2) elimination of the phenylsulfanol, which 
usually requires heating. The use of the phenyl ester, however, facilitated both of these 
steps, and both reactions took place even at !78 °C. Therefore two sources of acidic 
protons, phenol and phenylsulphanol, are generated before the end of the reaction, which 
might potentially quench the anionic annulation donor or related anionic intermediates 
(Figure 4.8). By using two extra equivalents of base, the acidic species are quenched 
before the full consumption of the annulation donor. By using a total of 3 equivalents of 
amide base, tetracyclic product 4.28 was obtained in high yield. 
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Scheme 4.6 Annulation of sulfoxide 4.27 and enone 2.42.
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The tetracycle 4.28 was advanced to the targeted new dimerization precursor in 
four steps (Scheme 4.7). A sequence of reactions used to prepare dimerization precursor 
2.62 was identically applied.8 First the C5 ketone was masked as a dioxolane to give 
compound 4.29. During the reaction 5-10% of orthoester byproduct 4.32 was detected. It 
is believed that the reaction takes place through a retro-Claisen reaction of initially 
formed product 4.29, which is initiated by protonation with TfOH, followed by 
oxocarbenium ion trapping. It is believed that TfOH is generated by reaction of TMSOTf 
with water. Therefore rigorously anhydrous conditions were required to maximize the 
yield. The protected tetracycle was then alkylated to give allyl ether 4.33. Unfortunately, 
the reaction was contaminated with formation of the C11 allylation product 4.34. After 
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
(8) See Scheme 2.18 and 2.19. 
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full protection, the pivalate ester was converted to the ketone uneventfully to provide the 
new dimerization precursor 4.13. 
As we anticipated, oxanorbornanone 4.13 underwent smooth dimerization 
(Scheme 4.8).9 In the initial attempt, less than 20% of symmetric dimer 4.12 was isolated 
from a 0.02 M solution of 4.13 in 16 hours. Since the reaction is a bimolecular reaction, 
an increase in concentration should enhance the conversion. 0.06 or 0.07 M solution 
provided the product in a synthetically useful yield in three to four days. Due to problems 
with solubility, it was not possible to increase the concentration further. The dimerization 
reaction was reasonably scalable and reproducible. During the course of future studies 
more than 9 g of dimer 4.12 was prepared in several different batches. 
 
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
(9) Lee, H. G.; Ahn, J. Y.; Lee, A. S.; Shair, M. D., Chem.–Eur. J. 2010, 16, 13058-
13062. 
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Scheme 4.8 Oxidative enolate dimerization of oxanorbornanone 4.13.
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The product was isolated as a single diastereomer and the orientation of the C2–
C2’ connectivity was unambiguously assigned by nOe study (Figure 4.9). The proton at 
the C2 position showed a strong nOe cross peak with the C4a proton, a phenomenon 
which is possible only when the connectivity is exo (Figure 4.9a). An endo connectivity 
could not provide such an nOe correlation (Figure 4.9b). 
 
The oxanorbornane structure is not soley responsible for the great stereochemical 
outcome of the dimerization. Amy Lee, a coworker in this project, attempted a similar 
dimerization with a substrate having a substituent at C4 with the opposite relative 
stereochemistry (Figure 4.10).10 The dimerization precursor provided only exo-endo 
product in 44% yield. No exo-exo dimer was detected. It is believed that the bulky phenyl 
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
(10) Lee, A. S., Unpublished result, Harvard University, Cambridge, MA. 
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Figure 4.9 Stereochemistry of C2–C2' bond.
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sulfonyl group in 4.13, with an A-value of 2.5, reinforces the exo-exo selectivity of the 
reaction. 
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4.3. X-Ray Crystal Structure of the Dimer. 
Although the full connectivity and stereochemistry of the symmetric dimer 4.12 
could be elucidated by using solution state spectroscopic methods, no information 
regarding the relative orientation of each half is known. To investigate this area a single 
crystal X-ray structure of the dimer was obtained. Simply by removing the flexible allyl 
protecting group, the dimeric product 4.35 was obtained as a crystalline solid (Scheme 
4.9).11 
 
The crystal structure of 4.35 is shown in Figure 4.11. All the relative 
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
(11) CCDC 777057 contains the crystallographic data of 4.35. For details see Appendix 
2. 
Reagents and conditions: (a) PdCl2(PPh3)2, Bu3SnH, AcOH, CH2Cl2, 0 °C.
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Scheme 4.9 Removal of allyl protecting group in dimer 4.12.
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stereochemistry of the molecule confirmed the results gained from the NMR data, 
assuring the correct C2–C2’ connectivity. Interestingly, the molecule possesses a 
conformation where the two naphthyl rings are oriented in the same direction. 
The crystal structure revealed that the C11 hydrogen atom is in close proximity to 
the C1’ ketone oxygen atom (and conversely the C11’ hydrogen and C1 ketone oxygen). 
In fact the interatomic distance between H11 and O1’ is 3.01 Å, only 0.29 Å greater than 
the sum of their van der Waals radii (Figure 4.12). The close contact between the C11 
substituent and O1’ may explain why the first dimerization with the C11 allyloxy group 
failed (Scheme 4.1). If the precursor with a C11 allyloxy group had dimerized, it would 
have suffered a non bonded interaction with O1’. 
 
Closer inspection of the crystal structure showed that the dihedral angle for 
H2C2C2’H2’ is 142 ° (Figure 4.13). It is a structure that closely resembles the postulated 
structure with the 180 ° dihedral angle discussed in Figure 4.3. It seems that the distorted 
H2C2C2’H2’ dihedral angle is the result of alleviating non-bonded interactions in two 
different ways. A dihedral angle greater than 142 ° would result steric repulsion between 
the two ethyl groups, as in the structure with the 180 ° dihedral angle. And a smaller 
dihedral angle than 142 ° would put H11 and O1’ (and H11’ and O1) in close proximity,, 
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generating contact between these two atoms, an interaction discussed in Figure 4.12. 
Therefore the central dihedral angle is locked in 142 °, which balances these two 
interactions. Also the naphthyl rings of the dimer are highly distorted (see the side view 
of Figure 4.13), which suggests existence of additional repulsion between substituents of 
the two naphthyl rings. 
 
The presence of C2–C2’ torsional strain in 4.35 and the potential for severe non-
bonded interactions in the crystal structure suggested to us that there may be a 
measurable barrier to rotation about the C2–C2’ bond, resulting in atropisomerism.12 
Unfortunately, heating to 140 °C or cooling to !80 °C did not result in a change in the 1H 
NMR spectrum of 4.35, preventing us from determining whether dimer 4.35 exhibits 
atropisomerism. 
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
(12) Oki, M., “Topics in Stereochemistry”; John Wiley & Sons: New York, 1983; Vol. 
14, pp. 1-81. 
  Chapter 4 
 
 88!
If there is a significant barrier to rotation, it can be speculated that the two 
reaction partners are approaching each other near 180 ° H2C2C2’H2’ dihedral angle, or 
in between a 120 ° and 240 ° dihedral angle range. Then the product thus formed does not 
undergo further rotation through C2–C2’ bond and stays with 142 ° dihedral angle, which 
accompanies distortion of other parts of the molecule. It is not clear why other modes of 
approach, such as dimerization in 0-120 ° or 240-360 ° range, are not observed. 
In summary, successful formation of the targeted dimeric structure 4.12 was 
achieved (Figure 4.14). The desired annulation precursor 4.13 was prepared by using a 
modified Hauser annulation of sulfoxide 4.27 and enonoe 2.42. Key to the success was 
control of a non-obvious remote steric effect of the C11 substituent, as well as careful 
control of temperature to avoid side reactions. The X-ray crystal structure of the dimer 
has revealed that the interaction between the C11 substituent and the C1’ carbonyl 
Figure 4.14 Summary of chapter 4.
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oxygen atom may be responsible for the unsuccessful dimerization when the C11 
substituent was larger than a hydrogen atom. 
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Chapter 5 
 Attempted Completion of the Synthesis 
 
5.1. Introduction of the C4 Hydroxyl Group 
In chapter 4, the successful oxidative dimerization reaction to form the full carbon 
skeleton of the lomaiviticin aglycone was discussed.1 With the dimer in hand, the focus 
of research shifted to finishing the synthesis of the lomaiviticin aglycone. 
Figure 5.1 describes plans for the rest of the synthesis. First a ketal protecting 
group of dimer 4.12 at C5 would be removed to expose a handle for the key oxygen-
bridge opening in the oxanorbornanone D-ring (5.1). With the handle in place, a cascade 
reaction discussed in section 1.4 would be investigated in the real system (5.1 to 5.4).2 
The reaction involves an elimination to cleave C11b–O bond (5.1 to 5.2) and 
displacement of allylic sulfone at the C4 position with an oxygen nucleophile (5.2 to 5.3). 
It is expected that the initially formed product 5.3 would exist as a bishemiketal (5.4) as 
in the natural product lomaiviticin B. The next step would be removal of the allyl 
protecting group and subsequent introduction of hydrazone functionality at the C5 
position (5.5). As was observed in previous studies, removal of B-ring protecting group is 
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
(1) Lee, H. G.; Ahn, J. Y.; Lee, A. S.; Shair, M. D., Chem.–Eur. J. 2010, 16, 13058-
13062. 
(2) Krygowski, E. S.; Murphy-Benenato, K.; Shair, M. D., Angew. Chem. Int. Ed. 2008, 
47, 1680-1684. 
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crucial for the successful introduction of a nucleophile at the C5 position.3 Next, a global 
oxidation of B and B’ rings, as well as the C5 and C5’ hydrazones would provide 
protected the lomaiviticin aglycone (not shown). The selective oxidation of an 
unprotected phenol in the presence of a proximal alkylated hydroquinone is well 
documented in the literature.4 It should be noted that the transformation works even in the 
presence of an electron-withdrawing group attached to the phenol ring; therefore the 
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
(3) See Scheme 2.18. 
(4) (a) Magnus, P.; Eisenbeis, S. A.; Fairhurst, R. A.; Iliadis, T.; Magnus, N. A.; Parry, 
D., J. Am. Chem. Soc. 1997, 119, 5591-5605. (b) Couladouros, E. A.; Strongilos, 
A. T., Eur. J. Org. Chem. 2002, 2002, 3341-3350. 
MeO
O
OMe
O
MeOOMe
O O
Et EtPhO2S SO2Ph
O O
H
H O
OO
O
H H
MeO
O
OMe
O
MeOOMe
O O
Et EtPhO2S SO2Ph
O O
H
H
O OHH
MeO
O
OMe
O
MeOOMe
PhO2S SO2Ph
O O
H
H
O O
Et EtHO OH
MeO
O
OMe
O
MeOOMe
O O
H
H
O O
Et EtHO OHHO OH
MeO
MeO O O
H
H
O O OMe
OMe
OH
HO
O
O
Et
OH
HO
Et
HO
HO O
O
N
N
H
H
N
O
O OH
OH
N
OH
HO
O
O
Et
OH
HO
Et
MeO
MeO HO N
H
H
N OH OMe
OMe
OH
HO
O
O
Et
OH
HO
Et
NHR
RHN
[O]H2NNHR
bishemiketal
formation
ketal
deprotection
sulfone
displacement
oxygen-bridge
opening
4.12 5.1
5.25.3
5.4 5.5 ent-1.3
Figure 5.1 Synthetic plans to complete synthesis of the lomaiviticin aglycone.
11b
4
B
B'
A
A'
  Chapter 5 
 
 92!
presence of C5 hydrazone, a partly electron donating group, should not be problematic. 
Finally, nucleophilic removal of the methyl protecting groups in the A-ring would 
provide the aglycone of the natural product. 
Although this plan looked straightforward, we had contingency plans to deal with 
unpredicted reactivities of the intermediates. As was observed in the model study, the 
central 1,4-diketone system may form a cyclic hydrate as in 1.104 when a ketone 
functionality is exposed at C5 position. Although, the model core 1.104 underwent the 
desired cascade reaction to provide 1.106, attempts to isomerize the product to the 
lomaiviticin B core 5.6 failed under acidic conditions (Figure 5.2). 
 
In the real synthesis, however, we expected that the naphthoquinone AB-rings 
could facilitate the isomerization (Figure 5.3). It was believed that the cyclic hydrate 5.7 
would undergo identical cascade reactions to provide compound 5.8, which may be 
reluctant to liberate water to form a bishemiketal such as 5.4. However, if the B-ring 
phenol is oxidized to a quinone, the core pocket would not be spacious enough to 
accommodate two extra oxygen atoms, inferred from the crystal structure of the dimer 
(Figure 4.12). Therefore, it was believed that bisquinone 5.10 would be forced to lose a 
central water molecule and undergo bishemiketal formation. Further oxidation and 
removal of methyl protecting groups would provide lomaiviticin aglycone ent-1.3. 
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The original strategy for the oxygen bridge-opening relied on the donation of 
electron density from the C4a position (Figure 5.4). Either the C5–C4a enolate (5.13) or 
the C4–C4a enolate (5.14) may facilitate such a transformation, although the C5–C4a 
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enolate is a better candidate due to greater orbital overlap.5 Therefore, a strategy 
involving the C5–C4a enolate was tested initially. 
As a prelude to enolate formation, C5 ketone was revealed by removal of the 
dioxolane protecting group (Scheme 5.1). Treatment of dimer 4.12 with TfOH in 
acetone/water released ethylene glycol, exposing two ketone functionalities at C5 and 
C5’ in 78% yield. As was expected, the product exists as a stable cyclic hydrate 5.7. 
Unfortunately, ketone 5.7 did not undergo the desired cascade reaction. Investigation of a 
large number of bases in protic solvent (e.g., MeOH, EtOH, t-BuOH, or water) only 
resulted in slow decomposition of the starting material. Stronger bases such as LDA, 
LiHMDS, KOt-Bu, or KOt-Pn, in THF decomposed 5.7 even more quickly. 
 
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
(5) (a) McMorris, T. C.; Staake, M. D.; Kelner, M. J., J. Org. Chem. 2004, 69, 619-623. 
(b) Jung, M. E.; Min, S.-J., Tetrahedron 2007, 63, 3682-3701. 
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The pathway of decomposition is not clear, since no characterizable compound 
was isolated in the reaction (Figure 5.5). The decomposition may arise from dehydration 
across the C1, C1’ ketone 5.1 under basic conditions. Or we cannot exclude the 
possibility that the desired product 5.15 underwent decomposition. An antiaromatic 
indenone product 5.15 may be in equilibrium with the starting material through reclosure 
and may undergo unwanted nucleophilic attack under the reaction conditions. 
 
In order to test the first hypothesis, we decided to protect the central cyclic 
hydrate in a base-tolerant form. Of the numerous conditions used, MeOTf/NaHMDS 
combination worked best (Scheme 5.2). When the THF solution of NaHMDS is added to 
the cold premixed solution of 5.7 and MeOTf, the two hydroxyl groups of the cyclic 
hydrate were cleanly masked as methyl ethers. Methyl ether 5.16 was much more tolerant 
to basic conditions. However, the reactivity pattern was completely different from that of 
the model system. When 5.16 was treated with KOH in aqueous THF solution, !-hydroxy 
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ketone 5.17 was isolated as a major product together with two other diastereomers.6 5.17 
contained (4R, 4’R) configuration and the structure was unequivocally assigned by X-ray 
crystallography. 
 
The suspected reaction pathway is described in Figure 5.6. First, ketone 5.16 
underwent enolate formation to give 5.18 under the given reaction conditions. The 
potassium enolate 5.18 did not undergo desired oxygen bridge opening to form 5.19. 
Instead, the C4 sulfone at another ! position was eliminated to form enone intermediate 
5.20, followed by hydroxide addition across the Re (convex) face to the !-hydroxy 
ketone 5.17. Obviously, the mode of hydroxide attack was governed by the overall 
concavity of the molecule, rather than the local predisposition of the oxanorbornane ring. 
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
(6) The minor diastereomers were assigned to be unsymmetric (4R, 4’S)-diastereomer 
and symmetric (4S, 4’S)-diastereomer. 
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This scenario was partially supported by an independent synthesis of enone 5.20 
(Scheme 5.3). Enone 5.20, prepared from a mesylation/elimination sequence from !-
hydroxy ketone 5.17, regenerated 5.17 under the identical reaction conditions. 
 
Although the desired C11b–O bond scission was not realized at this stage, !-
hydroxy ketone 5.17 was a useful intermediate in that the C4 hydroxyl group was 
introduced in a stereoselective manner. Therefore, compound 5.17 was used as the 
starting point of all remaining strategies for the rest of the investigation. 
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!-Hydroxyketone 5.17 did not undergo further oxygen-bridge opening (Scheme 
5.4); 5.17 was highly stable under a variety of basic conditions and only decomposition 
was observed under forcing conditions. Even 1,3-diketone 5.22, an oxidation product of 
5.17, did not undergo this transformation. The fact that the system did not eliminate 
oxygen substituent suggested inherent innertness of the system, possibly originating from 
the antiaromatic character of the potential product. Therefore, a strategy that does not 
involve formation of antiaromatic intermediate was sought in the future. 
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Scheme 5.4 Attempted oxygen bridge opening of 5.17.
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5.2. Reductive Approaches to C11b–O Bond Cleavage 
After encountering unexpected reactivity that disfavor the desired cascade 
reaction, alternative approaches were sought. The first approach involves donation of 
electron density from the C1 carbon (Figure 5.7). One-electron reduction of the C1 
ketone would generate a ketyl radical species at the C1 position (5.25), which can 
undergo a ring-opening reaction to provide the lomaiviticin D-ring structure.7 
 
The revised overall synthetic plan is summarized in Figure 5.8. Reduction of both 
C1 and C1’ ketone would provide lomaiviticin D and D’ ring structure as compound 
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Figure 5.7 Oxygen bridge opening assisted from C1.
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5.27. One drawback of this strategy is that an extra oxidation is required to install a C–C 
double bond at the CD-ring junction. A benzylic oxidation of 5.27 would provide 
intermediate 5.28, which has desired oxidation state at C4a and C11b. For the rest of the 
synthesis, strategies discussed in the previous section were applied. 
To test the idea, dimer 4.12 was treated with freshly prepared SmI2 in the 
presence of protic solvent (Scheme 5.5).8 To our surprise, however, a diol 5.28 was 
isolated as the major product, along with a small amount of monomer 4.13.9 No desired 
product 5.27 was isolated. 
 
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
(7) Jae Young Ahn performed experiments associated with this approach.  
(8) For review, see: (a) Molander, G. A.; Harris, C. R., Chem. Rev. 1996, 96, 307-338. 
(b) Edmonds, D. J.; Johnston, D.; Procter, D. J., Chem. Rev. 2004, 104, 3371-3404. 
(9) A similar reaction pathway of the DD’ core was observed in the model study. See: 
Krygowski, E. S., Ph. D. Thesis, Harvard University, Cambridge, MA, 2008. 
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Apparently, the initially formed ketyl radical species undergoes either an 
intramolecular pinacol coupling (path I), or C2–C2’ bond cleavage (path II) (Figure 5.9). 
Pinacol coupling product 5.28 was characterized only by 1H NMR and HRMS. No 13C 
NMR was acquirable due to the marginal stability of the compound. It should be noted 
that the chemical shift of protons at the C11 methoxy group is much more upfield than 
was expected (5.28: " = 2.62 ppm in CDCl3, 4.12: " = 3.83 ppm in CDCl3). It is believed 
that the magnetic anisotropy, arising from the naphthyl ring on the other end of the 
molecule, is responsible for the abnormal upfield chemical shift. 
 
The undesired reactivity was rationalized based on the crystal structure of the 
dimer 4.35 (Figure 5.10). In the crystal structure, the C1 and C1’ ketones are in close 
proximity, only 2.74 Å away from each other (Figure 5.10a). Therefore, as soon as one 
ketone is reduced, it may undergo pinacol coupling with the other ketone. The 
regeneration of monomer 4.13 is understood on the basis of orbital alignment (Figure 
5.10b).  The #* orbital of the C11b–O bond is sitting almost orthogonal to the $ orbital of 
the C1 ketone, which may have the identical orientation as the half-filled orbital of the 
reduced species. On the other hand, the #* orbital of C2-C2’ bond is parallel to the C1 $ 
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Figure 5.9 Formation of compound 5.28 and 4.13.
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orbital. Thus, C2-C2’ bond cleavage is more favorable than the desired C11b–O bond 
cleavage. 
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Figure 5.10 Aspects of the crystal structure 4.35 help explain the formation of 5.28 and 4.13.
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5.3. Attempted B-Ring Oxidation 
The next strategy for C11b–O bond cleavage relied on the assistance from the 
C11a position of the electron-rich naphthyl ring (Figure 5.11). In order to donate electron 
density to the #* orbital of C11b–O bond, oxdation of B-ring to a hydroquinone, such as 
5.30, was required. 
 
Synthetic plans involving this strategy are outlined in Figure 5.12. First, B-ring of 
the dimer 4.12 would be oxidized to the hydroquinone oxidation state to give 
intermediate 5.31. The next step involved elimination of the benzylic oxygen substituent 
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Figure 5.11 Oxygen bridge opening assisted from C11a.
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proximal to C11b with the assistance of the C11 phenol to form a quinone methide 
species such as 5.32. Analogous eliminations of heteroatom leaving groups are well 
documented in the literature.10 Next, the highly unstable quinone methide species 5.32 
would undergo deprotonative rearomatization to provide a hydroquinone species such as 
5.33. Intermediate 5.33 was expected to be converted to the lomaiviticin aglycone with a 
similar strategy described in section 5.1. 
The prerequisite for this strategy was oxidation of the B-ring phenol to a quinone 
or a hydroquinone (Scheme 5.6). Dimer 5.34 was chosen to be the most favorable 
oxidation substrate because the electron-withdrawing ketone, which retards the oxidation 
of naphthyl ring, was masked as a ketal. Ketal 5.34, however, did not undergo the desired 
oxidation under standard conditions such as CAN, DDQ, PIFA, salcomine/O2, or 
Fremy’s salt. 5.35 or 5.36, B-ring phenol intermediates having a ketone oxidation state at 
the C5 position, did not undergo any oxidation either. In all cases, starting material 
rapidly decomposed or did not react at all. 
 
In an effort to improve oxidation propensity, a partially electron-donating 
functional group, a hydrazone, was installed at C5 (Scheme 5.7). The hydrazone would !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
(10) Kende, A. S.; Johnson, S., J. Org. Chem. 1985, 50, 727-729. 
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Scheme 5.6 Attempted oxidation of B-ring phenol.
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be used as a handle for the oxidation of the B-ring as well as a precursor to the C5 diazo 
group. By using a standard protocol, ketones 5.35 and 5.36 were successfully converted 
to the corresponding tosyl hydrazones 5.37 and 5.38, respectively. However, only 
decomposition was observed upon treatment of 5.37 or 5.38 with various oxidants. 
 
As was discussed previously about the 4.35 crystal structure, extremely little 
space is available between two naphthyl rings of the dimeric species (Figure 4.12). 
Therefore, we hypothesized that more space would be available by removing the cyclic 
hydrate of the dimer. However, all attempts to remove methyl-protected cyclic hydrate in 
aqueous acidic media were unsuccessful (Scheme 5.8). No 1,4-diketone, such as 5.39 or 
5.40, was detected prior to the decomposition of the starting material. This result is in 
accordance with the previous observation that the C1 ketal deprotection in the monomeric 
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Scheme 5.7 Attempted oxidation of B-ring phenol with hydrazone functionality at C5.
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system was highly challenging (Scheme 2.8). 
The only possible oxidation of the naphthyl ring was distal A-ring oxidation 
(Scheme 5.9). !-Hydroxy ketone 5.17 underwent smooth A-ring oxidation to the 
corresponding quinone 5.41 in the presence of AgO only when the B-ring allyl protecting 
group was present. Quinone 5.41 was easily reduced to the hydroquinone 5.42. This mild 
oxidation/reduction sequence could potentially be used for the removal of the methyl 
protecting group of the A-ring at the end of the synthesis. 
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Scheme 5.9 Oxidation of A ring.
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5.4. Oxidation of the B-Ring 
Confronted with the challenge of C11b–O bond cleavage, a strategy that did not 
involve generation of an antiaromatic intermediate was conceived (Figure 5.13). By 
removing the carbonyl group at the C5 position, the elimination product would be an 
indene, such as 5.44, instead of an antiaromatic indenone. By targeting an aromatic 
intermediate, it was anticipated that we would be able to isolate the desired elimination 
product. However, use of C5 methylene intermediates such as 5.43 would necessitate a 
major modification in the synthetic plan. 
 
The overall post-elimination transformations would be almost identical to the 
previously discussed strategies, except for the introduction of C5 diazo group. Since the 
C5 carbonyl group would not be present, the hydrazone formation/oxidation sequence is 
not applicable. Instead, a Regitz diazo transfer utilized in the kinamycin F synthesis by 
Herzon would be utilized (Figure 5.14).11 To apply this strategy, oxidation of the B-ring 
to a quinone oxidation state would have to be accompanied, as in the B-ring of compound 
5.45. 
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
(11) Woo, C. M.; Lu, L.; Gholap, S. L.; Smith, D. R.; Herzon, S. B., J. Am. Chem. Soc. 
2010, 132, 2540-2541. 
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Figure 5.13 Strategy involving C5 methylene intermediates.
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Accordingly, the synthetic challenge was reduced to removal of C5 carbonyl 
group. After extensive experimentations, a practical route to remove C5 carbonyl group 
was found (Scheme 5.10). !-Hydroxy ketone 5.17 was chosen as the starting point, since 
it already contained C4 oxygen functionality. 5.17 was treated with LiBHEt3 and the 
resulting tetraol was peracetylated to provide tetraacetate 5.47. 5.47 underwent ionic 
reduction in the presence of Et3SiH and TfOH to liberate C5 acetate. It should be noted 
that use of a strong acid in a narrow temperature window was crucial for this 
transformation. The reaction was slow below %15 °C, and decomposition started took 
place above %10 °C. Other less acidic proton donors were not effective. The C4 acetate 
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Figure 5.14 Herzon's diazo transfer reaction in the synthesis of kinamycin F.
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Scheme 5.10 Removal of the C5 carbonyl group.
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reduction product 5.48 was converted to C4 ketone 5.49 in two steps involving acetate 
removal and Ley oxidation. 
Since the C5 carbonyl group was no longer present in 5.49 , a C5–C4a enolate was 
not available (Figure 5.4). Therefore, only two options of electron-density donation 
remained: C4–C4a enolate or C11a (Figure 5.15). A strategy involving the C4–C4a 
enolate as a handle for C11b–O bond cleavage was investigated initially. 
 
To our disappointment, ketone 5.49 did not undergo desired C11b–O bond 
cleavage under a variety of conditions (Scheme 5.11). It was highly stable towards bulky 
strong bases and underwent decomposition when exposed to nucleophilic bases or strong 
acids. 
 
One benefit of this investigation was that we could introduce C4 hydroxyl group 
with the stereochemistry of the natural product (Scheme 5.12). By delivering a hydride 
from the convex face of the molecule, diketone 5.49 was reduced to the C4, C4’ diol 5.51 
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Figure 5.15 Possible source of electron density to cleave C11b–O bond.
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Scheme 5.11 Attempted C11b–O cleavage using a C4–C4a enolate.
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in 81% yield. The delivery of hydride was highly diastereoselective, and the orientation 
of hydride attack is in accordance with prior observations regarding hydroxide attack 
(Scheme 5.2). 
 
At this point we focused on B-ring of the dimer in order to reveal another source 
of electron density, as was discussed in Figure 5.15. Unlike the previously unsuccessful 
oxidation of the B-ring, a practical oxidation protocol was found by using C5-methylene 
intermediates (Scheme 5.13). When diol 5.51 was deallylated and treated with a 
hypervalent iodine oxidant, an oxidized product 5.53 was isolated as the major product. 
Surprisingly, the B-ring of the molecule possessed a hydroquinone oxidation state in a 
very unusual 4-hydroxy cyclohexadienone form, an unaromatized tautomer of 
hydroquinone. To our delight, exposure of compound 5.53 to a second oxidant provided 
quinone 5.54 in 78% yield over two steps. It was believed that removal of electron-
withdrawing heteroatom substituents at C5, which inductively hampered the B-ring 
oxidation, facilitated the oxidation reaction. 
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Scheme 5.12 Diastreoselective reeduction of the C4 ketone.
5.49 5.51
  Chapter 5 
 
 111!
 
A similar oxidation is known in a hindered setting (Figure 5.16). Schreiber and 
coworkers found that oxidation of phenol 5.55 takes place with the intermediacy of 4-
hydroxy cyclohexadienone 5.56, eventually providing quinone 5.57.12 
 
With the oxidized B-ring in hand, a synthetic plan to use it as a source of electron 
density was devised (Figure 5.17). The first strategy was to use a reduced form of the B-
ring, such as hydroquinone 5.58 (path I). As was explained in Figure 5.12, hydroquinone !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
(12) Chikashita, H.; Porco, J. A.; Stout, T. J.; Clardy, J.; Schreiber, S. L., J. Org. Chem. 
1991, 56, 1692-1694. 
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Scheme 5.13 Oxidation of the B-ring.
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Figure 5.16 Schreiber's oxidation of phenol to 4-hydroxy cyclohexadienenone.
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5.58 may undergo formation of quinone methide 5.59, followed by rearomatizition to 
give 5.60. Alternatively, a tautomeric form of quinone 5.54, 5.61, can also participate in a 
related sequence (path II). With a similar mechanistic rationale, intermediate 5.62 may be 
obtained, which may undergo [1,5]-hydride shift to regenerate quinone functionality in 
the B-ring. 
 
The strategy involving path II was investigated first. When 5.54 was exposed to 
bases, whose conjugate acid pKa is greater than 12, decomposition took place (Scheme 
5.14). Interestingly, when 5.54 was exposed to a tertiary amine, such as Et3N, electron 
transfer between the quinone and the amine took place, providing hydroquinone 5.58 and 
Et3NO. Residual water or oxygen may be the oxygen source leading to amine oxide. 
Upon isolation, hydroquinone 5.58 was quickly oxidized back to quinone 5.54, with a 
half life of 30 minutes. 
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Figure 5.17 B ring assisted C11b–O bond cleavage.
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Next, path II was investigated. Due to the short life time of the hydroquinone, a 
model monomeric hydroquinone was used instead (Scheme 5.15). The corresponding 
quinone 5.68 was prepared in 9 steps from compound 4.28 with approximately 10% 
overall yield. 
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Scheme 5.15 Synthesis of model quinone 5.68.
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The quinone was easily reduced to hydroquinone 5.69 upon exposure to Et3N or 
Na2S2O4 (Scheme 5.16a). Hydroquinoe 5.69 did not undergo the desired C11b–O bond 
cleavage. Instead, oxidation of the B-ring to either a quinone or an epoxide was the 
dominant reaction pathway (Scheme 5.16b). Although use of rigorously degassed solvent 
partially retarded this unwawnted oxidation, complete obstruction was not achievable. 
The oxidation of hydroquinone to the corresponding epoxide under basic conditions has 
been documented.13 It is proposed that both 1O2 and 3O2 may be responsible for the 
transformation. 
 
The introduction of diazo functionality was also investigated (Scheme 5.17). 
Quinone 5.54 was not an ideal substrate for Regitz diazo transfer (Scheme 5.17a). Unlike 
Herzon’s intermediate 5.45, 5.54 was not capable of forming a fulvene-type tautomer, 
which has a greater C5 nucleophilicity than the quinone tautomer. We then focused on 
conversion of an azide to the diazo group (Scheme 5.17b).14 Azide 5.72 could be !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
(13) (a) Paquette, L. A.; Bellamy, F.; Boehm, M. C.; Gleiter, R., J. Org. Chem. 1980, 45, 
4913-4921. (b) De, S. R.; Ghorai, S. K.; Mal, D., J. Org. Chem. 2009, 74, 1598-
1604. 
(14) Myers, E. L.; Raines, R. T., Angew. Chem. Int. Ed. 2009, 48, 2359-2363. 
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Scheme 5.16 Attempted C11b–O bond cleavage of monomeric quinone 5.68 or hydroquinone 5.69.
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prepared from intermediate 5.64 in 10 steps. However, the desired oxidation did not take 
place. Instead, oxidation of phosphine 5.87 with concomitant reduction of quinone 5.72 
took place. 
 
While we were addressing challenges associated with C11b–O bond cleavage, an 
article demonstrating the futillity of our current approach was published from the Herzon 
group (Figure 5.18).15 In this article, synthetic diazofluorene 5.74 was exposed to 
reductive conditions and subsequently underwent addition of a solvent molecule with 
corresponding loss of stereochemical integrity at the C4 position. The authors isolated 
intermediate 5.75 in the course of the reaction and postulated this arose from quinone 
methide intermediate 5.76. 
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
(15) Mulcahy, S. P.; Woo, C. M.; Ding, W.; Ellestad, G. A.; Herzon, S. B., Chem. 
Sci. 2012, 3, 1070. 
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Although we may eventually effect the desired C11b–O bond (i.e., 5.54 to 5.63), 
the product may be in equilibrium with a fulvene tautomer 5.78 based on Herzon’s result 
(Figure 5.19). Compound 5.78 may be highly prone to elimination of the C4 oxygen 
substituent to form a quinone methide species 5.79, before undergoing diazo transfer. 
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Figure 5.18 Herzon's reductive solvolysis of daizofluorene 5.87.
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Chapter 6 
 Summary and Outlook 
 
In summary, the full carbon skeleton of the lomaiviticin aglycone could be 
constructed by using a late-stage oxidative enolate dimerization strategy, although the 
dimeric product could not be elaborated to the synthetic target (Figure 6.1). The starting 
point of the synthesis was oxanorbornanone intermediate 1.101, which is accesible in 
large quantities in an enantio-enriched form. By using a serendipitously discovered 
reductive transesterification protocol, oxanorbornanone 1.101 was transformed to allyl 
ester 2.36, where the C1 and C5 oxygens are differentiated. Allyl ester 2.36 was 
converted to the key annulation precursor enone 2.42, which was subjected to the 
modified Hauser annulation with sulfoxide 4.27 to provide tetracyclic intermediate 4.28. 
Tetracycle 4.28 was advanced to the desired dimerization precursor 4.13. In order to 
prepare 4.13 for a successful dimerization, a judicious choice of protecting group strategy 
was critical. 4.13 underwent successful oxidative enolate dimerization in a stereoselective 
manner to give dimer 4.12 in a synthetically practical yield. During the course of this 
study, a remarkable remote steric effect of the C11 substituent was disclosed. In addition, 
careful control of the reaction temperature was required to minimize side reactions. Upon 
removal of the C5 ketal of dimer 4.12, we discovered thata single molecule of water had 
been incorporated into the central 1,4-ketone moiety to form stable cyclic hydrate 5.7. 
Ketone 5.7 exhibited a completely different reaction profile from the model core toward 
basic fragmentation reaction conditions. Instead of going through the anticipated C11b–O 
bond cleavage, the C4 sulfone was displaced with net retention of stereochemistry. In 
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order to avoid the difficulty associated with B-ring oxidation, due to inductive 
destabilization, the C5 carbonyl group was removed to give intermediate 5.51. During the 
course of prepraring 5.51, the C4 stereochemistry was adjusted to that of the natural 
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product. Intermediate 5.51 was advanced to the B-ring quinone 5.54. Quinone 5.54 
differs from the lomaiviticin aglycone (ent-1.3) in three aspects: 1) existence of the C11b–
O bond–the oxygen bridge; 2) lack of the C5 diazo functionality; 3) the central 1,4-
diketone moiety locked in a methyl protected cyclic hydrate form. 
 Obviously, there was a major discrepancy in the ability of the oxanorbornane 
C11b–O bond to undergo cleavage between the model system and the forefront 
intermediates. It seems that subtle electronic and conformational modifications arising 
from the AB-ring of the latter is the reason for the difference in the elimination behavior 
of the oxanorbornanes. Since we were not able to cleave the C11b–O bond of the 
oxanorbornane, and hence could not expect stabilization of the C5 diazo group, we were 
unable to successfully introduce the diazo group. In addition, the existence of a central 
cyclic hydrate has made significant differences in manipulating the forefront 
intermediates due to the steric reasons. 
One possible solution to address this problem would be to cleave the C11b–O 
bond at an earlier stage. Since the oxanorbornane structure is essential for the 
diastereoselectivity of the dimerization, the cleavage should take place at a post 
dimerization stage. Therefore an intermediate resembling the model CDD’C’ core might 
undergo the desired C11b–O bond cleavage after dimerization, which could then be 
expanded to the full structure of the aglycone. However a way of introducing the A and B 
rings is not clear. Currently realization of this strategy is an active subject of research in 
the Shair group. 
!
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Appendix 1 
 Experimental Section 
 
General Procedures. All reactions were performed in oven or flame-dried glassware 
under a positive pressure of argon unless noted otherwise. Flash column chromatography 
was performed either as described by Still et al. (Still, W. C.; Kahn, M.; Mitra, A. J. Org. 
Chem. 1978, 43, 2923-2925.), employing E. Merck silica gel 60 (230-400 mesh ASTM). 
Tetrahydrofuran, diethyl ether, dichloromethane, toluene, and dimethylformamide were 
degassed with argon and passed through a solvent purification system (designed by J.C. 
Meyer of Glass Contour) utilizing alumina columns. TLC analyses were performed on 
250 µm Silica Gel 60F254 plates purchased from EM science. 
Instrumentation. 1H and 13C NMR spectra were recorded on a Varian INOVA600, 
INOVA500, or INOVA500C spectrometer. Chemical shifts for proton and carbon 
resonances are reported in ppm (!) relative to chloroform-d (! 7.26 ppm, 77.0 ppm 
respectively). Mass spectra were obtained from the Harvard University Mass 
Spectrometry Laboratory. 
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To a flask containing 0.5 mL of diethyl ether was added MeOH (0.0167 mL, 0.412 mmol, 
1.10 equiv). Then the solution was cooled to 0 °C and 2.0 M THF solution of LiBH4 
(0.206 mL, 0.412 mmol, 1.10 equiv) was added in one portion. Then the mixture was 
cannulated to the 0 °C solution of ketone 1.101 (245 mg, 0.375 mmol, 1.00 equiv) in 2.0 
mL of diethyl ether. The pale yellow solution was vigorously stirred at 0 °C for 30 min. 
Upon completion of the reaction, the mixture was quenched with saturated aqueous 
NH4Cl solution (5mL), and the aqueous phase was extracted with diethyl ether (3 " 5 
mL). The combined organic layer was dried over anhydrous MgSO4 and filtered through 
celite. The crude product was purified by flash column chromatography (EtOAc/hexane = 
1/2 to 2/1) to provide diol 2.3 (143 mg, 0.296 mmol, 79%). 
To a solution of oxalyl chloride (0.152 mL, 1.74 mmol, 6.00 equiv) in dichloromethane 
(3 mL) was added DMSO (0.123 mL, 1.74 mmol, 6.00 equiv) over a 5 minute period at –
78 °C. Gas evolution was observed. 30 minutes later, a solution of diol 2.3 (140 mg, 
0.290 mmol, 1.00 equiv) in 2 mL of dichloromethane (plus 2 " 0.5 mL rinse) was 
cannulated to the reaction mixture over a 5 minute period. After stirring for 30 minutes, 
Et3N (0.485 mL, 3.48 mmol, 12.0 equiv) was added in one portion to give a white 
suspension. The reaction system was warmed to 0 °C over 30 minutes and diluted with 
50 mL of diethyl ether. The resulting slurry was filtered through a pad of celite/florisil 
and the filter cake was washed with diethyl ether. After concentration, the crude aldehyde 
was used for the next step without further purification. 
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The intermediate aldehyde was dissolved in 10 mL of t-BuOH together with 2-methyl-2-
butene (0.307 mL, 2.90 mmol, 10.0 equiv). The mixture was cooled to 0 °C and a 
solution of NaClO2 (164 mg, 1.45 mmol, 5.00 equiv) and NaH2PO4·H2O (200 mg, 1.45 
mmol, 5.00 equiv) in 10 mL of water was added by a dropping funnel over 30 minutes. 
After addition, the reaction mixture was slowly warmed to 23 °C over 1 hour. Then the 
mixture was quenched with water (20 mL) and the aqueous phase was extracted with 
diethyl ether (3 " 10 mL). The combined organic layer was dried over anhydrous Na2SO4 
and filtered through celite. The crude acid 2.2 (126 mg, 0.255 mmol, 88%) was used for 
the next step without further purification. 1H NMR (500 MHz, CDCl3) ! = 7.87 (d, J = 
7.3 Hz, 2H), 7.67 (t, J = 1.0 Hz, 1H), 7.58 (t, J = 7.8 Hz, 2H), 4.23 (d, J = 5.0 Hz, 1H), 
4.09 (q, J = 7.3 Hz, 1H), 4.01 (d, J = 5.0 Hz, 1H), 3.32 (d, J = 18.3 Hz, 1H), 3.15 - 3.09 
(m, 1H), 3.03 (t, J = 5.7 Hz, 1H), 2.51 (dd, J = 5.5, 15.1 Hz, 1H), 2.35 (d, J = 17.9 Hz, 
1H), 2.26 (dd, J = 9.2, 15.1 Hz, 1H), 1.94 (q, J = 7.5 Hz, 3H), 0.97 (t, J = 7.3 Hz, 3H), 
0.78 (s, 9H), -0.05 (s, 3H), -0.34 ppm (s, 3H); HRMS (ESI) calcd for C24H38O7SSi 
[M+H+] 495.1873, found: 495.1866. 
 
To the solution of acid 2.2 (81.0 mg, 0.164 mmol, 1.00 equiv) in 10 mL of benzene were 
added Pb(OAc)4 (145 mg, 0.327 mmol, 2.00 equiv) and Cu(OAc)2·H2O (8.2 mg, 0.041 
mmol, 0.250 equiv). Then trifluoroacetic acid (0.0505 mL, 0.655 mmol, 4.00 equiv) was 
added to the solution. The mixture was heated to 80 °C and vigorously stirred. In 3 hours, 
the mixture was cooled to 23 °C and quenched with water (10mL). The aqueous phase 
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was extracted with diethyl ether (3 " 10 mL) and the combined organic layer was dried 
over anhydrous MgSO4. After concentration, the crude product was purified by flash 
column chromatography (EtOAc/hexane = 1/10 to 1/5) to provide olefin 2.1 (31.0 mg, 
0.0689 mmol, 42%) as a pale yellow film. 1H NMR (500 MHz, CDCl3) ! = 7.90 (d, J = 
7.8 Hz, 2H), 7.71 - 7.66 (m, 1H), 7.62 - 7.55 (m, J = 7.8 Hz, 2H), 6.26 (dd, J = 2.3, 6.0 
Hz, 1H), 6.04 (d, J = 6.0 Hz, 1H), 4.36 (dd, J = 2.3, 6.4 Hz, 1H), 4.10 (d, J = 6.0 Hz, 1H), 
3.48 (d, J = 18.3 Hz, 1H), 3.01 (t, J = 6.4 Hz, 1H), 2.43 (d, J = 17.4 Hz, 1H), 2.09 - 1.93 
(m, 2H), 1.00 (t, J = 7.3 Hz, 3H), 0.77 (s, 9H), -0.05 (s, 3H), -0.26 ppm (s, 3H); HRMS 
(ESI) calcd for C23H32NaO5SSi [M+Na+] 471.1637, found: 471.1665. 
 
TBS ether 2.1 (51.0 mg, 0.114 mmol, 1 equiv) was dissolved in 3 mL of acetonitrile. To 
the solution was added 0.5 mL of aqueous solution of hydrofluoric acid in one portion at 
23 °C. After stirring for 16 hours, the mixture was slowly quenched with saturated 
solution of NaHCO3, and the aqueous phase was extracted with dichloromethane (3 " 10 
mL). The combined organic layer was dried over anhydrous MgSO4 and concentrated. 
The crude product was purified by flash column chromatography (EtOAc/hexane = 1/2 to 
1/1) to provide alcohol 2.8 (36 mg, 0.107 mmol, 94%) as a white film. 1H NMR (500 
MHz, CDCl3) ! = 7.93 (d, J = 7.3 Hz, 2H), 7.73 - 7.67 (m, 1H), 7.64 - 7.58 (m, 2H), 6.34 
(dd, J = 2.4, 5.9 Hz, 1H), 6.09 (d, J = 5.9 Hz, 1H), 4.05 - 4.00 (m, 2H), 3.47 (d, J = 18.1 
Hz, 1H), 2.86 (t, J = 6.6 Hz, 1H), 2.52 (dd, J = 1.2, 18.3 Hz, 1H), 2.11 (quind, J = 7.4, 
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14.4 Hz, 2H), 1.28 - 1.23 ppm (m, 3H); HRMS (ESI) calcd for C16H22NO5S [M+NH4+] 
352.1219, found: 352.1201. 
 
To the solution of alcohol 2.8 (8.3 mg, 0.025 mmol, 1.00 equiv) in 1 mL of 
dichloromethane was added Dess-Martin periodinane (15.8 mg, 0.0370 mmol, 1.50 
equiv) in one portion. The mixture was vigorously stirred at 23 °C. 3 hour later, the 
reaction mixture was quenched with saturated aqueous NaHCO3 solution (1 mL) and the 
aqueous phase was extracted with diethyl ether (3 " 2 mL). The combined organic layer 
was dried over anhydrous MgSO4 and concentrated. The crude product was purified by 
flash column chromatography (EtOAc/hexane = 1/5) to provide enone 1.111 (7.5 mg, 
0.0225 mmol, 90%) as a white film. 1H NMR (500 MHz, CDCl3) ! = 7.92 (d, J = 7.3 Hz, 
2H), 7.73 - 7.65 (m, 1H), 7.59 - 7.62 (m, 2H), 7.48 (d, J = 5.8 Hz, 1H), 6.29 (d, J = 5.9 
Hz, 1H), 3.64 (d, J = 6.5 Hz, 1H), 3.51 (d, J = 18.0 Hz, 1H), 3.24 (d, J = 6.6 Hz, 1H), 
2.61 (d, J = 18.3 Hz, 1H), 2.18 (quind, J = 7.4, 14.2 Hz, 2H), 1.05 ppm (t, J = 7.5 Hz, 
3H); HRMS (ESI) calcd for C17H20NO5S [M+NH4+] 350.1062, found: 350.1077. 
 
Ketone 2.8 (8.2 mg, 0.025 mmol, 1.00 equiv) was dissolved in 2 mL of benzene. To the 
solution were added 2,2-dimethylpropane-1,3-diol (5.1 mg, 0.049 mmol, 2.00 equiv) and 
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p-TsOH·H2O (0.5 mg, 0.0025 mmol, 0.100 equiv). Then the reaction flask was equipped 
with a Dean-Stark condenser and the mixture was heated to reflux for 2 hours. After 
completion of the reaction, the mixture was cooled to 23 °C and diluted with 10 mL of 
diethyl ether. The organic phase was washed with saturated aqueous solution of NaHCO3 
(3 " 5 mL). After concentration, the crude product was purified by flash column 
chromatography (EtOAc/hexane = 1/1) to provide dioxane 2.14 (8.3 mg, 0.020 mmol, 
79%) as a pale yellow solid. 1H NMR (500 MHz, CDCl3) ! = 7.95 (d, J = 7.3 Hz, 2H), 
7.66 (t, J = 7.8 Hz, 1H), 7.60 - 7.55 (m, 2H), 6.26 - 6.21 (m, 2H), 3.93 (d, J = 7.3 Hz, 
1H), 3.87 (br. s, 1H), 3.63 - 3.55 (m, 3H), 3.51 - 3.46 (m, 1H), 3.28 (t, J = 6.6 Hz, 1H), 
3.10 (d, J = 13.3 Hz, 1H), 2.19 - 2.09 (m, 1H), 2.07 (d, J = 13.3 Hz, 1H), 2.03 - 1.94 (m, 
1H), 1.15 (s, 3H), 1.05 (t, J = 7.6 Hz, 3H), 0.77 ppm (s, 3H); HRMS (ESI) calcd for 
C22H28NaO6S [M+Na+] 443.1504, found: 443.1493. 
 
To the solution of alcohol 2.14 (8.3 mg, 0.020 mmol, 1.00 equiv) in 1 mL of 
dichloromethane was added Dess-Martin periodinane (12.7 mg, 0.030 mmol, 1.50 equiv) 
in one portion. The mixture was vigorously stirred at 23 °C. 1.5 hour later, the reaction 
mixture was quenched with saturated aqueous NaHCO3 solution (1 mL) and the aqueous 
phase was extracted with diethyl ether (3 " 2 mL). The combined organic layer was dried 
over anhydrous MgSO4 and concentrated. The crude product was purified by flash 
column chromatography (EtOAc/hexane = 1/5) to provide enone 2.15 (7.7 mg, 0.0184 
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mmol, 92%) as a white film. 1H NMR (500 MHz, CDCl3) ! = 7.92 (d, J = 7.3 Hz, 2H), 
7.73 - 7.69 (m, 1H), 7.62 - 7.58 (m, 2H), 7.58 (d, J = 6.0 Hz, 1H), 6.20 (d, J = 6.0 Hz, 
1H), 3.71 (d, J = 6.9 Hz, 1H), 3.68 - 3.52 (m, 4H), 3.11 (d, J = 13.3 Hz, 2H), 2.23 - 2.18 
(m, 1H), 2.18 - 2.15 (m, J = 1.0 Hz, 1H), 2.01 (td, J = 7.7, 14.9 Hz, 1H), 1.19 (s, 3H), 
1.01 (t, J = 7.3 Hz, 3H), 0.80 ppm (s, 3H); HRMS (ESI) calcd for C22H27O6S [M+H+] 
419.1528, found: 419.1542. 
 
To the solution of acid 2.2 (8.2 mg, 0.0216 mmol, 1.00 equiv) in 2 mL of DMF were 
added allyl bromide (0.0020 mL, 0.0237 mmol, 1.10 equiv) and Cs2CO3 (7.0 mg, 0.0216 
mmol, 1.00 equiv), successively. The heterogeneous mixture was vigorously stirred at 23 
°C. 1 hour later, the reaction mixture was quenched with saturated aqueous solution of 
NH4Cl, and the aqueous phase was extracted with diethyl ether (3 " 5 mL). The 
combined organic layer was washed with saturated aqueous solution of LiCl (2 " 5 mL), 
and dried over anhydrous MgSO4. After concentration, the crude product was purified by 
flash column chromatography (EtOAc/hexane = 1/10 to 1/5) to provide allyl ester 2.20 
(8.3 mg, 0.0197 mmol, 91%) as a white film. 1H NMR (500 MHz, CDCl3) ! = 7.88 (d, J 
= 7.3 Hz, 2H), 7.72 - 7.66 (m, J = 7.3 Hz, 1H), 7.61 - 7.56 (m, 2H), 5.97 - 5.87 (m, 1H), 
5.34 (dd, J = 1.4, 17.4 Hz, 1H), 5.28 (dd, J = 0.9, 10.5 Hz, 1H), 4.61 (d, J = 6.0 Hz, 2H), 
4.23 (dd, J = 2.1, 6.6 Hz, 1H), 4.05 (dd, J = 1.1, 5.3 Hz, 1H), 3.35 (d, J = 17.9 Hz, 1H), 
3.16 - 3.11 (m, J = 2.5, 3.0 Hz, 1H), 3.06 - 3.02 (m, 1H), 2.47 (dd, J = 6.0, 15.1 Hz, 1H), 
2.37 (dd, J = 1.4, 18.3 Hz, 1H), 2.27 (dd, J = 8.7, 15.1 Hz, 1H), 1.96 (q, J = 7.5 Hz, 2H), 
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1.00 (t, J = 7.6 Hz, 3H), 0.80 (s, 9H), -0.06 (s, 3H), -0.31 ppm (s, 3H); HRMS (ESI) 
calcd for C27H39O7SSi [M+H+] 535.2186, found: 535.2199. 
 
Ketone 2.20 (28.3 mg, 0.0529 mmol, 1.00 equiv) was dissolved in 2 mL of benzene. To 
the solution were added 2,2-dimethylpropane-1,3-diol (6.1 mg, 0.0582 mmol, 1.10 equiv) 
and p-TsOH·H2O (1.0 mg, 0.0529 mmol, 0.100 equiv). Then the reaction flask was 
equipped with a Dean-Stark condenser and the mixture was heated to reflux for 6 hours. 
After completion of the reaction, the mixture was cooled to 23 °C and diluted with 10 mL 
of diethyl ether. The organic phase was washed with saturated aqueous solution of 
NaHCO3 (3 " 5 mL). After concentration, the crude product was purified by flash column 
chromatography (EtOAc/hexane = 1/10) to provide dioxane 2.21 (32.0 mg, 0.0513 mmol, 
97%) as white foam. 1H NMR (500 MHz, CDCl3) ! = 7.91 (d, J = 7.3 Hz, 2H), 7.64 (dd, 
J = 7.2, 7.3 Hz, 1H), 7.58 - 7.53 (m, 2H), 5.97 - 5.87 (m, 1H), 5.37 - 5.29 (m, 1H), 5.25 
(d, J = 10.5 Hz, 1H), 4.58 (dd, J = 6.0, 12.4 Hz, 2H), 4.28 (dd, J = 2.7, 6.9 Hz, 1H), 3.98 
(d, J = 5.5 Hz, 1H), 3.55 - 3.38 (m, 4H), 3.03 - 2.98 (m, 1H), 2.96 (d, J = 13.3 Hz, 1H), 
2.36 - 2.32 (m, 2H), 1.94 - 1.86 (m, 1H), 1.82 (d, J = 13.3 Hz, 1H), 1.85 - 1.77 (m, 1H), 
0.94 (t, J = 7.3 Hz, 3H), 0.78 (s, 9H), -0.10 (s, 3H), -0.31 ppm (s, 3H); 13C NMR (125 
MHz, CDCl3) ! = 173.3, 140.8, 133.6, 132.0, 129.3, 128.4, 128.3, 118.5, 104.4, 98.4, 
90.2, 73.9, 73.3, 70.5, 65.8, 65.5, 54.8, 49.2, 38.9, 30.2, 29.7, 27.9, 27.7, 25.8, 22.5, 21.8, 
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17.8, 8.1, -4.7, -5.4 ppm; HRMS (ESI) calcd for C32H49O8SSi [M+H+] 621.2917, found: 
621.2945. 
 
TBS ether 2.21 (64.0 mg, 0.103 mmol, 1.00 equiv) was dissolved in 5 mL of THF. The 
mixture was cooled to 0 °C and 1.0 M THF solution of TBAF (0.113 mL, 0.113 mmol, 
1.10 equiv) was added in one portion. The reaction mixture was warmed to 23 °C and 
vigorously stirred for 2 hour. Then the mixture was quenched with saturated aqueous 
solution of NH4Cl (5 mL), and the aqueous phase was extracted with EtOAc (3 " 5 mL). 
The combined organic layer was dried over anhydrous MgSO4 and concentrated. The 
crude alcohol was used for the next step without further purification. 
To the solution of the crude alcohol in 3 mL of dichloromethane was added Dess-Martin 
periodinane (65.5 mg, 0.155 mmol, 1.50 equiv) in one portion. The mixture was 
vigorously stirred at 23 °C. 1.5 hour later, the reaction mixture was quenched with 
saturated aqueous NaHCO3 solution (5 mL) and the aqueous phase was extracted with 
diethyl ether (3 " 5 mL). The combined organic layer was dried over anhydrous MgSO4 
and concentrated. The crude product was purified by flash column chromatography 
(EtOAc/hexane = 1/5) to provide ketone 2.16 (44.5 mg, 0.0883 mmol, 85% over two 
steps) as white film. 
To the solution of #-keto ester 2.16 (21.0 mg, 0.0416 mmo, 1.00 equiv) in 5 mL of 
toluene was added PdCl2(PPh3)2 (0.6 mg, 0.00083 mmol, 0.0200 equiv), followed by 
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Bu3SnH (0.0121 mL, 0.0458 mmol, 1.10 equiv). The mixture was stirred at 23 °C for 30 
minutes, then heated to reflux for 30 minutes. The mixture was concentrated under 
reduced pressure and the crude product was purified by flash column chromatography 
(EtOAc/hexane = 1/5) to provide ketone 2.22 (15.6 mg, 0.0370 mmol, 89%) as white 
foam. 1H NMR (500 MHz, CDCl3) ! = 7.90 (d, J = 7.3 Hz, 2H), 7.70 - 7.65 (m, 1H), 7.60 
- 7.54 (m, 2H), 3.67 - 3.57 (m, 4H), 3.51 - 3.41 (m, 4H), 3.04 (d, J = 12.8 Hz, 1H), 2.48 - 
2.22 (m, 6H), 2.13 (qd, J = 7.5, 14.9 Hz, 1H), 1.98 (d, J = 12.8 Hz, 1H), 2.06 - 1.95 (m, 
1H), 1.22 (s, 3H), 0.98 (t, J = 7.3 Hz, 3H), 0.77 ppm (s, 3H); HRMS (ESI) calcd for 
C22H29O6S [M+H+] 421.1685, found: 421.1683. 
 
Ketone 2.22 (20.3 mg, 0.0483 mmol, 1.00 equiv) was dissolved in 5 mL of toluene. To 
the solution was added benzeneseleninic anhydride (20.9 mg, 0.0579 mmol, 1.20 equiv), 
followed by NaHCO3 (6.1 mg, 0.0725 mmol, 1.50 mmol). The mixture was heated to 
reflux, while the progress of the reaction was monitored by NMR. In 5 hours, the reaction 
mixture was quenched with water and the aqueous phase was extracted with diethyl ether 
(3 " 5 mL). After concentration, the crude product was purified by flash column 
chromatography (EtOAc/hexane = 1/5) to provide enone 2.15 (16.1 mg, 0.0382 mmol, 
79%) as white foam. The product was identical to the previously prepared compound in 
all aspects. 
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A two-neck flask was flame dried with a cold finger on it and charged with HMDS 
(0.0555 mL, 0.263 mmol, 5.00 equiv) in 0.5 mL of THF, and 1.60 M hexane solution of 
n-BuLi (0.164 mL, 0.263 mmol, 5.00 equiv), successively at –78 °C. 10 minutes later 
HMPA (45.8 µL, 0.263 mmol, 5.00 equiv) was added to the LiHMDS solution. In 
another 10 minutes, cyanophthalide 2.10 (44.0 mg, 0.158 mmol, 3.00 equiv) in 0.5 mL of 
THF (plus 2 " 0.3 mL rinse) was cannulated into the reaction mixture to give a bright 
yellow solution. The solution was stirred at –78 °C for 20 minutes, then enone 2.15 (22.0 
mg, 0.0526 mmol, 1.00 equiv) in 0.5 mL of THF (plus 2 " 0.3 mL rinse) was cannulated 
to the reaction mixture. Stirring was continued at –78 °C for 10 minutes, then the reaction 
system was heated to 50 °C for 20 minutes. After completion of the reaction, the mixture 
was cooled to 23 °C, and quenched with saturated aqueous solution of NH4Cl, and the 
aqueous phase was extracted with dichloromethane (3 " 10 mL). After concentration, the 
crude product was purified by flash column chromatography (EtOAc/hexane = 1/3 to 
1/1.5) to provide tetracycle 2.26 (14.4 mg, 0.0216 mmol, 41%) as bright yellow foam. 1H 
NMR (500 MHz, CDCl3) ! = 10.39 (s, 1H), 10.36 (s, 1H), 7.98 (d, J = 7.8 Hz, 2H), 7.74 - 
7.70 (m, 1H), 7.64 - 7.60 (m, 2H), 7.15 (d, J = 8.8 Hz, 1H), 7.06 (d, J = 8.8 Hz, 1H), 5.29 
(s, 2H), 5.17 - 5.11 (m, 2H), 4.20 (d, J = 6.8 Hz, 1H), 3.91 - 3.86 (m, 1H), 3.85 - 3.79 (m, 
1H), 3.76 - 3.68 (m, 2H), 3.64 (d, J = 6.3 Hz, 1H), 3.58 (s, 3H), 3.51 (s, 3H), 3.31 - 3.26 
(m, 1H), 2.25 (d, J = 12.8 Hz, 1H), 2.30 - 2.20 (m, 1H), 2.16 - 2.06 (m, 1H), 1.24 (s, 3H), 
1.02 (t, J = 7.3 Hz, 3H), 0.85 ppm (s, 3H); 13C NMR (125 MHz, CDCl3) ! = 199.0, 151.8, 
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150.3, 149.4, 145.1, 139.9, 134.2, 129.4, 128.5, 121.0, 120.1, 115.5, 112.5, 106.2, 98.5, 
96.4, 93.5, 92.3, 74.3, 71.3, 68.3, 56.9, 56.8, 56.4, 39.1, 36.6, 30.5, 27.9, 22.3, 21.6, 8.1 
ppm; HRMS (ESI) calcd for C34H39O12S [M+H+] 671.2162, found: 671.2134. 
 
Without heating, in the reaction above, Michael adduct 2.28 was isolated in 45% yield. 
1H NMR (500 MHz, CDCl3) ! = 7.86 (d, J = 7.3 Hz, 2H), 7.70 - 7.65 (m, 1H), 7.60 - 7.54 
(m, 2H), 7.30 (d, J = 9.2 Hz, 1H), 7.18 (d, J = 9.2 Hz, 1H), 5.28 (s, 2H), 5.24 (d, J = 6.9 
Hz, 1H), 5.12 (d, J = 6.9 Hz, 1H), 3.89 (t, J = 10.1 Hz, 1H), 3.77 (d, J = 5.0 Hz, 1H), 3.67 
- 3.55 (m, 2H), 3.49 (s, 3H), 3.45 (s, 3H), 3.54 - 3.42 (m, 2H), 3.30 (d, J = 4.6 Hz, 1H), 
2.88 (d, J = 12.8 Hz, 1H), 2.82 - 2.67 (m, 2H), 1.96 - 1.83 (m, 2H), 1.79 (d, J = 13.3 Hz, 
1H), 1.35 (s, 3H), 0.78 (s, 3H), 0.75 ppm (t, J = 7.3 Hz, 3H); 13C NMR (125 MHz, 
CDCl3) ! = 208.8, 164.9, 150.1, 146.5, 139.8, 134.3, 134.1, 129.3, 128.3, 128.2, 121.0, 
118.9, 115.5, 115.4, 104.2, 95.3, 94.8, 94.4, 91.3, 75.8, 74.3, 70.1, 69.8, 58.1, 56.5, 56.4, 
40.3, 39.2, 36.9, 30.1, 29.7, 27.4, 22.5, 21.7, 7.7 ppm; HRMS (ESI) calcd for 
C35H40NO12S [M+H+] 698.2271, found: 698.2264. 
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Hydroquinone 2.26 (156 mg, 0.233 mmol, 1.00  equiv) was dissolved in 5 mL of DMF. 
To the solution was added allyl bromide (0.099 mL, 1.17 mmol, 5.00 equiv) n-Bu4NI (86 
mg, 0.233 mmol, 1.00 equiv), and Cs2CO3 (227 mg, 0.699 mmol, 3.00 equiv), 
successively. The heterogeneous mixture was stirred at 23 °C for 2 hours. After 
completion of the reaction, the reaction system was quenched with saturated aqueous 
solution of NH4Cl, and the aqueous phase was extracted with dichloromethane (3 " 10 
mL). The combined organic layer was dried over anhydrous Na2SO4 and concentrated. 
The crude product was purified by flash column chromatography (EtOAc/hexane = 1/4 to 
1/3) to provide bisallyl ether 2.27 (159 mg, 0.212 mmol, 91%) as bright yellow foam. 1H 
NMR (500 MHz, CDCl3) ! = 7.99 (d, J = 7.3 Hz, 2H), 7.73 - 7.68 (m, 1H), 7.63 - 7.58 
(m, 2H), 7.19 - 7.16 (m, 1H), 7.12 - 7.09 (m, 1H), 6.19 - 6.04 (m, 2H), 5.38 - 5.30 (m, 
1H), 5.25 - 5.16 (m, 1H), 5.15 (s, 2H), 5.14 - 5.08 (m, 2H), 4.62 (dd, J = 4.9, 11.2 Hz, 
1H), 4.43 (d, J = 5.9 Hz, 2H), 4.34 - 4.32 (m, 1H), 3.63 - 3.55 (m, 4 H), 3.17 (d, J = 13.2 
Hz, 1H), 2.21 (dd, J = 1.0, 13.2 Hz, 1H), 2.11 (dq, J = 2.2, 7.4 Hz, 2H), 1.08 (s, 3H), 0.98 
(t, J = 7.3 Hz, 3H), 0.80 ppm (s, 3H); HRMS (ESI) calcd for C40H47O12S [M+H+] 
751.2788, found: 751.2801. 
 
Ketone 1.102 (29.0 mg, 0.0640 mmol, 1.00 equiv) was dissolved in 3 mL of MeOH and 
cooled to 0 °C. To the solution was added NaBH4 (24.0 mg, 0.640 mmol, 10.0 equiv) in 
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one portion. After stirring for 5 minutes, the mixture was quenched with saturated 
aqueous solution of NH4Cl (5mL), then the aqueous phase was extracted with ethyl 
acetated (3 " 10 mL). The combined organic layer was dried over anhydrous MgSO4 and 
concentrated. The crude product was used for the next step without further purification. 
The crude alcohol was dissolved in 5 mL of dichloromethane. To the solution was added 
MEMCl (0.0219 mL, 0.192 mmol, 3.00 eqiv), followed by DIEA (0.0557 mL, 0.320 
mmol, 5.00 equiv) and the mixture was heated to reflux for 12 hours. At the end of the 
reaction, the reaction mixture was quenched with water and the aqueous phase was 
extracted with dichloromethane (3 " 10 mL). The combined organic layer was dried over 
anhydrous Na2SO4 and concentrated. The crude product was purified by flash column 
chromatography (EtOAc/hexane = 1/3 to 1/2) to provide the corresponding MEM ether 
(30.8 mg, 0.0570 mmol, 89%) as colorless film. 
The MEM ether (16.8 mg, 0.0310 mmol, 1.00 equiv) was dissolved in 5 mL of THF. To 
the solution was added 1.0 M THF solution of TBAF (0.0341 mL, 0.0341 mmol, 1.10 
equiv) in one portion. The reaction mixture was vigorously stirred at 23 °C for 12 hours. 
At the end of the reaction, the mixture was quenched with saturated aqueous solution of 
NH4Cl (5 mL), and the aqueous phase was extracted with EtOAc (3 " 10 mL). The 
combined organic layer was dried over anhydrous MgSO4 and concentrated. The crude 
alcohol was used for the next step without further purification. 
The intermediate alcohol was charged in a flask with 5 mL of dichloromethane. To the 
solution was added TPAP (0.5 mg, 0.00160 mmol, 0.0500 equiv), followed by NMO (5.4 
mg, 0.0470 mmol, 1.50 equiv) and 20 mg of 4 Å MS. The heterogeneous mixture was 
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vigorously stirred for 1 hour at 23 °C. At the end of the reaction, the reaction system was 
diluted with 10 mL of diethyl ether and filtered through silica gel. After concentration, 
the crude ketone was used for the next step without further purification. 
The ketone was dissolved in 5 mL of toluene. To the solution was added 
benzeneseleninic anhydride (16.7 mg, 0.0465 mmol, 1.50 equiv), followed by NaHCO3 
(7.8 mg, 0.0930 mmol, 3.00 mmol). The mixture was heated to reflux, while the progress 
of the reaction was monitored by NMR. In 5 hours, the reaction mixture was quenched 
with water and the aqueous phase was extracted with diethyl ether (3 " 5 mL). After 
concentration, the crude product was purified by flash column chromatography 
(EtOAc/hexane = 1/2 to 1/1) to provide enone 2.31 (9.4 mg, 0.0223 mmol, 72% over 
three steps) as white foam. 1H NMR (500 MHz, CDCl3) ! = 7.97 - 7.92 (m, 2H), 7.74 - 
7.69 (m, 1H), 7.64 - 7.58 (m, 2H), 7.41 (d, J = 5.9 Hz, 1H), 6.15 (d, J = 6.3 Hz, 1H), 4.86 
- 4.80 (m, 2H), 4.41 (dd, J = 3.9, 9.8 Hz, 1H), 3.82 - 3.77 (m, 2H), 3.71 - 3.65 (m, 1H), 
3.60 - 3.51 (m, 3H), 3.39 (s, 3H), 2.80 (dd, J = 4.4, 13.7 Hz, 1H), 2.29 (ddd, J = 1.5, 10.3, 
13.7 Hz, 1H), 2.10 (qd, J = 7.5, 15.0 Hz, 1H), 1.97 (qd, J = 7.5, 15.0 Hz, 1H), 0.98 ppm 
(t, J = 7.6 Hz, 3H); HRMS (ESI) calcd for C21H26NaO7S [M+Na+] 445.1297, found: 
445.1311. 
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A two-neck flask was flame dried with a cold finger on it and charged with HMDS 
(0.0175 mL, 0.0830 mmol, 5.00 equiv) in 0.5 mL of THF, and 1.60 M hexane solution of 
n-BuLi (0.0520 mL, 0.0830 mmol, 5.00 equiv), successively at –78 °C. 10 minute later 
HMPA (0.0144 mL, 0.0830 mmol, 5.00 equiv) was added to the LiHMDS solution. In 
another 10 minutes, cyanophthalide 2.10 (13.9 mg, 0.0497 mmol, 3.00 equiv) in 0.5 mL 
of THF (plus 2 " 0.3 mL rinse) was cannulated into the reaction mixture to give a bright 
yellow solution. The solution was stirred at –78 °C for 20 min, then enone 2.31 (7.0 mg, 
0.0166 mmol, 1.00 equiv) in 0.5 mL of THF (plus 2 " 0.3 mL rinse) was cannulated to 
the reaction mixture. Stirring was continued at –78 °C for 10 minutes, then the reaction 
system was heated to 50 °C for 20 minutes. After completion of the reaction, the mixture 
was cooled to 23 °C, and quenched with saturated aqueous solution of NH4Cl, and the 
aqueous phase was extracted with dichloromethane (3 " 10 mL). After concentration, the 
crude product was used for the next step without further purification. 
The crude hydroquinone was dissolved in 3 mL of DMF. To the solution was added allyl 
bromide (0.0070 mL, 0.0830 mmol, 5.00 equiv) n-Bu4NI (6.1 mg, 0.0166 mmol, 1.00 
equiv), and Cs2CO3 (16.2 mg, 0.0498 mmol, 3.00 equiv), successively. The 
heterogeneous mixture was stirred at 23 °C for 2 hours. After completion of the reaction, 
the reaction system was quenched with saturated aqueous solution of NH4Cl (5 mL), and 
the aqueous phase was extracted with dichloromethane (3 " 5 mL). The combined 
organic layer was dried over anhydrous Na2SO4 and concentrated. The crude product was 
purified by flash column chromatography (EtOAc/hexane = 1/2) to provide bisallyl ether 
2.32 (4.0 mg, 0.00531 mmol, 32% over two steps) as bright yellow foam. 1H NMR (500 
MHz, CDCl3) ! = 8.00 (d, J = 7.8 Hz, 2H), 7.74 - 7.68 (m, 1H), 7.65 - 7.58 (m, 2H), 7.21 
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(d, J = 8.8 Hz, 1H), 7.11 (d, J = 8.8 Hz, 1H), 6.14 (ddd, J = 5.4, 11.0, 16.8 Hz, 1H), 5.51 
- 5.43 (m, 1H), 5.40 - 5.21 (m, 3H), 5.20 - 5.11 (m, 2H), 4.89 - 4.77 (m, 2H), 4.61 - 4.38 
(m, 4 H), 4.24 (d, J = 6.3 Hz, 1H), 3.87 - 3.81 (m, 1H), 3.70 (d, J = 6.3 Hz, 1H), 3.66 - 
3.60 (m, 2H), 3.55 (s, 3H), 3.51 (s, 3H), 3.49 - 3.45 (m, 2H), 3.33 (s, 3H), 2.82 (dd, J = 
3.9, 13.7 Hz, 1H), 2.38 - 2.29 (m, 1H), 2.05 (q, J = 7.3 Hz, 2H), 0.97 ppm (t, J = 7.3 Hz, 
3H); HRMS (ESI) calcd for C39H47O13S [M+H+] 755.2737, found: 755.2761. 
 
To the solution of ketone 1.101 (48.0 mg, 0.0734 mmol, 1.00 equiv) in 0.5 mL of MeOH 
was added NaBH4 (28.0 mg, 0.734 mmol, 10.0 equiv). In 5 minutes, the starting material 
was fully consumed. Then the mixture was quenched with water (2 mL), and the aqueous 
phase was extracted with diethyl ether (3 " 5 mL). The combined organic layer was dried 
over anhydrous MgSO4 and filtered through celite. The crude product was purified by 
flash column chromatography (EtOAc/hexane = 1/2 to 2/1) to provide diol 2.3 (24.1 mg, 
0.0499 mmol, 68%). The product was identical to the previously prepared compound in 
all aspects. 
 
To the solution of ketone 1.101 (15.8 mg, 0.0241 mmol, 1.00 equiv) in 0.5 mL of MeOH 
was added NaBH4 (4.6 mg, 0.121 mmol, 5.00 equiv). In 5 minutes, the starting material 
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was fully consumed. Then the mixture was quenched with anhydrous acetone (2 mL), 
and the mixture was warmed to 23 °C. The volatiles were removed under reduced 
pressure, and the resulting suspension was quenched with 2 mL of water. The aqueous 
phase was extracted with diethyl ether (3 " 5 mL). The combined organic layer was dried 
over anhydrous MgSO4 and filtered through celite. The crude product was purified by 
flash column chromatography (EtOAc/hexane = 1/2) to provide methyl ester 2.35 (8.5 
mg, 0.0169 mmol, 70%). 1H NMR (500 MHz, CDCl3) ! = 7.90 (d, J = 7.8 Hz, 2H), 7.70 - 
7.65 (m, 1H), 7.61 - 7.56 (m, 2H), 4.40 (dd, J = 3.7, 8.1 Hz, 1H), 4.19 (d, J = 8.8 Hz, 
1H), 4.10 - 4.04 (m, 1H), 3.70 (s, 3H), 3.43 (dd, J = 4.4, 7.8 Hz, 1H), 3.36 - 3.28 (m, 1H), 
3.04 (d, J = 3.9 Hz, 1H), 2.49 (dd, J = 2.9, 14.2 Hz, 1H), 2.27 (dd, J = 8.3, 14.2 Hz, 1H), 
2.18 - 2.06 (m, 2H), 1.74 (q, J = 7.3 Hz, 2H), 0.91 (t, J = 7.6 Hz, 3H), 0.76 (s, 9 H), -0.10 
(s, 3H), -0.35 ppm (s, 3H); HRMS (ESI) calcd for C25H39O7SSi [M+H+] 511.2186, found: 
511.2205. 
 
A round bottomed flask was charged with NaBH4 (654 mg, 17.3 mmol, 2.00 equiv). Then 
allyl alcohol (15 mL) was added to give a turbid suspension. After cooling to –78 °C, a 
solution of oxazolidinone 1.101 (5.65 g, 8.64 mmol, 1.00 equiv) in 10 mL of diethyl ether 
(plus 2 " 2 mL rinse) was cannulated to the reaction mixture. 5 minutes later, the pale 
yellow suspension was quenched with 20 mL of anhydrous acetone at –78 °C, then 
warmed to room temperature over 15 minutes. Volatiles were removed under reduced 
pressure and the residue was quenched with 50 mL of water. Then the aqueous phase was 
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extracted with diethyl ether (3 ! 50 mL) and the combined organic layers were dried over 
MgSO4. After concentration, the crude product was purified by flash column 
chromatography (EtOAc/hexane = 1/4) to give allyl ester 2.36 (4.13 g, 7.69 mmol, 89%) 
as a colorless oil. 1H NMR (500 MHz, CDCl3) !  = 7.88 (d, J = 7.8 Hz, 2H), 7.66 (t, J = 
7.6 Hz, 1H), 7.56 (t, J = 7.8 Hz, 2H), 5.88 (dddd, J = 16.9, 11.0, 5.6, 5.6 Hz, 1H), 5.17 - 
5.38 (m, 2H), 4.58 (d, J = 5.4 Hz, 2H), 4.37 (dd, J = 7.6, 3.7 Hz, 1H), 4.13 - 4.22 (m, 
1H), 4.04 (d, J = 4.4 Hz, 1H), 3.41 (dd, J = 7.6, 4.6 Hz, 1H), 3.29 (d, J = 8.3 Hz, 1H), 
3.05 (ddd, J = 8.3, 8.3, 3.9 Hz, 1H), 2.47 (dd, J = 14.2, 2.9 Hz, 1H), 2.27 (dd, J = 14.4, 
8.1 Hz, 1H), 2.05 - 2.16 (m, 2H), 1.73 (q, J = 7.7 Hz, 2H), 0.90 (t, J = 7.3 Hz, 3H), 0.74 
(s, 9H), -0.12 (s, 3H), -0.37 ppm (s, 3H); 13C NMR (125 MHz, CDCl3) ! = 174.0, 140.2, 
134.0, 131.7, 129.5, 128.2, 118.6, 97.6, 90.3, 73.5, 72.1, 67.0, 65.5, 55.4, 48.1, 39.8, 30.4, 
27.6, 25.7, 17.7, 8.1, -4.7, -5.8 ppm; HRMS (ESI) calcd for C27H44NO7Si [M+NH4+] 
554.2602, found: 554.2616. 
 
To the solution of allyl ester 2.36 (3.48 g, 6.48 mmol, 1.00 equiv) in 10 mL of 
dichloromethane was added pyridine (1.20 mL, 9.72 mmol, 1.50 equiv), followed by 
trimethylacetyl chloride (1.05 mL, 13.0 mmol, 2.00 equiv). The mixture was heated 
under reflux for 24 hours. After completion of the reaction, the mixture was quenched 
with saturated aqueous NH4Cl solution (10 mL), and the aqueous phase was extracted 
with diethyl ether (3 ! 20 mL). The combined organic layers were dried over MgSO4 and 
concentrated. The crude product was purified by flash column chromatography 
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(EtOAc/hexane = 1/10 to 1/8). 
To the solution of the trimethylacetyl ester in 25 mL of THF was added 1.0 M TBAF 
solution in THF (7.78 mL, 7.78 mmol, 1.20 equiv) at room temperature. 16 hours later, 
the mixture was quenched with saturated aqueous NH4Cl solution (20 mL), and the 
aqueous phase was extracted with diethyl ether (3 ! 50 mL). Then the combined organic 
layers were dried over MgSO4. The crude product was purified by flash column 
chromatography (EtOAc/hexane = 1/4 to 1/3) to give compound 2.37 (2.99 g, 5.90 mmol, 
91% over two steps) as a colorless oil. 1H NMR (500 MHz, CDCl3) ! = 7.85 - 7.93 (m, 
2H), 7.66 (d, J = 7.3 Hz, 1H), 7.57 (t, J = 8.0, 8.0 Hz, 2H), 5.82 - 5.92 (m, 1H), 5.20 - 
5.32 (m, 2H), 4.87 (dd, J = 10.1, 3.9 Hz, 1H), 4.52 - 4.63 (m, 2H), 4.17 (dd, J = 8.7, 6.4 
Hz, 1H), 3.99 (dd, J = 6.2, 1.6 Hz, 1H), 3.45 (dd, J = 8.7, 6.2 Hz, 1H), 3.07 (ddd, J = 
10.0, 7.0, 7.0 Hz, 1H), 2.54 (dd, J = 14.0, 3.9 Hz, 1H), 2.17 - 2.26 (m, 2H), 1.98 (dd, J = 
14.4, 10.3 Hz, 1H), 1.87 (br. s, 1H), 1.74 (q, J = 7.6 Hz, 2H), 1.27 (s, 9H), 0.87 ppm (t, J 
= 7.4 Hz, 3H); 13C NMR (125 MHz, CDCl3) ! = 178.2, 172.9, 140.0, 133.9, 131.7, 129.3, 
128.1, 118.5, 94.1, 89.8, 72.5, 72.3, 66.8, 65.5, 52.5, 47.1, 38.7, 36.5, 29.4, 27.2, 27.1, 7.7 
ppm; HRMS (ESI) calcd for C26H35O8S [M+H+] 507.2047, found: 507.2046. 
 
To a solution of oxalyl chloride (1.54 mL, 17.7 mmol, 3.00 equiv) in dichloromethane 
(30 mL) was added DMSO (1.26 mL, 17.7 mmol, 3.00 equiv) over a 5-minute period at –
78 °C. Gas evolution was observed. 30 minutes later, a solution of alcohol 2.37 (2.99 g, 
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5.90 mmol, 1.00 equiv) in 15 mL of dichloromethane (plus 2 ! 5 mL rinse) was 
cannulated to the reaction mixture over a 5-minute period. After stirring for 30 minutes, 
Et3N (4.11 mL, 29.5 mmol, 5.00 equiv) was added in one portion to give a white 
suspension. The reaction system was warmed to room temperature over 30 minutes and 
diluted with 50 mL of diethyl ether. The resulting slurry was filtered through a pad of 
celite/florisil and the filter cake was washed with diethyl ether. After concentration, the 
crude $-chloro #-keto ester 2.39 was used for the next step without further purification. 
The $-chloro #-keto ester 2.39 was dissolved in acetic acid (20 mL) and to the solution 
was added zinc dust at room temperature. The heterogeneous mixture was vigorously 
stirred for 2 hours, then diluted with dichloromethane (20 mL) before being filtered 
through a celite pad. After concentration under reduced pressure, the mixture was 
azeotroped with toluene to further remove residual acetic acid. The crude product was 
purified by flash column chromatography (EtOAc/hexane = 1/5 to 1/3) to give #-keto 
ester 2.40 (2.85 g, 5.66 mmol, 96% over two steps) as a colorless oil. 
To a solution of #-keto ester 2.40 (10.1 g, 20.0 mmol, 1.00 equiv) in 60 mL of toluene 
was added acetic acid (5.72 mL, 100 mmol, 5.00 equiv), PdCl2(PPh3)2 (702 mg, 1.00 
mmol, 0.050 equiv), and n-Bu3SnH (5.92 mL, 22.0 mmol, 1.10 equiv), successively at 0 
°C. After full conversion to the corresponding #-keto acid, the mixture was heated to 
reflux for 30 minutes. After completion of the decarboxylation, volatiles were removed 
under reduced pressure and the crude product was purified by flash column 
chromatography (EtOAc/hexane = 1/7 to 1/5) to give ketone 2.41 (7.15 g, 17.0 mmol, 
85%) as a white foam. 1H NMR (500 MHz, CDCl3) ! = 7.89 (dd, J = 8.0, 1.1 Hz, 2H), 
7.68 (tt, J = 7.3, 1.0 Hz, 1H), 7.59 (t, J = 7.8, 7.8 Hz, 2H), 4.97 (dd, J = 10.3, 3.4 Hz, 
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1H), 3.48 (dd, J = 5.0, 1.8 Hz, 1H), 3.42 (d, J = 5.0 Hz, 1H), 2.60 (dd, J = 14.2, 3.2 Hz, 
1H), 2.44 (dd, J = 10.3, 6.2 Hz, 2H), 2.31 (ddd, J = 14.3, 10.2, 2.1 Hz, 1H), 2.12 - 2.26 
(m, 2H), 1.96 (qd, J = 7.5, 1.8 Hz, 2H), 1.30 (s, 9H), 0.95 ppm (t, J = 7.6 Hz, 3H); 13C 
NMR (125 MHz, CDCl3) ! = 213.9, 178.1, 140.0, 134.0, 129.3, 128.1, 92.5, 91.4, 72.8, 
71.1, 54.2, 38.8, 36.8, 36.5, 27.2, 27.1, 23.2, 8.0 ppm; HRMS (ESI) calcd for 
C22H32NO6S [M+NH4+] 438.1945, found: 438.1902. 
 
LiHMDS solution was generated by adding n-BuLi (2.36 M in hexanes, 3.85 mL, 
9.08mmol, 1.10 equiv) to a solution of HMDS (1.92 mL, 9.08 mmol, 1.10 equiv) in 70 
mL of THF and stirring for 40 minutes at –78 °C. Then a solution of ketone 2.41 (3.47g, 
8.25 mmol, 1.00 equiv) in 25 mL of THF (plus 2 ! 5 mL rinse) was cannulated to the 
reaction mixture to give a pale yellow solution. After stirring for 30 minutes, a solution of 
phenylselenyl bromide (2.14 g, 9.08 mmol, 1.10 equiv) in 10 mL of THF was cannulated 
to the reaction mixture to give a deep yellow solution. In 5 minutes, the reaction was 
quenched with saturated aqueous NH4Cl, and the aqueous phase was extracted with 
diethyl ether (3 ! 50 mL). The crude selenide was concentrated under reduced pressure 
and was dissolved in 1:1 dichloromethane/THF. After cooling to 0 °C, a 30 wt% aqueous 
solution of H2O2 (1.85 mL, 18.2 mmol, 2.20 equiv) was added. The mixture was stirred at 
0 °C for 4 hours then quenched with a 0.1 M aqueous solution of Na2S2O3 (30 mL). The 
aqueous phase was extracted with diethyl ether (3 ! 50 mL) and the combined organic 
layers were dried with MgSO4. The crude enone was purified by flash column 
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chromatography (EtOAc/hexane = 1/7 to 1/5) to give enone 2.42 (2.52 g, 6.02 mmol, 
73%) as a colorless oil. 1H NMR (500 MHz, CDCl3) ! = 7.92 (dd, J = 8.5, 1.1 Hz, 2H), 
7.72 (tt, J = 7.8, 1.0 Hz, 1H), 7.62 (dd, J = 8.2, 8.2 Hz, 2H), 7.45 (d, J = 5.5 Hz, 1H), 6.14 
(d, J = 5.5 Hz, 1H), 5.23 (dd, J = 10.3, 3.9 Hz, 1H), 3.64 (d, J = 6.9 Hz, 1H), 3.60 (dd, J 
= 6.4, 1.4 Hz, 1H), 2.82 (dd, J = 14.0, 3.9 Hz, 1H), 2.43 (ddd, J = 14.2, 10.1, 1.8 Hz, 1H), 
2.09 (dq, J = 15.0, 7.4 Hz, 1H), 1.98 (dq, J = 14.9, 7.4 Hz, 1H), 1.27 (s, 9H), 0.99 ppm (t, 
J = 7.3 Hz, 3H); 13C NMR (125 MHz, CDCl3) ! = 202.8, 178.3, 152.5, 140.0, 138.6, 
134.1, 129.4, 128.2, 95.0, 91.8, 72.6, 68.3, 52.2, 38.8, 37.3, 27.8, 27.1, 7.9 ppm; HRMS 
(ESI) calcd for C22H27O6S [M+H+] 419.1523, found: 419.1514. 
 
LiHMDS-HMPA solution was prepared in a two neck flask equipped with a cold finger 
by mixing 1.60 M hexane solution of n-BuLi (0.0520 mL, 0.0832 mmol, 1.20 equiv), 
HMDS (0.0176 mL, 0.0832 mmol, 1.20 equiv), and HMPA (0.0145 mL, 0.0832 mmol, 
1.20 equiv) in 1.0 mL of THF at –78 °C. 20 minutes later, cyanophthalide 2.10 (23.0 mg, 
0.0832 mmol, 1.20 equiv) in 0.5 mL of THF (plus 0.5 mL rinse) was cannulated to the 
LiHMDS-HMPA solution to give a bright yellow solution. 30 minutes later, enone 2.42 
(29.0 mg, 0.0693 mmol, 1.00 equiv) in 1 mL of THF (plus 0.5 mL rinse) was cannulated 
to the reaction mixture at –78 °C. The mixture was stirred at –78 °C for 30 minutes, and 
warmed to 23 °C over 30 minutes. Then the flask was heated to 50 °C for 20 minutes. 
The mixture was cooled to 23 °C and quenched with saturated aqueous solution of 
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NH4Cl, and the aqueous phase was extracted with dichloromethane (3 " 5 mL). The 
combined organic layer was dried over anhydrous Na2SO4 and concentrated. The crude 
product was purified by flash column chromatography (EtOAc/hexane = 1/2 to 1.5/1) to 
provide hydroquinone 2.43 (39.5 mg, 0.0589 mmol, 85%). 1H NMR (500 MHz, CDCl3) ! 
= 10.17 (s, 1H), 9.52 (s, 1H), 7.98 (d, J = 7.8 Hz, 2H), 7.71 (d, J = 7.8 Hz, 1H), 7.67 - 
7.59 (m, 2H), 7.19 (d, J = 8.8 Hz, 1H), 7.02 (d, J = 8.8 Hz, 1H), 6.20 (dd, J = 3.7, 10.0 
Hz, 1H), 5.39 - 5.34 (m, 2H), 5.32 (s, 2H), 4.15 (d, J = 6.3 Hz, 1H), 3.79 (d, J = 5.9 Hz, 
1H), 3.56 (s, 3H), 3.52 (s, 3H), 2.75 (dd, J = 3.4, 14.2 Hz, 1H), 2.58 (d, J = 11.7 Hz, 1H), 
2.20 (dd, J = 7.6, 14.9 Hz, 1H), 2.11 - 2.00 (m, 1H), 1.23 (s, 9 H), 1.01 ppm (t, J = 7.3 
Hz, 3H); HRMS (ESI) calcd for C34H42NO12S [M+NH4+] 688.2428, found: 688.2422. 
 
To the solution of hydroquinone 2.43 (10.0 mg, 0.0150 mmol, 1.00 equiv) and PPh3 (11.8 
mg, 0.0450 mmol, 3.00 equiv) in 0.8 mL of THF were added allyl alcohol (0.0031 mL, 
0.0450 mmol, 3.00 equiv) and DIAD (0.0089 mL, 0.0450 mmol, 3.00 equiv) at 23 °C. 
The reaction flask was attached to a cold finger, then the mixture was heated to 50 °C for 
1 hour. After completion of the reaction, the mixture was concentrated under reduced 
pressure. The crude product was purified by flash column chromatography 
(EtOAc/hexane = 1/5 to 1/10) to provide bisallyl ether 2.44 (10.0 mg, 0.0133 mmol, 
89%). 1H NMR (500 MHz, CDCl3) ! = 7.97 (d, J = 7.8 Hz, 2H), 7.71 (d, J = 7.3 Hz, 1H), 
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7.66 - 7.60 (m, 2H), 7.24 (d, J = 8.8 Hz, 1H), 7.14 (d, J = 8.3 Hz, 1H), 6.15 (dd, J = 5.9, 
11.2 Hz, 2H), 6.08 (dd, J = 3.7, 10.0 Hz, 1H), 5.45 (d, J = 17.1 Hz, 1H), 5.39 - 5.30 (m, 
2H), 5.24 (d, J = 10.3 Hz, 1H), 5.20 - 5.14 (m, 4 H), 4.98 (s, 1H), 4.55 (d, J = 5.4 Hz, 
1H), 4.49 (dd, J = 6.3, 10.7 Hz, 1H), 4.45 (d, J = 3.9 Hz, 2H), 4.17 (d, J = 6.3 Hz, 1H), 
3.75 (d, J = 5.9 Hz, 1H), 3.55 (s, 3H), 3.52 (s, 3H), 2.73 (dd, J = 3.4, 14.2 Hz, 1H), 2.57 
(d, J = 10.7 Hz, 1H), 2.07 - 1.98 (m, 2H), 1.19 (s, 9 H), 0.97 ppm (t, J = 7.3 Hz, 3H); 
HRMS (ESI) calcd for C40H47O12S [M+H+] 751.2788, found: 751.2801. 
 
To the solution of ester 2.44 (26.7 mg, 0.0356 mmol, 1.00 equiv) in 1 mL of 
dichloromethane was added 1.0 M toluene solution of DIBAL-H (0.0710 mL, 0.0710 
mmol, 2.00 equiv) at –78 °C. After stirring for 2 hours, the mixture was quenched with 
saturated aqueous solution of potassium sodium tartrate (2 mL) and warmed to 23 °C. 
After stirring for 1 hour, the aqueous phase was extracted with dichloromethane (3 " 5 
mL), and the combined organic layer was dried over anhydrous Na2SO4. After 
concentration, the crude diol 2.45 was used for the next step without further purification. 
To the solution of oxalyl chloride (0.0310 mL, 0.356 mmol, 10.0 equiv) in 1.5 mL of 
dichloromethane was added DMSO (0.0250 mL, 0.356 mmol, 10.0 equiv) at –78 °C. 30 
minutes later, diol 2.45 in 1 mL of dichloromethane (plus 2 " 0.5 mL rinse) was 
cannulated to the reaction mixture. 1 hour later, Et3N (0.0740 mL, 0.534 mmol, 15 equiv) 
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was added in one portion, and the reaction system was warmed to 23 °C over 1 hour. The 
mixture was diluted with 5 mL of diethyl ether and filtered over a fluorisil pad. After 
concentration, the crude product was purified by flash column chromatography 
(EtOAc/hexane = 1/4 to 1/3) to provide ketone 2.46 (14.0 mg, 0.0210 mmol, 59% over 
two steps). 1H NMR (500 MHz, CDCl3) ! = 7.95 (d, J = 7.6 Hz, 2H), 7.77 - 7.71 (m, 1H), 
7.67 - 7.61 (m, 2H), 7.29 - 7.25 (m, 1H), 7.16 (d, J = 8.7 Hz, 1H), 6.16 - 6.01 (m, 2H), 
5.42 - 5.30 (m, 2H), 5.26 - 5.12 (m, 6 H), 4.63 (dd, J = 5.2, 11.6 Hz, 1H), 4.53 - 4.45 (m, 
2H), 4.38 (dd, J = 5.3, 11.4 Hz, 1H), 3.84 (d, J = 5.5 Hz, 1H), 3.58 (d, J = 5.5 Hz, 1H), 
3.55 (s, 3H), 3.52 (s, 3H), 2.74 (d, J = 17.9 Hz, 1H), 2.22 - 2.22 (m, 1H), 2.26 - 2.19 (m, 
1H), 1.06 ppm (t, J = 7.3 Hz, 3H); 13C NMR (125 MHz, CDCl3) ! = 202.7, 194.8, 152.0, 
151.4, 150.1, 149.2, 139.4, 134.4, 133.9, 133.8, 129.6, 128.3, 128.1, 126.9, 126.2, 126.1, 
118.1, 117.8, 116.7, 115.8, 97.5, 97.0, 92.6, 90.7, 76.9, 76.9, 68.4, 59.6, 56.5, 56.5, 45.1, 
36.6, 29.7, 27.8, 24.7, 7.9 ppm; HRMS (ESI) calcd for C35H37O11S [M+H+] 665.2057, 
found: 665.2059. 
 
LiHMDS-HMPA solution was prepared in a two neck flask equipped with a cold finger 
by mixing 0.80 M hexane solution of n-BuLi (0.266 mL, 0.213 mmol, 1.05 equiv), 
HMDS (0.047.1 mL, 0.223 mmol, 1.10 equiv), and HMPA (37.1 µL, 0.213 mmol, 1.05 
equiv) in 2.5 mL of THF at –78 °C. 20 minutes later, cyanophthalide 2.58 (46.7 mg, 
0.213 mmol, 1.05 equiv) in 1.5 mL of THF (plus 0.5 mL rinse) was cannulated to the 
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LiHMDS-HMPA solution to give a bright yellow solution. 30 minutes later, enone 2.42 
(85.0 mg, 0.203 mmol, 1.00 equiv) in 1 mL of THF (plus 0.5 mL rinse) was cannulated to 
the reaction mixture at –78 °C. The mixture was stirred at –78 °C for 30 minutes, and 
warmed to 23 °C over 30 minutes. Then the flask was heated to 50 °C for 20 minutes. 
The mixture was cooled to 23 °C and quenched with saturated aqueous solution of 
NH4Cl, and the aqueous phase was extracted with dichloromethane (3 " 5 mL). The 
combined organic layer was dried over anhydrous Na2SO4 and concentrated. The crude 
product was purified by flash column chromatography (EtOAc/hexane = 1/1 to 2/1) to 
provide hydroquinone 2.59 (111 mg, 0.172 mmol, 85%). 1H NMR (500 MHz, CDCl3) ! 
= 10.18 (s, 1H), 9.54 (s, 1H), 7.97 (d, J = 7.6 Hz, 2H), 7.73 - 7.65 (m, 1H), 7.64 - 7.57 
(m, 2H), 6.77 (d, J = 8.7 Hz, 1H), 6.67 (d, J = 8.7 Hz, 1H), 6.20 (dd, J = 3.3, 10.0 Hz, 
1H), 4.12 (d, J = 6.2 Hz, 1H), 3.96 (s, 3H), 3.95 (s, 3H), 3.78 (d, J = 6.0 Hz, 1H), 2.74 
(dd, J = 3.4, 14.0 Hz, 1H), 2.61 - 2.50 (m, 1H), 2.17 (td, J = 7.4, 14.8 Hz, 1H), 2.10 - 1.99 
(m, 1H), 1.22 (s, 9H), 1.01 ppm (t, J = 7.3 Hz, 3H); 13C NMR (125 MHz, CDCl3) ! = 
198.5, 178.0, 153.0, 151.2, 147.7, 145.4, 140.1, 133.9, 129.2, 128.2, 128.2, 120.9, 119.3, 
118.7, 118.2, 107.9, 106.0, 92.9, 89.1, 71.4, 68.8, 56.8, 56.6, 55.9, 38.7, 38.5, 27.6, 27.1, 
8.0 ppm; HMRS (ESI) calcd for C32H35O10S [M+H+] 611.1951, found: 611.1988. 
 
To a solution of ketone 2.59 (26.3 mg, 0.0430 mmol, 1.00 equiv) in 1 mL of 
dichloromethane was added 1,2-bis(trimethylsilyloxy)ethane (0.0211 mL, 0.0860 mmol, 
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2.00 equiv), followed by TMSOTf (0.0078 mL, 0.0430 mmol, 1.00 equiv) at 23 °C. The 
reaction was vigorously stirred for 36 hours. Upon completion of the reaction, the 
mixture was quenched with saturated aqueous NaHCO3 at 0 °C and the aqueous phase 
was extracted with dichloromethane (3 " 5 mL). The combined organic layers were dried 
over Na2SO4 and the crude product was purified by flash column chromatography 
(EtOAc/hexane = 1/1.5 to 1/1) to give dioxolane 2.60 (21.4 mg, 0.0327 mmol, 76%) as a 
pale yellow solid. 1H NMR (500 MHz, CDCl3) ! = 9.56 (s, 1H), 9.48 (s, 1H), 8.02 (d, J = 
7.6 Hz, 2H), 7.72 - 7.65 (m, 1H), 7.63 - 7.56 (m, 2H), 6.62 - 6.56 (m, 2H), 6.21 (dd, J = 
3.3, 10.2 Hz, 1H), 4.20 - 4.03 (m, 4 H), 3.94 (s, 3H), 3.93 (s, 3H), 3.30 - 3.22 (m, 1H), 
3.03 - 2.96 (m, 1H), 2.72 (dd, J = 3.3, 13.8 Hz, 1H), 2.52 - 2.42 (m, 1H), 2.16 - 2.06 (m, 
1H), 2.03 - 1.95 (m, 1H), 1.21 (s, 9 H), 1.05 ppm (t, J = 7.3 Hz, 3H); 13C NMR (125 
MHz, CDCl3) ! = 178.3, 151.5, 151.5, 145.2, 142.7, 141.0, 133.5, 129.1, 128.8, 127.5, 
118.6, 117.7, 116.7, 113.2, 104.7, 104.1, 92.6, 91.8, 71.3, 67.3, 65.6, 56.6, 56.3, 55.0, 
38.7, 38.2, 36.6, 29.7, 27.6, 27.1, 24.6, 8.0 ppm; HRMS (ESI) calcd for C34H38NaO11S 
[M+Na+] 677.2027, found: 677.2044. 
 
To a solution of hydroquinone 2.60 (20.3 mg, 0.0310 mmol, 1.00 equiv) in 0.6 mL of 
DMF was added allyl bromide (0.0027 mL, 0.310 mmol, 10.0 equiv), followed by 
Cs2CO3 (30.3 mg, 0.0930 mmol, 3.00 equiv). The resulting red solution was vigorously 
stirred for 2 hours, then the reaction was quenched with saturated aqueous NH4Cl, and 
O Et
SO2Ph
MeO
MeO
HO
HO
O
O
H
PivO
O Et
SO2Ph
MeO
MeO
O
O
O
O
H
PivO
2.60 2.61
  Appendix 1 
 
 148!
the aqueous phase was extracted with dichloromethane (3 " 5 mL). After drying over 
Na2SO4 and concentrating under reduced pressure, the crude product was purified by 
flash column chromatography (EtOAc/hexane = 1/3) to give bisallyl ether 2.61 (19.8 mg, 
0.0270 mmol, 87%) as a pale yellow foam. 1H NMR (500 MHz, CDCl3) ! = 8.00 (d, J = 
7.6 Hz, 2H), 7.70 - 7.64 (m, 1H), 7.63 - 7.55 (m, 2H), 6.78 (s, 2H), 6.23 - 6.07 (m, 2H), 
6.02 (dd, J = 2.5, 9.8 Hz, 1H), 5.40 (dd, J = 8.7, 17.2 Hz, 2H), 5.28 (d, J = 10.5 Hz, 1H), 
5.20 (d, J = 10.5 Hz, 1H), 4.46 - 4.37 (m, 3H), 4.36 - 4.30 (m, 1H), 4.14 - 4.05 (m, 3H), 
4.01 (d, J = 5.3 Hz, 1H), 3.86 (s, 3H), 3.81 (s, 3H), 3.23 (br. s, 1H), 2.98 (br. s, 1H), 2.65 
(dd, J = 2.7, 14.0 Hz, 1H), 2.56 - 2.46 (m, 1H), 1.98 (q, J = 7.1 Hz, 2H), 1.19 (s, 9 H), 
1.02 ppm (t, J = 7.2 Hz, 3H); 13C NMR (125 MHz, CDCl3) ! = 177.8, 150.8, 150.7, 
150.3, 148.1, 140.8, 135.7, 135.1, 134.0, 133.6, 129.1, 128.6, 128.2, 125.1, 124.8, 117.4, 
115.8, 113.3, 108.0, 107.5, 92.7, 91.8, 77.6, 76.6, 71.7, 69.1, 66.7, 65.4, 57.0, 56.8, 54.9, 
38.6, 36.8, 29.6, 27.6, 27.1, 8.1 ppm; HRMS (ESI) calcd for C40H46NaO11S [M+Na+] 
757.2653, found: 757.2748. 
 
The trimethylacetyl ester 2.61 (9.2 mg, 0.0125 mmol, 1.00 equiv) was dissolved in 1 mL 
of THF and cooled to 0 °C. To the solution was added 1.0 M NaBHEt3 solution in THF 
(0.0625 mL, 0.0625 mmol, 5.00 equiv) via syringe. The mixture was vigorously stirred at 
0 °C for 2 hours. After completion of the reaction, the mixture was quenched with 
saturated aqueous NH4Cl and the aqueous phase was extracted with dichloromethane (3 " 
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1 mL). After drying over Na2SO4 and concentrating under reduced pressure, the crude 
product was purified by flash column chromatography (EtOAc/hexane = 1/2 to 1/1.5) to 
give the corresponding alcohol as a white foam. 
A flask was charged with the alcohol, TPAP (0.2 mg, 0.000630 mmol, 0.0500 equiv), 
NMO (2.2 mg, 0.0188 mmol, 1.50 equiv), and 4 Å MS (5 mg), then 0.5 mL of 
dichloromethane was added. The reaction was vigorously stirred at room temperature for 
2 hours. After completion of the reaction, the mixture was diluted with 3 mL of diethyl 
ether and the resulting suspension was filtered through a pad of celite. After 
concentration, the crude product was purified by flash column chromatography 
(EtOAc/hexane = 1/3 to 1/2) to give ketone 2.62 (7.3 mg, 0.0113 mmol, 90% over two 
steps) as a white solid. 1H NMR (500 MHz, CDCl3) ! = 8.00 (d, J = 7.6 Hz, 2H), 7.74 - 
7.67 (m, 1H), 7.65 - 7.59 (m, 2H), 6.84 - 6.77 (m, 2H), 6.17 - 6.01 (m, 2H), 5.42 - 5.30 
(m, 2H), 5.24 - 5.16 (m, 2H), 4.53 (dd, J = 5.3, 11.4 Hz, 1H), 4.42 - 4.36 (m, 1H), 4.33 
(d, J = 5.5 Hz, 1H), 4.31 (d, J = 5.7 Hz, 1H), 4.12 - 4.06 (m, 1H), 4.05 - 3.98 (m, 2H), 
3.86 (s, 3H), 3.83 (s, 3H), 3.54 (d, J = 5.3 Hz, 1H), 3.42 (d, J = 17.9 Hz, 1H), 3.26 (d, J = 
6.4 Hz, 1H), 2.77 (q, J = 6.0 Hz, 1H), 2.70 (dd, J = 1.0, 17.7 Hz, 1H), 2.36 - 2.25 (m, 
1H), 2.25 - 2.17 (m, 1H), 1.12 ppm (t, J = 7.4 Hz, 3H); 13C NMR (125 MHz, CDCl3) ! = 
204.3, 151.0, 150.8, 150.1, 148.1, 140.1, 135.6, 135.1, 134.5, 134.0, 129.3, 128.9, 125.6, 
125.1, 123.1, 116.4, 116.0, 113.8, 108.5, 107.9, 93.9, 92.5, 77.2, 76.8, 68.2, 66.8, 65.3, 
58.7, 57.1, 57.0, 44.7, 29.7, 27.9, 8.1 ppm; HRMS (ESI) calcd for C35H37O10S [M+H+] 
649.2102, found: 649.2090. 
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To the cooled (–78 °C) solution of ketone 2.41 (115 mg, 0.273 mmol, 1.00 equiv) in 3 
mL of THF was added 1.0 M THF solution of NaHMDS (0.328 mL, 0.328 mmol, 1.20 
equiv). The mixture was stirred at –78 °C for 1 hour. Then TIPSOTf was added to the 
reaction mixture to give a pale yellow solution. The mixture was stirred at –78 °C for 1.5 
hour before being warmed to 23 °C over 30 minutes. After completion of the reaction, it 
was quenched with saturated aqueous solution of NH4Cl (5 mL), and the aqueous phase 
was extracted with diethyl ether (3 " 5 mL).  After concentration, the crude product was 
purified by flash column chromatography (EtOAc/hexane = 1/20 to 1/10) to provide 
enolsilane 3.2 (156 mg, 0.270 mmol, 99%). 1H NMR (500 MHz, CDCl3) ! = 7.89 (d, J = 
8.0 Hz, 2H), 7.62 (d, J = 7.6 Hz, 1H), 7.57 - 7.51 (m, 2H), 4.92 (dd, J = 3.4, 10.1 Hz, 
1H), 4.49 (br. s, 1H), 4.05 (d, J = 4.8 Hz, 1H), 3.61 (d, J = 4.6 Hz, 1H), 2.61 (dd, J = 3.5, 
14.1 Hz, 1H), 2.52 - 2.45 (m, 1H), 2.36 (dd, J = 2.5, 16.3 Hz, 1H), 2.27 - 2.19 (m, 1H), 
1.78 - 1.69 (m, 2H), 1.02 - 0.94 (m, 21H), 0.86 ppm (t, J = 7.3 Hz, 3H); HRMS (ESI) 
calcd for C31H48NaO6SSi [M+Na+] 599.2839, found: 599.2860. 
 
The trimethylacetyl ester 3.2 (25.0 mg, 0.0430 mmol, 1.00 equiv) was dissolved in 1 mL 
of THF and cooled to 0 °C. To the solution was added 1.0 M NaBHEt3 solution in THF 
O
Et
SO2PhO
OPiv
O
Et
SO2Ph
OPiv
TIPSOH H
2.41 3.2
O
Et
SO2Ph
OPiv
TIPSO
O
Et
SO2PhTIPSO
O
H H
O
Et
SO2Ph
OH
TIPSO H
3.2 3.3
  Appendix 1 
 
 151!
(0.215 mL, 0.215 mmol, 5.00 equiv) via syringe. The mixture was vigorously stirred at 0 
°C for 2 hours. After completion of the reaction, the mixture was quenched with saturated 
aqueous NH4Cl and the aqueous phase was extracted with dichloromethane (3 " 1 mL). 
After drying over Na2SO4 and concentrating under reduced pressure, the crude product 
was purified by flash column chromatography (EtOAc/hexane = 1/5 to 1/4) to give the 
corresponding alcohol as a white foam. 
A flask was charged with the alcohol, TPAP (0.8 mg, 0.00215 mmol, 0.0500 equiv), 
NMO (7.6 mg, 0.0645 mmol, 1.50 equiv), and 4 Å MS (10 mg), then 1 mL of 
dichloromethane was added. The reaction was vigorously stirred at 23 °C for 2 hours. 
After completion of the reaction, the mixture was diluted with 3 mL of diethyl ether and 
the resulting suspension was filtered through a pad of celite. After concentration, the 
crude product was purified by flash column chromatography (EtOAc/hexane = 1/20 to 
1/10) to give ketone 3.3 (19.8 mg, 0.0404 mmol, 94% over two steps) as a white solid. 1H 
NMR (500 MHz, CDCl3) ! = 7.89 (d, J = 7.8 Hz, 2H), 7.67 - 7.62 (m, 1H), 7.58 - 7.53 
(m, 2H), 4.53 (d, J = 1.6 Hz, 1H), 3.68 (d, J = 4.6 Hz, 1H), 3.64 (br. s, 1H), 3.37 (d, J = 
18.1 Hz, 1H), 2.85 (d, J = 16.7 Hz, 1H), 2.45 (d, J = 18.1 Hz, 1H), 2.30 (dd, J = 2.7, 16.7 
Hz, 1H), 2.10 - 2.00 (m, 2H), 1.00 (t, J = 7.4 Hz, 3H), 0.96 - 0.89 ppm (m, 21H); 13C 
NMR (125 MHz, CDCl3) ! = 206.7, 150.8, 140.4, 133.9, 129.4, 128.4, 99.0, 94.9, 88.9, 
67.7, 54.9, 44.9, 27.6, 27.1, 17.8, 17.8, 12.6, 7.7 ppm; HRMS (ESI) calcd for 
C26H39O5SSi [M+H+] 491.2287, found: 491.2266. 
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To the solution of enolsilane 3.3 (10.9 mg, 0.0222 mmol, 1.00 equiv) and Pd(OAc)2 (0.5 
mg, 0.00222 mmol, 0.100 equiv) in 0.5 mL of DMSO was heated to 80 °C under oxygen 
atmosphere. In 9 hours, the mixture was quenched with saturated aqueous soluution of 
NaHCO3 (2 mL) and the aqueous phase was extracted with EtOAc (3 " 5 mL). The 
combined organic layer was washed with water and brine, then the crude product was 
purified by flash column chromatography (EtOAc/hexane = 1/5) to provide enone 1.111 
(5.2 mg, 0.0158 mmol, 71%). The product was identical to the previously prepared 
compound in all aspects. 
 
#-elimination product 3.4 
1H NMR (500 MHz, CDCl3) ! = 7.84 (d, J = 7.3 Hz, 2H), 7.65 - 7.60 (m, 1H), 7.57 - 7.51 
(m, 2H), 5.49 (s, 1H), 4.56 (d, J = 2.3 Hz, 1H), 3.53 - 3.43 (m, 2H), 3.19 (d, J = 8.7 Hz, 
1H), 2.72 (d, J = 16.3 Hz, 1H), 2.57 (td, J = 7.5, 14.6 Hz, 2H), 2.36 (d, J = 16.0 Hz, 1H), 
1.29 (t, J = 7.6 Hz, 3H), 1.02 - 0.90 ppm (m, 21H); HRMS (ESI) calcd for C26H39O5SSi 
[M+H+] 491.2287, found: 491.2295. 
 
To the solution of HMDS (0.0876 mL, 0.415 mmol, 1.67 equiv) in 1 mL of THF was 
added 0.84 M hexane solution of n-BuLi (0.494 mL, 0.415 mmol, 1.67 equiv) and HMPA 
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(0.0722 mL, 0.415 mmol, 1.67 equiv) at –78 °C. 40 minutes later, ketone 3.3 (122 mg, 
0.249 mmol, 1.00 equiv) in 1 mL of THF (plus 0.3 mL rinse) was cannulated. 1 hour 
later, [Cp2Fe]PF6 (247 mg, 0.747 mmol, 3.00 equiv) was added from the solid addition 
adaptor and the reaction system was warmed to –60 °C. 16 hours later, the mixture was 
quenched with saturated aqueous solution of NH4Cl and warmed to 23 °C. The aqueous 
phase was extracted with diethyl ether (3 " 5 mL), and the combined organic layer was 
dried over anhydrous MgSO4. After concentration, the crude product was purified by 
flash column chromatography (EtOAc/hexane = 1/20 to 1/10) to provide dimer 3.5 (69.0 
mg, 0.142 mmol, 57%). 1H NMR (500 MHz, CDCl3) ! = 7.93 (d, J = 7.3 Hz, 2H), 7.68 - 
7.62 (m, 1H), 7.61 - 7.56 (m, 2H), 4.55 (br. s, 1H), 4.08 (s, 1H), 3.92 (d, J = 5.0 Hz, 1H), 
3.68 (d, J = 3.7 Hz, 1H), 2.80 (d, J = 16.7 Hz, 1H), 2.37 - 2.31 (m, 1H), 2.34 - 2.25 (m, 
1H), 1.85 (dd, J = 7.4, 14.8 Hz, 1H), 1.02 - 0.94 (m, 21H), 0.95 - 0.92 ppm (m, 3H); 13C 
NMR (125 MHz, CDCl3) ! = 205.8, 150.8, 140.0, 134.0, 129.5, 128.4, 128.3, 99.3, 93.3, 
90.5, 66.2, 53.8, 48.5, 27.1, 24.2, 17.8, 12.6, 7.7 ppm; HRMS (ESI) calcd for 
C52H78NO10S2Si2 [M+NH4+] 996.4600, found: 996.4600. 
 
To the solution of dimer 3.5 (30.5 mg, 0.0311 mmol, 1.00 equiv) and Pd(OAc)2 (14.0 mg, 
0.0622 mmol, 2.00 equiv) in 3 mL of DMSO was heated to 80 °C under oxygen 
atmosphere. In 16 hours, the mixture was quenched with saturated aqueous soliution of 
NaHCO3 (5 mL) and the aqueous phase was extracted with EtOAc (3 " 10 mL). The 
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combined organic layer was washed with water and brine, then the crude product was 
purified by flash column chromatography (EtOAc/hexane = 1/5) to provide enone 3.8 
(12.5 mg, 0.0183 mmol, 59%). 1H NMR (500 MHz, CDCl3) ! = 7.96 (d, J = 7.8 Hz, 2H), 
7.79 - 7.72 (m, 1H), 7.69 - 7.61 (m, 2H), 7.54 (d, J = 5.7 Hz, 1H), 6.27 (d, J = 5.7 Hz, 
1H), 3.92 (s, 1H), 3.80 (d, J = 6.6 Hz, 1H), 3.69 (d, J = 6.4 Hz, 1H), 3.33 (br. s, 1H), 2.98 
(s, 1H), 2.23 - 1.94 (m, 2H), 1.10 ppm (t, J = 6.9 Hz, 3H); 13C NMR (125 MHz, CDCl3) ! 
= 202.2, 149.6, 140.1, 139.4, 134.4, 129.5, 128.3, 114.2, 95.6, 93.3, 65.6, 54.0, 52.6, 
25.0, 8.4 ppm; HRMS (ESI) calcd for C34H32KO11S2 [M+K+] 719.1018, found: 719.1002. 
 
To the solution of dimer 3.8 (16.9 mg, 0.0248 mmol, 1.00 equiv) was dissolved in 0.2 mL 
of TMSCN. The mixture was heated to 80 °C for 8 hours. Upon completion of the 
reaction, volatiles were removed by azeotroping with toluene. After concentration, the 
crude product was purified by flash column chromatography (EtOAc/hexane = 1/6 to 1/4) 
to provide enone 3.10 (11.9 mg, 0.0144 mmol, 58%). 1H NMR (500 MHz, CDCl3) ! = 
7.96 (d, J = 7.8 Hz, 2H), 7.76 - 7.70 (m, 1H), 7.68 - 7.60 (m, 2H), 7.50 (d, J = 5.4 Hz, 
1H), 6.27 (d, J = 5.9 Hz, 1H), 3.75 (s, 1H), 3.72 (d, J = 6.8 Hz, 1H), 3.62 (d, J = 6.8 Hz, 
1H), 2.01 (dd, J = 7.3, 14.6 Hz, 1H), 1.95 - 1.83 (m, 1H), 1.05 - 0.95 (m, 3H), 0.13 ppm 
(s, 18 H); HRMS (ESI) calcd for C40H48NaO11S [M+Na+] 847.2069, found: 847.2068. 
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Enolsilane 4.2 
1H NMR (600 MHz, CDCl3) ! = 7.99 (d, J = 7.9 Hz, 2H), 7.66 (s, 1H), 7.61 - 7.55 (m, 
2H), 6.86 - 6.82 (m, 1H), 6.81 - 6.77 (m, 1H), 6.20 - 6.07 (m, 2H), 5.37 (dd, J = 10.4, 
17.1 Hz, 2H), 5.14 (s, 1H), 5.22 - 5.13 (m, 2H), 4.48 - 4.37 (m, 2H), 4.36 - 4.30 (m, 1H), 
4.11 - 4.04 (m, 2H), 3.90 (d, J = 4.4 Hz, 1H), 3.85 (s, 3H), 3.84 (s, 3H), 3.48 (d, J = 7.0 
Hz, 1H), 3.30 (d, J = 4.4 Hz, 1H), 3.25 - 3.18 (m, 1H), 3.05 (br. s, 1H), 2.54 - 2.44 (m, 
1H), 2.03 - 1.96 (m, 1H), 1.05 (t, J = 7.2 Hz, 3H), 0.29 ppm (s, 9 H); HRMS (ESI) calcd 
for C38H44NaO10SSi [M+Na+] 743.2322, found: 743.2329. 
#-Elimination product 4.3 
1H NMR (600 MHz, CDCl3) ! = 7.91 (d, J = 7.9 Hz, 2H), 7.68 - 7.64 (m, 1H), 7.59 - 7.53 
(m, 2H), 6.78 (q, J = 8.5 Hz, 2H), 6.17 (td, J = 5.5, 11.3 Hz, 1H), 5.93 (dd, J = 5.6, 11.1 
Hz, 1H), 5.56 (s, 1H), 5.45 (d, J = 17.3 Hz, 1H), 5.31 - 5.23 (m, 2H), 5.15 (d, J = 10.5 
Hz, 1H), 4.49 (dd, J = 5.6, 11.7 Hz, 1H), 4.43 - 4.38 (m, 1H), 4.38 - 4.33 (m, 2H), 4.27 - 
4.20 (m, 2H), 4.07 (q, J = 6.9 Hz, 2H), 3.85 (s, 3H), 3.77 (s, 3H), 3.63 (dd, J = 6.0, 15.7 
Hz, 1H), 3.21 (t, J = 4.8 Hz, 1H), 2.97 (dd, J = 4.2, 15.7 Hz, 1H), 2.55 (q, J = 7.4 Hz, 
2H), 1.29 - 1.23 ppm (m, 3H); HRMS (ESI) calcd for C35H37O10S [M+H+] 649.2107, 
found: 649.2111. 
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To the solution of hydroquinone 2.60 (13.9 mg, 0.0212 mmol, 1.00 equiv) in 0.5 mL of 
THF was added 0.92 M THF solution of NaHMDS (0.0692 mL, 0.0637 mmol, 3.00 
equiv) at –78 °C. In 5 minutes MeOTf (0.0233 mL, 0.212 mmol, 10.0 equiv) was added 
via syringe. 5 minutes later, the mixture was warmed to 23 °C over 10 minutes. The 
reaction mixture was quenched with saturated aqueous solution of NH4Cl, and the 
aqueous phase was extracted with diethyl ether (3 " 2 mL). After concentration, the crude 
product was purified by flash column chromatography (EtOAc/hexane = 1/1). 
The dimethyl hydroquinoe was dissolved in 0.5 mL of THF and mixture was cooled to 0 
°C. To the solution was added 1.0 M THF solution of NaBHEt3 (0.106 mL, 0.106 mmol, 
5.00 equiv) via syringe. In 5 minutes, the mixture was quenched with saturated aqueous 
solution of NH4Cl, and the aqueous phase was extracted with diethyl ether (3 " 2 mL). 
After concentration, the crude product was used for the next step without further 
purification. 
A flask was charged with the alcohol, TPAP (0.4 mg, 0.00106 mmol, 0.05 equiv), NMO 
(5.0 mg, 0.0424 mmol, 2.00 equiv), and 10 mg of 4 Å MS. Then the mixture was 
dissolved in 1 mL of dichloromethane, and the mixture was vigorously stirred at 23 °C. 
In 2 hours the mixture was diluted with 5 mL of diethyl ether and filtered through a pad 
of silica gel. After concentration, the crude product was purified by flash column 
chromatography (EtOAc/hexane = 1/1) to provide ketone 4.10 (5.9 mg, 0.00996 mmol, 
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47% over three steps). 1H NMR (500 MHz, CDCl3) ! = 7.99 (d, J = 8.0 Hz, 2H), 7.73 - 
7.66 (m, 1H), 7.63 - 7.56 (m, 2H), 6.86 - 6.75 (m, 2H), 4.10 - 4.02 (m, 2H), 3.99 (q, J = 
6.6 Hz, 1H), 3.88 (s, 3H), 3.87 (s, 3H), 3.77 (s, 3H), 3.72 (s, 3H), 3.55 (d, J = 5.3 Hz, 
1H), 3.46 (d, J = 17.6 Hz, 1H), 3.41 (br. s, 1H), 3.20 (q, J = 6.7 Hz, 1H), 2.90 (q, J = 6.0 
Hz, 1H), 2.76 (d, J = 17.9 Hz, 1H), 2.25 (tt, J = 7.4, 14.3 Hz, 2H), 1.12 ppm (t, J = 7.3 
Hz, 3H); 13C NMR (125 MHz, CDCl3) ! = 204.6, 151.2, 150.8, 150.6, 149.3, 140.0, 
135.0, 134.0, 129.2, 128.7, 128.2, 125.5, 124.6, 122.6, 113.6, 108.2, 107.5, 93.7, 92.4, 
70.5, 67.7, 66.7, 65.1, 63.7, 63.3, 58.7, 56.9, 56.7, 44.9, 27.7, 26.4, 8.0 ppm; HRMS 
(ESI) calcd for C31H32NaO10S [M+Na+] 619.1608, found: 619.1604. 
 
To the solution of HMDS (0.0193 mL, 0.0915 mmol, 1.70 equiv) in 0.6 mL of THF was 
added 0.71 M hexane solution of n-BuLi (0.129 mL, 0.0915 mmol, 1.70 equiv), followed 
by HMPA (0.0188 mL, 0.108 mmol, 2.00 equiv) at –78 °C. 40 minutes later ketone 4.10 
(32.1 mg, 0.0538 mmol, 1.00 equiv) in 1 mL of THF (plus 2 " 0.5 mL rinse) was 
cannulated to the mixture. The resulting pale yellow solution was vigorously stirred at –
78 °C for 2 hours. Then [Cp2Fe]PF6 (53.4 mg, 0.161 mmol, 3.00 equiv) was added from 
the solid addition adaptor. In 10 minutes the reaction system was warmed to –60 °C and 
stirred for 12 hours. The reaction mixture was quenched with saturated aqueous solution 
of NH4Cl (5 mL), and the aqueous phase was extracted with dichloromethane (3 " 5 mL). 
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After concentration, the crude product was purified by flash column chromatography 
(EtOAc/hexane = 2/1 to 4/1) to provide marginally stable dimer 4.11. HRMS (ESI) cald 
for C62H62NaO20S2 [M+Na+] 1213.3169, found: 1213.3160. 
 
To the solution of 2,3-dimethylhydroquinone (5.00 g, 36.2 mmol, 1.00 equiv) in 100 mL 
of anhydrous acetone was added Me2SO4 (7.55 mL, 79.6 mmol, 2.20 equiv), followed by 
K2CO3 (11.0 g, 79.6 mmol, 2.20 equiv). The suspension was heated to reflux for 12 
hours. Upon completion of the reaction, the mixture was cooled to 23 °C, and volatiles 
were removed under reduced pressure. The resulting suspension was quenched with 100 
mL of water, and the aqueous phase was extracted with diethyl ether (3 " 50 mL). After 
concentration, the crude product was used for the next step without further purification. 
The dimethoxybenzene was dissolved in 50 mL of CCl4 together with NBS (6.44 g, 36.2 
mmol, 1.00 equiv), and AIBN (297 mg, 1.81 mmol, 0.0500 equiv). The mixture was 
heated to reflux for 50 minutes, then cooled to 23 °C. Volatiles were removed under 
reduced pressure, and the resulting suspension was diluted with 100 mL of 1:2 mixture of 
EtOAc and hexane. The suspension was filtered through a pad of silica gel and 
concentrated. The crude product was used for the next step without further purification. 
The arylbromide was dissolved in 80 mL of dioxane and 20 mL of water. To the solution 
was added CaCO3 (7.25 g, 72.4 mmol, 2.00 equiv). The mixture was heated to 50 °C with 
vigorous stirring for 6 hours. After completion of the reaction, the reaction system was 
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quenched with 10% aqueous HCl, and the aqueous phase was extracted with diethyl ether 
(3 " 50 mL). After concentration, the crude product was purified by flash column 
chromatography (EtOAc/hexane = 1/5 to 1/3) to provide alcohol 4.24 (4.02 g, 22.1 mmol, 
61% over three steps). 1H NMR (500 MHz, CDCl3) ! = 6.80 - 6.65 (m, 2H), 4.76 (d, J = 
6.8 Hz, 2H), 3.82 (s, 3H), 3.78 (s, 3H), 2.27 ppm (s, 3H); HRMS (ESI) calcd for 
C10H15O3 [M+H+] 183.1021, found: 183.1022. 
 
Alcohol 4.24 (6.33 g, 34.7 mmol, 1.00 equiv), TPAP, (610 mg, 1.74 mmol, 0.0500 
equiv), NMO (6.10 g, 52.1 mmol, 1.50 equiv), and 17.4 g of 4 Å MS were charged in a 
flask. The mixture was dissolved in 100 mL of dichloromethane, and the reaction mixture 
was vigorously stirred for 2 hours. After completion of the reaction, the reaction system 
was diluted with 100 mL of diethyl ether, and filter over a pad of silica gel. After 
concentration, the crude product was used for the next step without further purification. 
The aldehyde was dissolved in 100 mL of t-BuOH together with 2-methyl-2-butene (36.7 
mL, 347 mmol, 10.0 equiv). The mixture was cooled to 0 °C, and a solution of NaClO2 
(19.6 g, 174 mmol, 5.00 equiv) and NaH2PO4·H2O (24.0 g, 174 mmol, 5.00 equiv) in 100 
mL of water was added by a dropping funnel over 30 minutes. After addition, the 
reaction mixture was slowly warmed to 23 °C over 1 hour. Then the mixture was 
quenched with water (100 mL) and the aqueous phase was extracted with 
dichloromethane (3 " 10 mL). The combined organic layer was dried over anhydrous 
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Na2SO4 and filtered through celite. The crude acid 4.25 (5.72 g, 29.1 mmol, 84% over 
two steps) was used for the next step without further purification. 1H NMR (600 MHz, 
CDCl3) ! = 6.87 (d, J = 8.8 Hz, 1H), 6.77 (d, J = 8.8 Hz, 1H), 3.86 (s, 3H), 3.80 (s, 3H), 
2.31 ppm (s, 3H); HRMS (ESI) calcd for C10H12NaO4 [M+Na+] 219.0633, found: 
219.0647. 
 
Acid 4.25 (4.88 g, 24.9 mmol, 1.00 equiv) was dissolved in 100 mL of benzene together 
with DMF (6.52 mL, 74.7 mmol, 3.00 equiv). After cooling to 0 °C, oxalyl chloride (5.78 
mL, 74.7 mmol, 3.00 equiv) was added to the reaction mixture over a 10 minute period. 
The mixture was warmed to 23 °C and vigorously stirred for 2 hours. Then the reaction 
mixture was filtered over a pad of celite and concentrated under reduced pressure. The 
resulting oil was dissolved in 100 mL of dichloromethane and phenol (2.34 g, 24.9 mmol, 
1.00 equiv) was added. The mixture was cooled to 0 °C, then pyridine (10.0 mL, 124 
mmol, 5.00 equiv) was added dropwise over 5 minutes. After stirring for 6 hours, the 
mixture was quenched with 100 mL of water and the aqueous phase was extracted with 
diethyl ether (3 " 50 mL). After concentration, the crude product was purified by flash 
column chromatography (EtOAc/hexane = 1/15 to 1/10) to give phenyl ester 4.26 (5.28 g, 
19.4 mmol, 78%). 1H NMR (600 MHz, CDCl3) ! = 7.43 (t, J = 7.9 Hz, 2H), 7.31 - 7.23 
(m, 3H), 6.87 (d, J = 9.1 Hz, 1H), 6.78 (d, J = 8.8 Hz, 1H), 3.85 (s, 3H), 3.82 (s, 3H), 
2.31 ppm (s, 3H); HRMS (ESI) calcd for C16H17O4 [M+H+] 273.1127, found: 273.1131. 
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Compound 4.26 (510 mg, 1.87 mmol, 1.00 equiv) was was dissolved in 10 mL of CCl4 
together with NBS (400 mg, 2.25 mmol, 1.20 equiv), and AIBN (30.7 mg, 0.187 mmol, 
0.100 equiv). The mixture was heated to reflux for 3 hours, then cooled to 23 °C. 
Volatiles were removed under reduced pressure, and the resulting suspension was diluted 
with 50 mL of 1:2 mixture of EtOAc and hexane. The suspension was filtered through a 
pad of silica gel and concentrated. The crude product was used for the next step without 
further purification. 
The crude aryl bromide was dissolved in 10 mL of DMF and cooled to 0 °C. To the 
solution was added NaSPh (272 mg, 2.06 mmol, 1.10 equiv), and the reaction mixture 
was warmed to 23 °C. After stirring for 1 hour, the mixture was quenched with 10 mL of 
water, and the aqueous phase was extracted with diethyl ether (3 " 20 mL). After 
concentration, the crude product was used for the next step without further purification. 
The crude sulfide was dissolved in 10 mL of methanol. To the solution was added 2 mL 
of water, followed by NaIO4 (600 mg, 2.81 mmol, 1.50 equiv) to give a white suspension. 
The mixture was vigorously stirred at 23 °C for 24 hours. After completion of the 
reaction, volatiles were removed under reduced pressure and the resulting oil was 
quenched with 10 mL of water. The aqueous phase was extracted with diethyl ether (3 " 
20 mL). The combined organic layer was dried over anhydrous MgSO4 and filtered. After 
concentration, the crude product was purified by flash column chromatography 
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(EtOAc/hexane = 1/2 to 1/1) to give sulfoxide 4.27 (511 mg, 1.29 mmol, 69% over three 
steps) as colorless oil. 1H NMR (600 MHz, CDCl3) ! = 7.56 (dd, J = 1.9, 7.2 Hz, 2H), 
7.51 - 7.46 (m, 2H), 7.46 - 7.42 (m, 3H), 7.40 (d, J = 7.6 Hz, 2H), 7.35 - 7.29 (m, 1H), 
6.94 (d, J = 9.1 Hz, 1H), 6.84 (d, J = 9.1 Hz, 1H), 4.52 (d, J = 12.6 Hz, 1H), 4.41 (d, J = 
12.3 Hz, 1H), 3.89 (s, 3H), 3.55 ppm (s, 3H); 13C NMR (125 MHz, CDCl3) ! = 165.6, 
151.5, 150.9, 150.7, 143.5, 130.7, 129.2, 128.4, 125.8, 124.7, 124.0, 121.7, 118.1, 112.8, 
112.6, 56.6, 55.7, 55.7, 54.9 ppm; HRMS (ESI) calcd for C22H20NaO5S [M+Na+] 
419.0924, found: 419.0847. 
 
A solution of sulfoxide 4.27 (575 mg, 1.45 mmol, 1.05 equiv) in 2 mL of THF (plus 1 
mL rinse) was cannulated to a solution of LiHMDS (4.14 mmol, 3.00 equiv) in 12 mL of 
THF to give a bright yellow solution at –78 °C. The resulting solution was stirred at –60 
°C for 6 hours to give an orange solution. The mixture was cooled to –78 °C again and a 
solution of enone 2.42 (577 mg, 1.38 mmol, 1.00 equiv) in 2 mL of THF (plus 1 mL 
rinse) was added to the reaction. In 10 minutes, the mixture was quenched with saturated 
aqueous NH4Cl, and the aqueous phase was extracted with dichloromethane (3 " 20 mL). 
The crude product was purified by flash column chromatography (EtOAc/hexane = 1/1.5 
to 1.5/1) to give phenol 4.28 (650 mg, 1.09 mmol, 79%) as bright yellow foam. 1H NMR 
(500 MHz, CDCl3) ! = 10.63 (s, 1H), 7.98 (dd, J = 8.5, 1.1 Hz, 2H), 7.92 (s, 1H), 7.71 (tt, 
J = 7.8, 1.0 Hz, 1H), 7.62 (dd, J = 8.2, 8.2 Hz, 2H), 6.82 (d, J = 8.2 Hz, 1H), 6.77 (d, J = 
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8.2 Hz, 1H), 5.71 (dd, J = 9.8, 3.4 Hz, 1H), 4.13 (d, J = 6.0 Hz, 1H), 4.00 (s, 3H), 3.94 (s, 
3H), 3.82 (dd, J = 6.0, 1.8 Hz, 1H), 2.79 (dd, J = 13.7, 3.7 Hz, 1H), 2.59 (ddd, J = 14.3, 
10.0, 1.8 Hz, 1H), 2.16 (dq, J = 15.0, 7.4 Hz, 1H), 2.05 (dq, J = 15.0, 7.4 Hz, 1H), 1.21 
(s, 9H), 0.99 ppm (t, J = 7.3 Hz, 3H); 13C NMR (125 MHz, CDCl3) ! = 198.0, 178.1, 
155.8, 152.1, 150.4, 140.1, 138.4, 134.0, 131.6, 129.3, 128.2, 118.0, 116.6, 109.6, 107.3, 
105.8, 93.9, 89.5, 70.9, 69.6, 56.8, 55.9, 55.9, 38.7, 38.3, 27.7, 27.0, 8.0 ppm; HRMS 
(ESI) calcd for C32H35O9S [M+H+] 595.1996, found: 595.1996. 
 
To a solution of 4.28 (650 mg, 1.09 mmol, 1.00 equiv) in 3 mL of dichloromethane was 
added 1,2-(bistrimethylsilyloxy)ethane (0.534 mL, 2.18 mmol, 2.00 equiv), followed by 
TMSOTf (0.197 mL, 1.09 mmol, 1.00 equiv) at room temperature. The reaction was 
vigorously stirred for 2 days. Upon completion of the reaction, the mixture was quenched 
with saturated aqueous NaHCO3 at 0 °C and the aqueous phase was extracted with 
dichloromethane (3 " 10 mL). The combined organic layers were dried over Na2SO4 and 
the crude product was purified by flash column chromatography (EtOAc/hexane = 1/2.5 
to 1/2) to give dioxolane 4.29 (501 mg, 0.785 mmol, 72%) as a pale yellow solid. 1H 
NMR (500 MHz, CDCl3) ! = 10.02 (d, J = 1.0 Hz, 1H), 8.02 (d, J = 7.3 Hz, 2H), 7.79 (s, 
1H), 7.69 (t, J = 7.3 Hz, 1H), 7.61 (dd, J = 7.8, 7.8 Hz, 2H), 6.66 (d, J = 8.8 Hz, 1H), 
6.62 (d, J = 8.8 Hz, 1H), 5.59 (dd, J = 10.0, 3.7 Hz, 1H), 4.10 - 4.20 (m, 3H), 4.08 (d, J = 
5.9 Hz, 1H), 3.96 (s, 3H), 3.90 (s, 3H), 3.23 (ddd, J = 6.3, 6.3, 6.3 Hz, 1H), 2.98 (ddd, J = 
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6.3, 6.3, 6.3 Hz, 1H), 2.74 (dd, J = 14.2, 3.4 Hz, 1H), 2.49 - 2.57 (m, 1H), 2.06 - 2.15 (m, 
1H), 1.98 - 2.06 (m, 1H) 1.18 (s, 9H), 1.04 ppm (t, J = 7.3 Hz, 3H); 13C NMR (125 MHz, 
CDCl3) ! = 178.4, 151.0, 150.7, 150.6, 140.9, 134.0, 133.6, 129.7, 129.1, 128.8, 125.8, 
117.2, 113.3, 108.9, 104.6, 103.8, 93.7, 92.0, 71.6, 68.5, 67.3, 65.6, 56.6, 55.7, 55.4, 38.7, 
37.8, 27.8, 27.1, 8.0 ppm; HRMS (ESI) calcd for C34H39O10S [M+H+] 639.2258, found: 
639.2260. 
Byproduct 4.32 
1H NMR (500 MHz, CDCl3) ! = 9.38 (s, 1H), 7.89 (d, J = 7.3 Hz, 2H), 7.71 (d, J = 1.4 
Hz, 1H), 7.61 (d, J = 7.8 Hz, 1H), 7.57 - 7.49 (m, 2H), 6.91 (d, J = 1.4 Hz, 1H), 6.68 - 
6.58 (m, 2H), 4.94 (dd, J = 3.7, 10.5 Hz, 1H), 4.29 (d, J = 6.9 Hz, 1H), 4.20 (dd, J = 1.4, 
6.9 Hz, 1H), 3.97 (s, 3H), 3.88 (s, 3H), 3.55 (br. s. 2H), 3.42 (dd, J = 4.1, 6.9 Hz, 1H), 
3.40 - 3.34 (m, 1H), 3.28 - 3.17 (m, 2H), 3.05 - 2.97 (m, 1H), 2.88 - 2.80 (m, 1H), 2.68 
(dd, J = 3.7, 14.2 Hz, 1H), 2.49 (dd, J = 1.8, 10.5 Hz, 1H), 2.16 - 2.00 (m, 2H), 1.46 (s, 9 
H), 1.14 ppm (t, J = 7.3 Hz, 3H); 13C NMR (125 MHz, CDCl3) ! = 177.6, 169.8, 154.0, 
150.3, 149.7, 139.9, 135.1, 133.9, 129.3, 128.0, 127.7, 115.0, 110.0, 108.8, 103.6, 103.1, 
89.3, 88.5, 78.0, 72.0, 69.6, 68.0, 63.8, 61.6, 56.2, 55.4, 50.3, 38.8, 37.1, 27.2, 27.2, 8.0 
ppm; HRMS (ESI) calcd for C36H48NO12S [M+NH4+] 718.2892, found: 718.2892. 
 
To a solution of phenol 4.29 (1.62 g, 2.54 mmol, 1.00 equiv) in 8 mL of DMF was added 
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allyl bromide (0.241 mL, 2.79 mmol, 1.10 equiv), followed by Cs2CO3 (909 mg, 2.79 
mmol, 1.10 equiv). The resulting red solution was vigorously stirred for 2 hours, then the 
reaction was quenched with saturated aqueous NH4Cl, and the aqueous phase was 
extracted with dichloromethane (3 " 20 mL). After drying over Na2SO4 and 
concentrating under reduced pressure, the crude product was purified by flash column 
chromatography (EtOAc/hexane = 1/4 to 1/3) to give allyl ether 4.33 (1.32 g, 1.94 mmol, 
76%) as a pale yellow foam. 1H NMR (500 MHz, CDCl3) ! = 8.13 (s, 1H), 8.02 (d, J = 
7.3 Hz, 2H), 7.69 (t, J = 7.3 Hz, 1H), 7.61 (dd, J = 7.8, 7.8 Hz, 2H), 6.76 (d, J = 8.7 Hz, 
1H), 6.71 (d, J = 8.7 Hz, 1H), 6.15 (dddd, J=17.2, 10.5, 5.2, 5.2 Hz, 1H), 5.63 (dd, J = 
10.1, 3.7 Hz, 1H), 5.41 (dd, J = 17.4, 1.8 Hz, 1H), 5.21 (dd, J = 10.8, 1.6 Hz, 1H), 4.36 -
4.50 (m, 2H), 4.04 - 4.16 (m, 4H), 3.93 (s, 3H), 3.85 (s, 3H), 3.19 - 3.27 (m, 1H), 2.95 - 
3.03 (m, 1H), 2.71 (dd, J = 14.0, 3.4 Hz, 1H), 2.53 (ddd, J = 14.2, 10.1, 1.8 Hz, 1H), 1.93 
- 2.10 (m, 2H), 1.19 (s, 9H), 0.98 - 1.05 ppm (t, J = 7.3 Hz, 3H); 13C NMR (125 MHz, 
CDCl3) ! = 178.4, 152.1, 150.3, 150.2, 140.9, 135.2, 135.1, 133.7, 132.8, 130.4, 129.2, 
128.7, 122.8, 116.0, 114.4, 113.6, 107.2, 104.5, 93.7, 91.7, 76.7, 71.6, 68.9, 66.8, 65.4, 
57.0, 55.8, 55.4, 38.7, 37.4, 27.7, 27.1, 8.1 ppm; HRMS (ESI) calcd for C37H43O10S 
[M+H+] 679.2571, found: 679.2545. 
Byproduct 4.34 
1H NMR (600 MHz, CDCl3) ! = 8.01 (d, J = 7.3 Hz, 2H), 7.68 (d, J = 7.3 Hz, 1H), 7.63 - 
7.58 (m, 2H), 6.81 - 6.72 (m, 2H), 6.15 (dd, J = 5.7, 11.3 Hz, 1H), 5.63 - 5.55 (m, 1H), 
5.40 (dd, J = 1.2, 17.3 Hz, 1H), 5.21 (d, J = 10.5 Hz, 1H), 4.91 (d, J = 10.3 Hz, 1H), 4.44 
(d, J = 4.1 Hz, 2H), 4.19 (d, J = 6.2 Hz, 1H), 4.14 (d, J = 6.4 Hz, 1H), 4.03 (t, J = 6.0 Hz, 
2H), 3.83 (s, 3H), 3.77 (s, 3H), 2.66 (dd, J = 3.2, 14.1 Hz, 1H), 2.47 (br. s, 1H), 2.00 - 
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1.88 (m, 2H), 1.16 (s, 9 H), 1.01 ppm (d, J = 14.9 Hz, 3H); HRMS (ESI) calcd for 
C40H47O10S [M+H+] 719.2890, found: 719.2889. 
 
The trimethylacetyl ester 4.33 (1.32 g, 1.94 mmol, 1.00 equiv) was dissolved in 12 mL of 
THF and cooled to 0 °C. To the solution was added 1.0 M NaBHEt3 solution in THF 
(9.72 mL, 9.72 mmol, 5.00 equiv) via syringe. The mixture was vigorously stirred at 0 °C 
for 2 hours. After completion of the reaction, the mixture was quenched with saturated 
aqueous NH4Cl and the aqueous phase was extracted with dichloromethane (3 " 20 mL). 
After drying over Na2SO4 and concentrating under reduced pressure, the crude product 
was purified by flash column chromatography (EtOAc/hexane = 1/2 to 1/1.5) to give the 
corresponding alcohol (1.15 g, 1.93 mmol, 99%) as a white foam. 
A flask was charged with the alcohol (270 mg, 0.454 mmol, 1.00 equiv), TPAP (8.0 mg, 
0.0227 mmol, 0.0500 equiv), NMO (80.0 mg, 0.681 mmol, 1.50 equiv), and 4Å MS (230 
mg), then 5 mL of dichloromethane was added. The reaction was vigorously stirred at 
room temperature for 2 hours. After completion of the reaction, the mixture was diluted 
with 10 mL of diethyl ether and the resulting suspension was filtered through a pad of 
celite. After concentration, the crude product was purified by flash column 
chromatography (EtOAc/hexane = 1/3 to 1/2) to give ketone 4.13 (240 mg, 0.405 mmol, 
89%) as a white solid. 1H NMR (500 MHz, CDCl3) ! = 8.14 (s, 1H), 8.01 (dd, J = 8.5, 
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1.1 Hz, 2H), 7.72 (tt, J = 7.5, 1.2 Hz, 1H), 7.63 (dd, J = 8.2, 8.2 Hz, 2H), 6.78 (d, J = 8.7 
Hz, 1H), 6.72 (d, J = 8.7 Hz, 1H), 6.14 (dddd, J = 17.2, 10.5, 5.4, 5.4 Hz, 1H), 5.36 - 5.42 
(m, 1H), 5.19 - 5.24 (m, 1H), 4.32 - 4.46 (m, 2H), 4.09 - 4.20 (m, 2H), 4.03 (ddd, J = 6.9, 
6.9, 6.9 Hz, 1H), 3.91 (s, 3H), 3.85 (s, 3H), 3.60 (d, J = 5.5 Hz, 1H), 3.53 (d, J = 18.3 Hz, 
1H), 3.27 (ddd, J = 6.4, 6.4, 6.4 Hz, 1H), 2.81 (ddd, J = 6.4, 6.4, 6.4 Hz, 1H), 2.71 (dd, J 
= 18.1, 1.6 Hz, 1H), 2.24 (qd, J = 7.4, 2.5 Hz, 2H), 1.11 ppm (t, J = 7.3 Hz, 3H); 13C 
NMR (125 MHz, CDCl3) ! = 204.9, 152.1, 150.3, 150.1, 140.1, 135.1, 134.0, 130.6, 
129.5, 129.3, 128.8, 128.3, 122.9, 117.2, 116.2, 113.6, 107.5, 104.7, 93.8, 91.9, 76.9, 
67.8, 66.9, 65.3, 58.7, 56.8, 55.7, 44.5, 27.8, 7.9 ppm; HRMS (ESI) calcd for C32H33O9S 
[M+H+] 593.1840, found: 593.1837. 
 
A two-neck flask was equipped with a solid addition adaptor containing [Cp2Fe]PF6 (2.32 
g, 7.00 mmol, 5.00 equiv). To the flask was added 8 mL of THF, HMDS (0.502 mL, 2.38 
mmol, 1.70 equiv), n-BuLi solution (2.29 M in hexanes, 1.04 mL, 2.38 mmol, 1.70 
equiv), and HMPA (0.487 mL, 2.80 mmol, 2.00 equiv) at –78°C, successively. 40 
minutes later a solution of ketone 4.13 (830 mg, 1.40 mmol, 1.00 equiv) in 10 mL of THF 
(plus 2 " 1 mL rinse) was cannulated to the LiHMDS-HMPA solution to give a pale 
yellow solution. 2 hours later, [Cp2Fe]PF6 was added to the reaction system from the 
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solid addition adaptor. The initially deep blue suspension turned yellowish-green in 30 
minutes. The reaction mixture was stirred at –60 °C for 3 days. The reaction mixture was 
quenched with saturated aqueous NH4Cl and warmed to room temperature. The aqueous 
phase was extracted with dichloromethane (3 " 20 mL) and the combined organic layers 
were dried over Na2SO4. The crude product was purified by flash column 
chromatography (EtOAc/hexane = 1/1 to 1.5/1) to give dimer 4.12 (665 mg, 1.12 mmol, 
80%) as a pale yellow solid. 1H NMR (500 MHz, CDCl3) ! = 8.32 (s, 2H), 8.04 (d, J = 
7.6 Hz, 4H), 7.71 (t, J = 7.1 Hz, 2H), 7.64 (dd, J = 7.3, 7.3 Hz, 4H), 6.75 (d, J = 8.5 Hz, 
2H), 6.69 (d, J = 8.2 Hz, 2H), 6.14 (dddd, J = 15.8, 10.1, 4.8, 4.8 Hz, 2H), 5.40 (d, J = 
17.2 Hz, 2H), 5.21 (d, J = 10.3 Hz, 2H), 4.48 (d, J = 95.0 Hz, 2H), 4.35 - 4.45 (m, 4H), 
4.28 (s, 2H), 4.16 (ddd, J = 6.6, 6.6, 6.6 Hz, 2H), 4.07 (ddd, J = 6.2, 6.2, 6.2 Hz, 2H), 
3.84 (s, 6H), 3.83 (s, 6H), 3.65 (d, J = 5.0 Hz, 2H), 3.27 - 3.34 (m, 2H), 2.94 - 3.02 (m, 
2H), 2.44 – 2.57 (m, 2H), 2.20 - 2.31 (m, 2H), 1.20 ppm (t, J = 7.0 Hz, 6H); 13C NMR 
(125 MHz, CDCl3) ! = 205.3, 151.9, 150.5, 150.0, 140.0, 135.2, 135.1, 134.1, 130.8, 
129.6, 129.5, 128.6, 122.8, 117.7, 116.0, 113.8, 107.3, 104.8, 93.9, 93.2, 76.8, 66.8, 65.4, 
65.3, 58.2, 56.7, 55.9, 51.0, 24.6, 7.8 ppm; HRMS (ESI) calcd for C64H63O18S2 [M+H+] 
1183.3450, found: 1183.3501. 
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To the solution of dimer 4.12 (19.7 mg, 0.0166 mmol, 1.00 equiv), in 0.5 mL of 
dichloromethane was added acetic acid (0.0095 mL, 0.166 mmol, 10.0 equiv), n-Bu3SnH 
(0.0098 mL, 0.0365 mmol, 2.2 equiv), and PdCl2(PPh3)2 (1.2 mg, 0.00166 mmol, 0.100 
equiv), successively at 0 °C. In 30 minutes, volatiles were removed under reduced 
pressure, and the crude product was purified by flash column chromatography 
(EtOAc/hexane = 2/1 to 4/1) to give dimer 4.35 (16.4 mg, 0.0149 mmol, 90%) as white 
solid. The product was recrystallized over dichloromethane/pentane for X-ray analysis. 
 
To the solution of dioxolane 4.12 (128 mg, 0.108 mmol, 1.00 equiv) in 3 mL of acetone 
was added 0.5 mL of water. The solution was cooled to 0 °C and 0.5 mL of TfOH was 
added dropwise over 5 minutes. The mixture was warmed to 23 °C and vigorously stirred 
for 24 hours. At the end of the reaction, the reaction system was cooled to 0 °C and 10 
mL of saturated aqueous NaHCO3 solution was added. The aqueous phase was quenched 
with dichloromethane (3 " 10 mL), and the combined organic layer was dried over 
Na2SO4 and filtered. After concentration the crude product was purified by flash column 
chromatography (EtOAc/hexane = 1/1 to 1.5/1) to give ketone 5.7 (94.0 mg, 0.0844 
mmol, 78%) as bright yellow solid. 1H NMR (500 MHz, CDCl3) ! = 9.00 (s, 1H), 8.06 
(d, J = 7.3 Hz, 2H), 7.80 - 7.73 (m, 1H), 7.72 - 7.63 (m, 2H), 6.92 - 6.82 (m, 2H), 6.26 - 
6.13 (m, 1H), 5.39 (d, J = 17.2 Hz, 1H), 5.26 (d, J = 10.1 Hz, 1H), 4.65 - 4.53 (m, 2H), 
4.20 (d, J = 6.0 Hz, 1H), 4.09 (d, J = 6.2 Hz, 1H), 4.08 (br. s, 1H), 3.90 (s, 3H), 3.80 (s, 
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3H), 3.63 (br. s, 1H), 2.28 - 2.07 (m, 2H), 1.06 ppm (t, J = 7.1 Hz, 3H); 13C NMR (125 
MHz, CDCl3) ! = 197.2, 155.9, 152.3, 150.2, 139.8, 136.4, 134.3, 134.1, 132.6, 129.5, 
128.4, 128.3, 126.5, 123.0, 117.8, 117.7, 115.8, 108.6, 107.3, 93.7, 90.2, 76.8, 67.5, 57.2, 
56.8, 55.7, 54.0, 24.7, 8.4 ppm; HRMS (ESI) calcd for C60H56NaO17S2 [M+Na+] 
1135.2851, found: 1135.2847. 
 
To the solution of cyclic hydrate 5.7 (11.4 mg, 0.0101 mmol, 1.00 equiv) in 0.5 mL of 
THF was added MeOTf (0.00340 mL, 0.0302, 3.00 equiv). The solution was cooled to –
78 °C, then 0.92 M THF solution of NaHMDS (0.0231 mL, 0.0212 mmol, 2.10 equiv) 
was added to the reaction system via syringe. In 5 minutes, the mixture was quenched 
with saturated aqueous solution of NH4Cl, and the aqueous phase was extracted with 
dichloromethane (3 " 5 mL). The combined organic layer was dried over Na2SO4 and 
filtered. After concentration the crude product was purified by flash column 
chromatography (EtOAc/hexane = 1/1.5 to 1/1) to provide methyl ether 5.16 (10.4 mg, 
0.00911 mmol, 90%). 1H NMR (500 MHz, CDCl3) ! = 9.00 (s, 1H), 8.06 (d, J = 7.3 Hz, 
2H), 7.78 - 7.71 (m, 1H), 7.70 - 7.63 (m, 2H), 6.91 - 6.82 (m, 2H), 6.25 - 6.14 (m, 1H), 
5.40 (dd, J = 1.1, 17.2 Hz, 1H), 5.26 (d, J = 10.1 Hz, 1H), 4.69 - 4.62 (m, 1H), 4.60 - 4.54 
(m, 1H), 4.14 (d, J = 5.5 Hz, 1H), 4.12 (s, 1H), 4.09 (d, J = 6.0 Hz, 1H), 3.90 (s, 3H), 
3.82 (s, 3H), 3.58 (s, 3H), 2.32 - 2.22 (m, 1H), 2.17 (qd, J = 7.5, 14.9 Hz, 1H), 1.04 ppm 
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(t, J = 7.1 Hz, 3H); 13C NMR (125 MHz, CDCl3) ! = 197.7, 155.9, 152.5, 150.1, 140.2, 
138.4, 134.1, 134.0, 132.6, 129.4, 128.3, 126.1, 122.8, 119.5, 117.7, 117.4, 108.2, 107.8, 
93.8, 90.8, 76.9, 67.6, 58.1, 57.1, 56.1, 54.2, 53.1, 24.5, 8.6 ppm; HRMS (ESI) calcd for 
C62H60NaO17S2 [M+Na+] 1163.3164, found: 1163.3166. 
 
To the solution of sulfone 5.16 (31.0 mg, 0.0272 mmol, 1.00 equiv) in 0.5 mL of THF 
and 0.5 mL of water was added KOH (15.0 mg, 0.272 mmol, 10.0 equiv) at 0 °C. The 
mixture was warmed to 23 °C and vigorously stirred for 12 hours. Upon completion of 
the reaction, the reaction system was quenched with saturated aqueous solution of NH4Cl, 
and the aqueous phase was extracted with dichloromethane (3 " 5 mL). The combined 
organic layer was dried over Na2SO4 and filtered. After concentration, the crude product 
was purified by flash column chromatography (EtOAc/hexane = 1/1.5 to 1/1) to provide 
diol 5.17 (21.9 mg, 0.0245 mmol, 90%) as a 10:1 diastereomeric mixture. 1H NMR (500 
MHz, CDCl3) ! = 8.97 (s, 1H), 6.92 - 6.81 (m, 2H), 6.39 - 6.25 (m, 1H), 5.53 - 5.46 (m, 
1H), 5.31 (d, J = 10.1 Hz, 1H), 4.76 (dd, J = 5.7, 10.8 Hz, 1H), 4.70 - 4.62 (m, 2H), 3.94 
(s, 3H), 3.84 (s, 3H), 3.49 (s, 3H), 3.39 (s, 1H), 3.37 (d, J = 3.2 Hz, 1H), 2.01 - 1.92 (m, 
2H), 1.03 ppm (t, J = 7.6 Hz, 3H); 13C NMR (125 MHz, CDCl3) ! = 201.2, 156.1, 152.6, 
150.1, 140.4, 134.3, 132.8, 126.7, 122.7, 120.4, 117.8, 117.1, 107.9, 107.6, 91.4, 89.7, 
77.3, 64.0, 57.1, 56.1, 53.8, 49.8, 29.7, 24.0, 7.8 ppm; HRMS (ESI) calcd for C50H53O15 
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[M+H+] 893.3384, found: 893.3389. The product was recrystallized over 
dichloromethane/pentane for X-ray analysis. 
 
To the solution of diol 5.17 (3.5 mg, 0.00392 mmol, 1.00 equiv) in 0.5 mL of 
dichloromethane was added Et3N (0.0054 mL, 0.0392 mmol, 10.0 equiv), followed by 
MsCl (0.0015 mL, 0.0196 mmol, 5.00 equiv) at 0 °C. In 30 minutes the reaction mixture 
was quenched with 1 mL of water, and the aqueous phase was extracted with 
dichloromethane (3 " 2 mL). The combined organic layer was dried over Na2SO4 and 
filtered. After concentration the crude mesylate was dissolved in 0.5 mL of THF and 0.5 
mL of water, and the solution was cooled to 0 °C. To the solution was added K2CO3 (5.3 
mg, 0.0392 mmol, 10.0 equiv). The mixture was vigorously stirred at 0 °C for 3 hr before 
completion of the reaction. At the end of the reaction, the mixture was quenched with 1 
mL of saturated aqueous solution of NH4Cl, and the aqueous phase was extracted with 
dichloromethane (3 " 2 mL). The combined organic layer was dried over Na2SO4 and 
filtered. After concentration the crude product was purified by flash column 
chromatography (EtOAc/hexane = 1/1.5 to 1/1) to provide enone 5.20 (2.8 mg, 0.00327 
mmol, 83%). 1H NMR (600 MHz, CDCl3) ! = 8.28 (s, 1H), 6.95 (s, 1H), 6.80 (s, 2H), 
6.39 - 6.30 (m, 1H), 5.50 - 5.46 (m, 1H), 5.33 - 5.29 (m, 1H), 4.80 - 4.75 (m, 1H), 4.71 - 
4.67 (m, 1H), 3.92 (s, 3H), 3.75 (s, 3H), 3.40 (s, 3H), 2.81 (s, 1H), 2.16 - 2.08 (m, 1H), 
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2.04 - 1.95 (m, 1H), 1.12 ppm (t, J = 7.5 Hz, 3H); HRMS (ESI) calcd for C50H49O13 
[M+H+] 857.3168, found: 857.3175. 
 
To the solution of enone 5.20 (2.8 mg, 0.00327 mmol, 1.00 equiv) in 0.5 mL of THF and 
0.5 mL of water was added KOH (4.5 mg, 0.0327, 10.0 equiv) at 0 °C. The solution was 
warmed to 23 °C and vigorously stirred for 6 hours. Upon completion of the reaction, the 
mixture was quenched with 1 mL of saturated aqueous solution of NH4Cl, and the 
aqueous phase was extracted with dichloromethane (3 " 2 mL). The combined organic 
layer was dried over Na2SO4 and filtered. After concentration the crude product was 
purified by flash column chromatography (EtOAc/hexane = 1/1.5 to 1/1) to provide diol 
5.17 (2.7 mg, 0.00302 mmol, 92%). The product was identical to the previously prepared 
compound in all aspects. 
 
To the solution of oxalyl chloride (0.0022 mL, 0.0251 mmol, 4.00 equiv) in 0.5 mL of 
dichloromethane was added DMSO (0.0018 mL, 0.0251 mmol, 4.00 equiv) at –78 °C. In 
20 minutes, diol 5.17 (5.6 mg, 0.00627 mmol, 1.00 equiv) in 0.3 mL of dichloromethane 
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(plus 0,2 mL rinse) was cannulated to the reaction mixture. The reaction mixture was 
stirred for 20 minutes, then DIEA (0.0070 mL, 0.0502 mmol, 8.00 equiv) was added in 
one portion. The reaction system was vigorously stirred for 30 minutes, then quenched 
with water. The mixture was warmed to 23 °C, and the aqueous phase was extracted with 
dichloromethane (3 " 2 mL). The combined organic layer was dried over Na2SO4 and 
filtered. After concentration the crude product was purified by flash column 
chromatography (EtOAc/hexane = 1/2 to 1/1.2) to provide ketone 5.22 (3.8 mg, 0.00433 
mmol, 69%). 1H NMR (600 MHz, CDCl3) ! = 9.00 (s, 1H), 6.97 - 6.88 (m, 2H), 6.36 - 
6.27 (m, 1H), 5.48 (d, J = 17.3 Hz, 1H), 5.31 (d, J = 10.3 Hz, 1H), 4.78 (dd, J = 5.9, 10.8 
Hz, 1H), 4.66 (dd, J = 6.2, 10.3 Hz, 1H), 3.95 (s, 3H), 3.90 (s, 1H), 3.88 (s, 3H), 3.56 (s, 
3H), 2.82 (s, 1H), 1.94 - 1.80 (m, 2H), 0.97 ppm (t, J = 7.3 Hz, 3H); 13C NMR (125 MHz, 
CDCl3) ! = 200.5, 188.5, 157.4, 152.7, 150.0, 138.7, 134.0, 132.4, 125.8, 122.9, 120.8, 
118.2, 118.1, 116.6, 108.3, 108.2, 93.3, 89.0, 77.4, 64.7, 57.1, 56.1, 54.4, 54.2, 20.6, 7.5 
ppm; HRMS (ESI) calcd for C50H53O15 [M+H+] 893.3379, found: 893.3266. 
 
Ketone 4.12 (29.0 mg, 0.0245 mmol, 1.00 equiv) was dissolved in 1 mL of MeOH 
containing 0.3 mL of water. The solution was cooled to 0 °C and freshly prepared 1.0 M 
THF solution of SmI2 (0.0980 mL, 0.0980 mmol, 4.00 equiv) was added via syringe. The 
mixture was stirred for 2 hours, then quenched with water. The aqueous phase was 
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extracted with dichloromethane (3 " 2 mL). The combined organic layer was dried over 
Na2SO4 and filtered. After concentration the crude product was purified by flash column 
chromatography (EtOAc/hexane = 1/1 to 1/1.2) to provide diol 5.28 (17.4 mg, 0.0147 
mmol, 60%) and approximately 1 mg of monomer 4.13. 1H NMR (500 MHz, CDCl3) ! = 
8.74 (s, 1H), 8.09 (d, J = 7.8 Hz, 2H), 7.70 (d, J = 7.3 Hz, 1H), 7.66 - 7.61 (m, 2H), 6.68 
(d, J = 8.3 Hz, 1H), 6.31 (d, J = 8.3 Hz, 1H), 6.24 - 6.13 (m, 1H), 5.43 (d, J = 16.1 Hz, 
1H), 5.25 (d, J = 10.7 Hz, 1H), 4.47 (d, J = 4.9 Hz, 1H), 4.52 - 4.44 (m, 1H), 4.41 - 4.38 
(m, 1H), 4.38 - 4.35 (m, 1H), 4.22 (s, 1H), 4.17 (d, J = 6.8 Hz, 1H), 4.10 - 4.04 (m, 1H), 
3.83 (s, 3H), 3.49 - 3.43 (m, 1H), 3.36 (s, 1H), 2.62 (s, 3H), 2.38 - 2.18 (m, 1H), 1.23 
ppm (br. s. 3H); HRMS (ESI) calcd for C64H64NaO18S2 [M+Na+] 1207.3426, found: 
1207.3400. 
 
To the solution of ketone 5.17 (80.0 mg, 0.0896 mmol, 1.00 equiv) in 2 mL of THF was 
added 1.0 M THF solution of LiBHEt3 (0.448 mL, 0.448 mmol, 5.00 equiv) at –78 °C. In 
5 minutes the mixture was quenched with saturated aqueous solution of NH4Cl (5 mL), 
then the aqueous phase was extracted with dichloromethane (3 " 2 mL). The combined 
organic layer was dried over Na2SO4 and filtered. After concentration the crude product 
was purified by flash column chromatography (EtOAc/hexane = 2/1 to 3/1) to give 
intermediate tetraol. 
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The alcohol was dissolved in 3 mL of dichloromethane and to the solution was added 
Ac2O (0.0423 mL, 0.448 mmol, 5.00 equiv) and DMAP (109 mg, 0.896 mmol, 10.0 
equiv) at 0 °C. The mixture was warmed to 23 °C and stirred for 2 hours. Upon 
completion of the reaction, the reaction system was quenched with 5 mL of water, and 
the aqueous phase was extracted with dichloromethane (3 " 5 mL). The combined 
organic layer was dried over Na2SO4 and filtered. After concentration the crude product 
was purified by flash column chromatography (EtOAc/hexane = 1/1.5 to 1/1) to give 
tetraacetate 5.47 (53.4 mg, 0.0502 mmol, 56%) as a pale yellow film. 1H NMR (500 
MHz, CDCl3) ! = 8.86 (s, 1H), 6.89 (d, J = 7.8 Hz, 1H), 6.79 (d, J = 8.3 Hz, 1H), 6.75 - 
6.70 (m, 1H), 6.30 - 6.18 (m, 1H), 5.40 (d, J = 17.6 Hz, 1H), 5.37 (br. s, 1H), 5.29 (d, J = 
10.3 Hz, 1H), 4.59 (dd, J = 5.9, 10.3 Hz, 1H), 4.53 - 4.45 (m, 1H), 3.92 (s, 3H), 3.75 (s, 
3H), 3.34 (s, 3H), 3.27 - 3.22 (m, 1H), 3.17 (s, 1H), 2.18 (s, 3H), 2.13 (s, 3H), 2.06 - 1.96 
(m, 1H), 1.85 (qd, J = 7.0, 14.5 Hz, 1H), 1.03 ppm (t, J = 7.1 Hz, 3H); 13C NMR (125 
MHz, CDCl3) ! = 170.0, 169.6, 153.1, 150.4, 150.0, 136.0, 134.4, 134.3, 130.8, 128.3, 
122.4, 120.3, 117.4, 117.2, 106.4, 104.5, 95.2, 89.3, 76.6, 75.5, 69.6, 56.6, 55.9, 53.4, 
52.9, 50.6, 23.6, 21.0, 20.9, 7.3 ppm; HRMS (ESI) calcd for C58H68NO19S2 [M+NH4+] 
1082.4380, found: 1082.4413. 
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Tetraacetate 5.47 (13.8 mg, 0.0130 mmol, 1.00 mmol) was dissolved in 0.8 mL of 
dichloromethane, and the solution was cooled to –15 °C. To the solution was added 
Et3SiH (0.0208 mL, 0.130 mmol, 10.0 quiv), followed by TfOH (0.00011 mL, 0.00130 
mmol, 0.100 equiv). The resulting dark green solution was vigorously stirred at –13 °C 
for 6 hours. At the end of the reaction, the mixture was quenched with saturated aqueous 
solution of NaHCO3 (2 mL), then the aqueous phase was extracted with dichloromethane 
(3 " 5 mL). The combined organic layer was dried over Na2SO4 and filtered. After 
concentration the crude product was purified by flash column chromatography 
(EtOAc/hexane = 1/3 to 1/2.5) to give tetraacetate 5.48 (7.0 mg, 0.00741 mmol, 57%) as 
a pale yellow film. 1H NMR (500 MHz, CDCl3) ! = 8.85 (s, 1H), 6.77 (d, J = 8.3 Hz, 
1H), 6.65 (d, J = 8.3 Hz, 1H), 6.29 - 6.16 (m, 1H), 5.44 (d, J = 17.1 Hz, 1H), 5.29 (d, J = 
10.3 Hz, 1H), 5.01 (d, J = 2.9 Hz, 1H), 4.49 (d, J = 5.4 Hz, 2H), 3.92 (s, 3H), 3.75 (s, 
3H), 3.37 (s, 3H), 3.14 (s, 1H), 3.18 - 3.09 (m, 1H), 3.07 - 2.98 (m, 1H), 2.17 (s, 3H), 
2.03 - 1.86 (m, 2H), 1.02 ppm (t, J = 7.3 Hz, 3H); 13C NMR (125 MHz, CDCl3) ! = 
170.7, 150.7, 149.7, 136.6, 136.4, 134.7, 129.4, 128.3, 122.3, 120.3, 117.1, 117.0, 106.7, 
103.1, 96.5, 88.6, 83.4, 75.0, 56.9, 55.8, 53.5, 51.3, 50.3, 33.4, 24.0, 21.2, 7.6 ppm; 
HRMS (ESI) calcd for C54H61O15 [M+H+] 949.4010, found: 949.4026. 
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Acetate 5.48 (7.0 mg, 0.00741 mmol, 1.00 equiv) was dissolved in 0.5 mL of MeOH and 
the solution was cooled to 0 °C. To the solution was added K2CO3 (10.2 mg, 0.0741 
mmol, 10.0 equiv). The mixture was warmed to 23 °C and stirred for 1 hour. After 
completion of the reaction, the reaction system was quenched with saturated aqueous 
solution of NH4Cl (1 mL), and the aqueous phase was extracted with dichloromethane (3 
" 2 mL). The combined organic layer was dried over Na2SO4 and filtered. After 
concentration the crude product was used for the next step without further purification. 
The diol was dissolved in 1 mL of dichloromethane. To the solution was added NMO 
(2.6 mg, 0.0222, 3.00 equiv), 10 mg of 4 Å MS, and TPAP (0.1 mg, 0.000371 mmol, 
0.05 equiv). After stirring for 30 minutes the mixture was diluted with 5 mL of diethyl 
ether, and filtered over a pad of silica gel. After concentration the crude product was 
purified by flash column chromatography (EtOAc/hexane = 1/3 to 1/2) to give ketone 
5.49 (5.4 mg, 0.00627 mmol, 85%) as a pale yellow film. 1H NMR (500 MHz, CDCl3) ! 
= 8.90 (s, 1H), 6.82 (d, J = 8.2 Hz, 1H), 6.71 (d, J = 8.7 Hz, 1H), 6.26 - 6.12 (m, 1H), 
5.43 (dd, J = 1.4, 16.9 Hz, 1H), 5.28 (d, J = 10.5 Hz, 1H), 4.55 - 4.44 (m, 2H), 3.93 (s, 
3H), 3.82 (s, 3H), 3.62 - 3.53 (m, 1H), 3.49 (s, 3H), 3.47 - 3.40 (m, 1H), 3.12 (dd, J = 8.7, 
16.0 Hz, 1H), 2.73 (s, 1H), 1.88 (tt, J = 7.2, 13.9 Hz, 2H), 1.00 ppm (t, J = 7.3 Hz, 3H); 
13C NMR (125 MHz, CDCl3) ! = 211.9, 151.3, 150.7, 149.8, 136.0, 135.6, 134.5, 129.4, 
122.5, 120.9, 117.4, 116.7, 110.7, 107.4, 103.8, 95.8, 91.8, 75.4, 57.0, 55.9, 54.1, 54.0, 
53.7, 27.9, 22.7, 7.7 ppm; HRMS (ESI) calcd for C50H53O13 [M+H+] 861.3486, found: 
861.3488. 
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To the solution of ketone 5.49 (20.0 mg, 0.0232 mmol, 1.00 equiv) in 2 mL of THF was 
added 1.0 M THF solution of LiBHEt3 (0.0511 mL, 0.0511 mmol, 2.20 equiv) at –78 °C. 
In 5 minutes the mixture was quenched with saturated aqueous solution of NH4Cl (2 mL), 
and the aqueous phase was extracted with dichloromethane (3 " 5 mL). The combined 
organic layer was dried over Na2SO4 and filtered. After concentration the crude product 
was purified by flash column chromatography (EtOAc/hexane = 1/2 to 1/1) to give diol 
5.51 (16.3 mg, 0.0188 mmol, 81%) as a pale yellow film. 1H NMR (600 MHz, CDCl3) ! 
= 8.78 (s, 1H), 6.77 (d, J = 8.5 Hz, 1H), 6.66 (d, J = 8.5 Hz, 1H), 6.22 (dt, J = 5.4, 11.2 
Hz, 1H), 5.44 (d, J = 17.3 Hz, 1H), 5.28 (d, J = 10.3 Hz, 1H), 4.56 - 4.45 (m, 1H), 4.28 
(dd, J = 6.9, 11.0 Hz, 1H), 3.93 (s, 3H), 3.78 (s, 3H), 3.51 - 3.45 (m, 1H), 3.32 (s, 3H), 
3.28 (d, J = 9.1 Hz, 1H), 2.36 (s, 1H), 2.07 - 1.96 (m, 1H), 1.83 (d, J = 11.1 Hz, 1H), 1.91 
- 1.78 (m, 1H), 1.02 ppm (t, J = 7.5 Hz, 3H); HRMS (ESI) calcd for C50H56NaO13 
[M+Na+] 887.3619, found: 887.3655. 
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To the solution of allyl ether 5.51 (8.0 mg, 0.00925 mmol, 1.00 equiv) in 1 mL of 
dichloromethane was added 0.010 mL of AcOH, Bu3SnH (0.0055 mL, 0.0203 mmol, 
2.20 equiv), and PdCl2(PPh3)2 (0.3 mg, 0.000460 mmol, 0.0500 equiv) at 0 °C. In 30 
minutes, volatiles were removed under reduced pressure and the crude product was 
purified by flash column chromatography (EtOAc/hexane = 1/1 to 2/1) to give phenol 
5.52 (6.5 mg, 0.00828 mmol, 90%) as colorless film. 1H NMR (500 MHz, CDCl3) ! = 
9.59 (s, 1H), 8.48 (s, 1H), 6.67 (d, J = 8.3 Hz, 1H), 6.58 (d, J = 8.3 Hz, 1H), 4.26 (dd, J = 
6.8, 10.7 Hz, 1H), 4.03 (s, 3H), 3.77 (s, 3H), 3.54 - 3.46 (m, 1H), 3.33 (s, 3H), 3.18 (d, J 
= 9.3 Hz, 2H), 2.35 (s, 1H), 2.08 - 1.96 (m, 1H), 1.92 - 1.76 (m, 1H), 1.01 ppm (t, J = 7.6 
Hz, 3H); HRMS (ESI) calcd for C44H49O13S [M+H+] 785.3173, found: 785.3177. 
!
Phenol 5.52 (32.5 mg, 0.0414 mmol, 1.00 equiv) was dissolved in 1 mL of acetonitrile 
and 1 mL of water, and the mixture was cooled to 0 °C. To the solution was added PIFA 
(89.0 mg, 0.207 mmol, 5.00 equiv) in one portion, and the mixture was vigorously stirred 
for 30 minutes. After full consumption of the starting material the mixture was quenched 
with saturated aqueous solution of NaS2O3 (1 mL), and the aqueous phase was extracted 
with dichloromethane (3 " 5 mL). The combined organic layer was dried over Na2SO4 
and filtered. After concentration the crude product was used for the next step. 
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The intermediate cyclohexadienone was dissolved in 2 mL of benzene and DDQ (28.1 
mg, 0.124 mmol, 3.00 equiv) was added to the solution. The mixture was heated to 50 °C 
for 3 hours, then cooled to 23 °C. After concentration, the crude product was purified by 
prep TLC (EtOAc/acetone=1/1) to give the quinone 5.54 (26.2 mg, 0.0323 mmol, 78% 
over two steps) as red solid. 1H NMR (500 MHz, CDCl3) ! = 7.33 - 7.29 (m, 1H), 7.25 - 
7.21 (m, 1H), 4.05 (br. s, 1H), 3.97 (s, 3H), 3.86 (s, 3H), 3.61 (s, 3H), 3.44 - 3.32 (m, 
2H), 3.11 - 3.02 (m, 1H), 2.96 - 2.85 (m, 1H), 2.06 - 1.95 (m, 1H), 1.83 (qd, J = 7.3, 14.6 
Hz, 1H), 0.94 (t, J = 7.6 Hz, 3H); HRMS (ESI) calcd for C44H48NaO15 [M+Na+] 
839.2885, found: 839.2780. 
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Appendix 2 
 X-Ray Crystalographic Data 
 
X-Ray Crystallography:  A crystal mounted on a diffractometer was collected data at 
100 K.  The intensities of the reflections were collected by means of a Bruker APEX II 
CCD diffractometer (MoK! radiation, "=0.71073 Å), and equipped with an Oxford 
Cryosystems nitrogen flow apparatus.  The collection method involved 0.5° scans in ! at 
28° in 2".  Data integration down to 0.82 Å resolution was carried out using SAINT 
V7.46 A (Bruker diffractometer, 2009) with reflection spot size optimisation.  Absorption 
corrections were made with the program SADABS (Bruker diffractometer, 2009).  The 
structure was solved by the direct methods procedure and refined by least-squares 
methods again F2 using SHELXS-97 and SHELXL-97 (Sheldrick, 2008).  Non-hydrogen 
atoms were refined anisotropically, and hydrogen atoms were allowed to ride on the 
respective atoms.  Crystal data as well as details of data collection and refinement are 
summarized in Table 1, geometric parameters are shown in Table 2 and hydrogen-bond 
parameters are list in Table 3. The Ortep plots produced with SHELXL-97 program, and 
the other drawings were produced with Accelrys DS Visualizer 2.0 (Accelrys, 2007). 
Compound 4.35 
Table 1.1 Experimental details 
 Dimer 
Crystal data 
Chemical formula C64H68Cl2O18S2 
Mr 1260.20 
Crystal system, space group Monoclinic, P21 
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Table 1.1 (Continued) 
Temperature (K) 100 
a, b, c (Å) 13.7688 (10), 13.2782 (10), 17.2333 (12) 
b (°) 110.610 (4) 
V (Å3) 2949.0 (4) 
Z 2 
Radiation type Mo Ka 
m (mm-1) 0.26 
Crystal size (mm) 0.32 ! 0.24 ! 0.16 
Data collection 
Diffractometer CCD area detector diffractometer 
Absorption correction Multi-scan  
SADABS (Sheldrick, 2009) 
 Tmin, Tmax 0.922, 0.960 
No. of measured, independent 
and observed [I > 2s(I)] 
reflections 
36391, 11575, 7985   
Rint 0.066 
Refinement 
R[F2 > 2s(F2)], wR(F2), S 0.070,  0.189,  1.09 
No. of reflections 11575 
No. of parameters 769 
No. of restraints 38 
H-atom treatment H-atom parameters constrained 
D#max, D#min (e Å-3) 0.76, -0.64 
Absolute structure Flack H D (1983), Acta Cryst. A39, 876-881 
Flack parameter 0.05 (9) 
 
  Computer programs: APEX2 v2009.3.0 (Bruker-AXS, 2009), SAINT 7.46A (Bruker-AXS, 2009), 
SHELXS97 (Sheldrick, 2008), SHELXL97 (Sheldrick, 2008), Bruker SHELXTL. 
       
Table 1.2 Geometric parameters (Å, º) 
S1—O2 1.411 (4) C28—H28B 0.9800 
S1—O3 1.423 (4) C28—H28C 0.9800 
S1—C20 1.744 (6) C29—H29A 0.9800 
S1—C3 1.778 (5) C29—H29B 0.9800 
S2—O12 1.403 (4) C29—H29C 0.9800 
S2—O13 1.424 (4) C31—C32 1.532 (7) 
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Table 1.2 (Continued) 
S2—C50 1.747 (5) C31—C47 1.538 (7) 
S2—C33 1.776 (5) C31—H31A 1.0000 
O1—C2 1.440 (6) C32—C48 1.509 (7) 
O1—C16 1.444 (6) C32—C33 1.558 (7) 
O4—C5 1.398 (6) C33—C34 1.505 (7) 
O4—C26 1.416 (7) C33—H33A 1.0000 
O5—C5 1.404 (6) C34—C46 1.534 (7) 
O5—C27 1.439 (6) C34—C35 1.547 (7) 
O6—C7 1.320 (6) C34—H34A 1.0000 
O6—H6O 0.8800 C35—C36 1.499 (7) 
O7—C9 1.374 (6) C36—C37 1.355 (7) 
O7—C28 1.451 (6) C36—C45 1.391 (7) 
O8—C12 1.367 (6) C37—C38 1.397 (8) 
O8—C29 1.417 (6) C38—C43 1.409 (8) 
O9—C17 1.198 (6) C38—C39 1.441 (8) 
O11—C32 1.425 (6) C39—C40 1.343 (9) 
O11—C46 1.440 (6) C40—C41 1.403 (10) 
O14—C56 1.381 (10) C40—H40A 0.9500 
O14—C35 1.389 (6) C41—C42 1.356 (9) 
O14—C56B 1.51 (3) C41—H41A 0.9500 
O15—C57B 1.23 (4) C42—C43 1.399 (8) 
O15—C35 1.420 (6) C43—C44 1.415 (8) 
O15—C57 1.491 (11) C44—C45 1.349 (7) 
O16—C37 1.371 (7) C44—H44A 0.9500 
O16—H16O 0.8799 C45—C46 1.484 (7) 
O17—C39 1.358 (8) C46—C47 1.497 (7) 
O17—C58 1.415 (8) C48—C49 1.504 (7) 
O18—C42 1.360 (8) C48—H48A 0.9900 
O18—C59B 1.40 (5) C48—H48B 0.9900 
O18—C59 1.444 (12) C49—H49A 0.9800 
O19—C47 1.201 (6) C49—H49B 0.9800 
C1—C17 1.533 (7) C49—H49C 0.9800 
C1—C31 1.536 (6) C50—C55 1.354 (8) 
C1—C2 1.549 (7) C50—C51 1.368 (8) 
C1—H1A 1.0000 C51—C52 1.365 (8) 
C2—C18 1.495 (7) C51—H51A 0.9500 
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C2—C3 1.595 (7) C52—C53 1.380 (9) 
C3—C4 1.519 (7) C52—H52A 0.9500 
C3—H3A 1.0000 C53—C54 1.374 (9) 
C4—C5 1.539 (7) C53—H53A 0.9500 
C4—C16 1.550 (6) C54—C55 1.363 (8) 
C4—H4A 1.0000 C54—H54A 0.9500 
C5—C6 1.518 (7) C55—H55A 0.9500 
C6—C7 1.366 (7) C56—C57 1.466 (16) 
C6—C15 1.418 (7) C56—H56A 0.9900 
C7—C8 1.424 (7) C56—H56B 0.9900 
C8—C13 1.416 (7) C57—H57A 0.9900 
C8—C9 1.433 (7) C57—H57B 0.9900 
C9—C10 1.331 (7) C56B—C57B 1.59 (5) 
C10—C11 1.393 (8) C56B—H56C 0.9900 
C10—H10A 0.9500 C56B—H56D 0.9900 
C11—C12 1.365 (8) C57B—H57C 0.9900 
C11—H11A 0.9500 C57B—H57D 0.9900 
C12—C13 1.396 (7) C58—H58A 0.9800 
C13—C14 1.431 (7) C58—H58B 0.9800 
C14—C15 1.342 (7) C58—H58C 0.9800 
C14—H14A 0.9500 C59—H59A 0.9800 
C15—C16 1.479 (7) C59—H59B 0.9800 
C16—C17 1.472 (7) C59—H59C 0.9800 
C18—C19 1.509 (8) C59B—H59D 0.9800 
C18—H18A 0.9900 C59B—H59E 0.9800 
C18—H18B 0.9900 C59B—H59F 0.9800 
C19—H19A 0.9800 C1S—Cl2S 1.732 (10) 
C19—H19B 0.9800 C1S—Cl1S 1.743 (12) 
C19—H19C 0.9800 C1S—H1SA 0.9900 
C20—C25 1.367 (9) C1S—H1SB 0.9900 
C20—C21 1.388 (9) C11S—C12S 1.483 (15) 
C21—C22 1.379 (8) C11S—H11B 0.9800 
C21—H21A 0.9500 C11S—H11C 0.9800 
C22—C23 1.314 (9) C11S—H11D 0.9800 
C22—H22A 0.9500 C12S—C13S 1.409 (11) 
C23—C24 1.345 (9) C12S—H12A 0.9900 
C23—H23A 0.9500 C12S—H12B 0.9900 
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C24—C25 1.391 (8) C13S—C14S 1.385 (11) 
C24—H24A 0.9500 C13S—H13A 0.9900 
C25—H25A 0.9500 C13S—H13B 0.9900 
C26—C27 1.479 (9) C14S—C15S 1.500 (12) 
C26—H26A 0.9900 C14S—H14B 0.9900 
C26—H26B 0.9900 C14S—H14C 0.9900 
C27—H27A 0.9900 C15S—H15A 0.9800 
C27—H27B 0.9900 C15S—H15B 0.9800 
C28—H28A 0.9800 C15S—H15C 0.9800 
 
O2—S1—O3 119.2 (2) C31—C32—C33 110.9 (4) 
O2—S1—C20 109.5 (3) C34—C33—C32 103.3 (4) 
O3—S1—C20 108.5 (3) C34—C33—S2 113.7 (3) 
O2—S1—C3 108.8 (2) C32—C33—S2 115.5 (3) 
O3—S1—C3 107.2 (2) C34—C33—H33A 108.0 
C20—S1—C3 102.4 (3) C32—C33—H33A 108.0 
O12—S2—O13 118.5 (2) S2—C33—H33A 108.0 
O12—S2—C50 109.4 (2) C33—C34—C46 101.0 (4) 
O13—S2—C50 108.3 (3) C33—C34—C35 119.3 (4) 
O12—S2—C33 106.9 (2) C46—C34—C35 104.9 (4) 
O13—S2—C33 109.8 (2) C33—C34—H34A 110.3 
C50—S2—C33 102.8 (2) C46—C34—H34A 110.3 
C2—O1—C16 99.0 (3) C35—C34—H34A 110.3 
C5—O4—C26 108.4 (4) O14—C35—O15 106.9 (4) 
C5—O5—C27 106.4 (4) O14—C35—C36 113.1 (4) 
C7—O6—H6O 113.5 O15—C35—C36 113.1 (4) 
C9—O7—C28 117.1 (4) O14—C35—C34 112.7 (4) 
C12—O8—C29 116.0 (4) O15—C35—C34 108.6 (4) 
C32—O11—C46 97.7 (3) C36—C35—C34 102.4 (4) 
C56—O14—C35 111.6 (6) C37—C36—C45 120.1 (5) 
C35—O14—C56B 104.1 (14) C37—C36—C35 127.5 (5) 
C57B—O15—C35 117 (2) C45—C36—C35 112.4 (4) 
C35—O15—C57 107.3 (6) C36—C37—O16 118.1 (5) 
C37—O16—H16O 115.5 C36—C37—C38 119.8 (5) 
C39—O17—C58 117.8 (6) O16—C37—C38 122.0 (5) 
C42—O18—C59B 129 (2) C37—C38—C43 119.2 (5) 
C42—O18—C59 114.0 (6) C37—C38—C39 122.9 (5) 
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C17—C1—C31 110.3 (4) C43—C38—C39 117.9 (5) 
C17—C1—C2 99.5 (4) C40—C39—O17 124.0 (6) 
C31—C1—C2 111.7 (4) C40—C39—C38 121.0 (6) 
C17—C1—H1A 111.6 O17—C39—C38 115.1 (5) 
C31—C1—H1A 111.6 C39—C40—C41 120.6 (6) 
C2—C1—H1A 111.6 C39—C40—H40A 119.7 
O1—C2—C18 110.2 (4) C41—C40—H40A 119.7 
O1—C2—C1 99.8 (4) C42—C41—C40 119.6 (6) 
C18—C2—C1 119.6 (4) C42—C41—H41A 120.2 
O1—C2—C3 98.5 (4) C40—C41—H41A 120.2 
C18—C2—C3 114.4 (4) C41—C42—O18 123.4 (6) 
C1—C2—C3 111.1 (4) C41—C42—C43 122.2 (6) 
C4—C3—C2 103.1 (4) O18—C42—C43 114.3 (5) 
C4—C3—S1 114.3 (3) C42—C43—C38 118.6 (5) 
C2—C3—S1 114.4 (3) C42—C43—C44 121.0 (6) 
C4—C3—H3A 108.2 C38—C43—C44 120.4 (5) 
C2—C3—H3A 108.2 C45—C44—C43 117.3 (5) 
S1—C3—H3A 108.2 C45—C44—H44A 121.4 
C3—C4—C5 119.7 (4) C43—C44—H44A 121.4 
C3—C4—C16 101.5 (4) C44—C45—C36 123.1 (5) 
C5—C4—C16 105.5 (4) C44—C45—C46 128.2 (5) 
C3—C4—H4A 109.8 C36—C45—C46 108.8 (4) 
C5—C4—H4A 109.8 O11—C46—C45 112.4 (4) 
C16—C4—H4A 109.8 O11—C46—C47 102.7 (4) 
O4—C5—O5 107.8 (4) C45—C46—C47 126.2 (4) 
O4—C5—C6 116.3 (4) O11—C46—C34 102.5 (4) 
O5—C5—C6 108.4 (4) C45—C46—C34 104.8 (4) 
O4—C5—C4 108.0 (4) C47—C46—C34 105.9 (4) 
O5—C5—C4 113.8 (4) O19—C47—C46 127.5 (5) 
C6—C5—C4 102.6 (4) O19—C47—C31 128.2 (5) 
C7—C6—C15 119.3 (5) C46—C47—C31 104.0 (4) 
C7—C6—C5 128.2 (5) C49—C48—C32 115.3 (4) 
C15—C6—C5 112.3 (4) C49—C48—H48A 108.5 
O6—C7—C6 117.4 (5) C32—C48—H48A 108.5 
O6—C7—C8 123.5 (5) C49—C48—H48B 108.5 
C6—C7—C8 118.9 (5) C32—C48—H48B 108.5 
C13—C8—C7 120.3 (4) H48A—C48—H48B 107.5 
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Table 1.2 (Continued) 
C13—C8—C9 116.8 (5) C48—C49—H49A 109.5 
C7—C8—C9 122.8 (5) C48—C49—H49B 109.5 
C10—C9—O7 124.1 (5) H49A—C49—H49B 109.5 
C10—C9—C8 121.2 (5) C48—C49—H49C 109.5 
O7—C9—C8 114.7 (5) H49A—C49—H49C 109.5 
C9—C10—C11 121.4 (5) H49B—C49—H49C 109.5 
C9—C10—H10A 119.3 C55—C50—C51 120.7 (5) 
C11—C10—H10A 119.3 C55—C50—S2 120.3 (4) 
C12—C11—C10 119.9 (5) C51—C50—S2 119.1 (5) 
C12—C11—H11A 120.1 C52—C51—C50 119.5 (6) 
C10—C11—H11A 120.1 C52—C51—H51A 120.2 
C11—C12—O8 123.3 (5) C50—C51—H51A 120.2 
C11—C12—C13 120.4 (5) C51—C52—C53 120.3 (6) 
O8—C12—C13 116.1 (4) C51—C52—H52A 119.9 
C12—C13—C8 120.1 (5) C53—C52—H52A 119.9 
C12—C13—C14 120.4 (5) C54—C53—C52 119.0 (5) 
C8—C13—C14 119.2 (4) C54—C53—H53A 120.5 
C15—C14—C13 117.9 (5) C52—C53—H53A 120.5 
C15—C14—H14A 121.0 C55—C54—C53 120.3 (6) 
C13—C14—H14A 121.0 C55—C54—H54A 119.9 
C14—C15—C6 123.6 (5) C53—C54—H54A 119.9 
C14—C15—C16 127.4 (5) C50—C55—C54 120.1 (6) 
C6—C15—C16 108.3 (4) C50—C55—H55A 119.9 
O1—C16—C17 103.4 (4) C54—C55—H55A 119.9 
O1—C16—C15 110.1 (4) O14—C56—C57 106.6 (8) 
C17—C16—C15 128.2 (4) O14—C56—H56A 110.4 
O1—C16—C4 102.5 (4) C57—C56—H56A 110.4 
C17—C16—C4 103.3 (4) O14—C56—H56B 110.4 
C15—C16—C4 106.4 (4) C57—C56—H56B 110.4 
O9—C17—C16 128.4 (5) H56A—C56—H56B 108.6 
O9—C17—C1 126.1 (5) C56—C57—O15 103.0 (10) 
C16—C17—C1 105.2 (4) C56—C57—H57A 111.2 
C2—C18—C19 113.9 (4) O15—C57—H57A 111.2 
C2—C18—H18A 108.8 C56—C57—H57B 111.2 
C19—C18—H18A 108.8 O15—C57—H57B 111.2 
C2—C18—H18B 108.8 H57A—C57—H57B 109.1 
C19—C18—H18B 108.8 O14—C56B—C57B 102 (3) 
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H18A—C18—H18B 107.7 O14—C56B—H56C 111.4 
C18—C19—H19A 109.5 C57B—C56B—H56C 111.4 
C18—C19—H19B 109.5 O14—C56B—H56D 111.4 
H19A—C19—H19B 109.5 C57B—C56B—H56D 111.4 
C18—C19—H19C 109.5 H56C—C56B—H56D 109.3 
H19A—C19—H19C 109.5 O15—C57B—C56B 103 (3) 
H19B—C19—H19C 109.5 O15—C57B—H57C 111.1 
C25—C20—C21 121.3 (6) O15—C57B—H57D 111.1 
C25—C20—S1 119.4 (5) C56B—C57B—H57D 111.1 
C21—C20—S1 119.2 (5) O17—C58—H58A 109.5 
C22—C21—C20 117.0 (6) O17—C58—H58B 109.5 
C22—C21—H21A 121.5 H58A—C58—H58B 109.5 
C20—C21—H21A 121.5 O17—C58—H58C 109.5 
C23—C22—C21 121.5 (7) H58A—C58—H58C 109.5 
C23—C22—H22A 119.2 H58B—C58—H58C 109.5 
C21—C22—H22A 119.2 O18—C59—H59A 109.5 
C22—C23—C24 122.5 (6) O18—C59—H59B 109.5 
C22—C23—H23A 118.8 O18—C59—H59C 109.5 
C24—C23—H23A 118.8 O18—C59B—H59D 109.5 
C23—C24—C25 119.0 (6) O18—C59B—H59E 109.5 
C23—C24—H24A 120.5 H59D—C59B—H59E 109.5 
C25—C24—H24A 120.5 O18—C59B—H59F 109.5 
C20—C25—C24 118.7 (6) H59D—C59B—H59F 109.5 
C20—C25—H25A 120.7 H59E—C59B—H59F 109.5 
C24—C25—H25A 120.7 Cl2S—C1S—Cl1S 112.6 (6) 
O4—C26—C27 102.1 (4) Cl2S—C1S—H1SA 109.1 
O4—C26—H26A 111.4 Cl1S—C1S—H1SA 109.1 
C27—C26—H26A 111.4 Cl2S—C1S—H1SB 109.1 
O4—C26—H26B 111.4 Cl1S—C1S—H1SB 109.1 
C27—C26—H26B 111.4 H1SA—C1S—H1SB 107.8 
H26A—C26—H26B 109.2 C12S—C11S—H11B 109.5 
O5—C27—C26 103.7 (5) C12S—C11S—H11C 109.5 
O5—C27—H27A 111.0 H11B—C11S—H11C 109.5 
C26—C27—H27A 111.0 C12S—C11S—H11D 109.5 
O5—C27—H27B 111.0 H11B—C11S—H11D 109.5 
C26—C27—H27B 111.0 H11C—C11S—H11D 109.5 
H27A—C27—H27B 109.0 C13S—C12S—C11S 106.4 (8) 
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O7—C28—H28A 109.5 C13S—C12S—H12A 110.4 
O7—C28—H28B 109.5 C11S—C12S—H12A 110.4 
H28A—C28—H28B 109.5 C13S—C12S—H12B 110.4 
O7—C28—H28C 109.5 C11S—C12S—H12B 110.4 
H28A—C28—H28C 109.5 H12A—C12S—H12B 108.6 
H28B—C28—H28C 109.5 C14S—C13S—C12S 110.1 (7) 
O8—C29—H29A 109.5 C14S—C13S—H13A 109.6 
O8—C29—H29B 109.5 C12S—C13S—H13A 109.6 
H29A—C29—H29B 109.5 C14S—C13S—H13B 109.6 
O8—C29—H29C 109.5 C12S—C13S—H13B 109.6 
H29A—C29—H29C 109.5 H13A—C13S—H13B 108.2 
H29B—C29—H29C 109.5 C13S—C14S—C15S 108.7 (8) 
C32—C31—C1 115.5 (4) C13S—C14S—H14B 110.0 
C32—C31—C47 99.4 (4) C15S—C14S—H14B 110.0 
C1—C31—C47 112.0 (4) C13S—C14S—H14C 110.0 
C32—C31—H31A 109.8 C15S—C14S—H14C 110.0 
C1—C31—H31A 109.8 H14B—C14S—H14C 108.3 
C47—C31—H31A 109.8 C14S—C15S—H15A 109.5 
O11—C32—C48 109.6 (4) C14S—C15S—H15B 109.5 
O11—C32—C31 101.4 (4) H15A—C15S—H15B 109.5 
C48—C32—C31 118.4 (4) C14S—C15S—H15C 109.5 
O11—C32—C33 100.0 (4) H15A—C15S—H15C 109.5 
C48—C32—C33 114.0 (4) H15B—C15S—H15C 109.5 
 
C16—O1—C2—C18 -176.5 (4) C47—C31—C32—C48 -159.6 (4) 
C16—O1—C2—C1 56.8 (4) C1—C31—C32—C33 -174.3 (4) 
C16—O1—C2—C3 -56.4 (4) C47—C31—C32—C33 65.7 (4) 
C17—C1—C2—O1 -40.8 (4) O11—C32—C33—C34 35.1 (4) 
C31—C1—C2—O1 75.6 (4) C48—C32—C33—C34 151.9 (4) 
C17—C1—C2—C18 -160.9 (4) C31—C32—C33—C34 -71.3 (5) 
C31—C1—C2—C18 -44.5 (6) O11—C32—C33—S2 159.9 (3) 
C17—C1—C2—C3 62.3 (5) C48—C32—C33—S2 -83.3 (5) 
C31—C1—C2—C3 178.7 (4) C31—C32—C33—S2 53.5 (5) 
O1—C2—C3—C4 36.2 (4) O12—S2—C33—C34 174.4 (3) 
C18—C2—C3—C4 153.1 (4) O13—S2—C33—C34 44.7 (4) 
C1—C2—C3—C4 -67.8 (5) C50—S2—C33—C34 -70.5 (4) 
O1—C2—C3—S1 161.0 (3) O12—S2—C33—C32 55.2 (4) 
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C18—C2—C3—S1 -82.1 (5) O13—S2—C33—C32 -74.6 (4) 
C1—C2—C3—S1 57.0 (5) C50—S2—C33—C32 170.3 (4) 
O2—S1—C3—C4 30.5 (4) C32—C33—C34—C46 -1.1 (5) 
O3—S1—C3—C4 160.5 (4) S2—C33—C34—C46 -127.1 (3) 
C20—S1—C3—C4 -85.4 (4) C32—C33—C34—C35 -115.3 (4) 
O2—S1—C3—C2 -88.1 (4) S2—C33—C34—C35 118.7 (4) 
O3—S1—C3—C2 41.9 (4) C56—O14—C35—O15 4.0 (6) 
C20—S1—C3—C2 156.0 (4) C56B—O14—C35—O15 -18.2 (13) 
C2—C3—C4—C5 -118.5 (4) C56—O14—C35—C36 129.1 (6) 
S1—C3—C4—C5 116.7 (4) C56B—O14—C35—C36 106.9 (13) 
C2—C3—C4—C16 -3.1 (5) C56—O14—C35—C34 -115.3 (6) 
S1—C3—C4—C16 -127.9 (4) C56B—O14—C35—C34 -137.5 (12) 
C26—O4—C5—O5 12.9 (6) C57B—O15—C35—O14 3 (3) 
C26—O4—C5—C6 -109.0 (5) C57—O15—C35—O14 9.8 (8) 
C26—O4—C5—C4 136.3 (4) C57B—O15—C35—C36 -122 (3) 
C27—O5—C5—O4 9.4 (5) C57—O15—C35—C36 -115.3 (8) 
C27—O5—C5—C6 136.1 (4) C57B—O15—C35—C34 125 (3) 
C27—O5—C5—C4 -110.4 (5) C57—O15—C35—C34 131.7 (8) 
C3—C4—C5—O4 -102.1 (5) C33—C34—C35—O14 13.3 (6) 
C16—C4—C5—O4 144.6 (4) C46—C34—C35—O14 -98.8 (5) 
C3—C4—C5—O5 17.6 (6) C33—C34—C35—O15 -105.1 (5) 
C16—C4—C5—O5 -95.7 (5) C46—C34—C35—O15 142.8 (4) 
C3—C4—C5—C6 134.5 (4) C33—C34—C35—C36 135.1 (4) 
C16—C4—C5—C6 21.2 (5) C46—C34—C35—C36 23.0 (5) 
O4—C5—C6—C7 52.5 (7) O14—C35—C36—C37 -71.8 (7) 
O5—C5—C6—C7 -69.1 (6) O15—C35—C36—C37 49.9 (7) 
C4—C5—C6—C7 170.2 (5) C34—C35—C36—C37 166.6 (5) 
O4—C5—C6—C15 -132.3 (4) O14—C35—C36—C45 109.3 (5) 
O5—C5—C6—C15 106.0 (5) O15—C35—C36—C45 -129.0 (4) 
C4—C5—C6—C15 -14.7 (5) C34—C35—C36—C45 -12.3 (5) 
C15—C6—C7—O6 175.6 (4) C45—C36—C37—O16 -177.4 (5) 
C5—C6—C7—O6 -9.5 (8) C35—C36—C37—O16 3.8 (9) 
C15—C6—C7—C8 -9.0 (7) C45—C36—C37—C38 2.7 (8) 
C5—C6—C7—C8 165.8 (5) C35—C36—C37—C38 -176.1 (5) 
O6—C7—C8—C13 179.0 (5) C36—C37—C38—C43 0.8 (8) 
C6—C7—C8—C13 3.9 (7) O16—C37—C38—C43 -179.2 (5) 
O6—C7—C8—C9 3.0 (8) C36—C37—C38—C39 178.7 (6) 
  Appendix 2 
 
 192 
Table 1.2 (Continued) 
C6—C7—C8—C9 -172.0 (5) O16—C37—C38—C39 -1.3 (9) 
C28—O7—C9—C10 -22.4 (8) C58—O17—C39—C40 -11.3 (10) 
C28—O7—C9—C8 156.1 (5) C58—O17—C39—C38 168.5 (6) 
C13—C8—C9—C10 -4.3 (8) C37—C38—C39—C40 -175.6 (6) 
C7—C8—C9—C10 171.7 (5) C43—C38—C39—C40 2.3 (9) 
C13—C8—C9—O7 177.1 (4) C37—C38—C39—O17 4.7 (9) 
C7—C8—C9—O7 -6.9 (7) C43—C38—C39—O17 -177.4 (5) 
O7—C9—C10—C11 179.1 (5) O17—C39—C40—C41 -179.7 (6) 
C8—C9—C10—C11 0.7 (8) C38—C39—C40—C41 0.5 (10) 
C9—C10—C11—C12 2.5 (8) C39—C40—C41—C42 -2.8 (10) 
C10—C11—C12—O8 -177.5 (5) C40—C41—C42—O18 179.3 (6) 
C10—C11—C12—C13 -1.8 (8) C40—C41—C42—C43 2.1 (10) 
C29—O8—C12—C11 23.4 (7) C59B—O18—C42—C41 -23 (2) 
C29—O8—C12—C13 -152.5 (5) C59—O18—C42—C41 -5.3 (9) 
C11—C12—C13—C8 -2.1 (8) C59B—O18—C42—C43 155 (2) 
O8—C12—C13—C8 173.9 (4) C59—O18—C42—C43 172.2 (7) 
C11—C12—C13—C14 -177.1 (5) C41—C42—C43—C38 0.9 (9) 
O8—C12—C13—C14 -1.1 (7) O18—C42—C43—C38 -176.6 (5) 
C7—C8—C13—C12 -171.2 (5) C41—C42—C43—C44 179.6 (6) 
C9—C8—C13—C12 5.0 (7) O18—C42—C43—C44 2.1 (8) 
C7—C8—C13—C14 3.9 (7) C37—C38—C43—C42 175.0 (5) 
C9—C8—C13—C14 -179.9 (5) C39—C38—C43—C42 -3.0 (8) 
C12—C13—C14—C15 168.6 (5) C37—C38—C43—C44 -3.8 (8) 
C8—C13—C14—C15 -6.5 (7) C39—C38—C43—C44 178.2 (5) 
C13—C14—C15—C6 1.4 (7) C42—C43—C44—C45 -175.5 (5) 
C13—C14—C15—C16 -167.3 (5) C38—C43—C44—C45 3.2 (8) 
C7—C6—C15—C14 6.6 (8) C43—C44—C45—C36 0.3 (8) 
C5—C6—C15—C14 -169.1 (5) C43—C44—C45—C46 180.0 (5) 
C7—C6—C15—C16 177.2 (5) C37—C36—C45—C44 -3.3 (8) 
C5—C6—C15—C16 1.5 (6) C35—C36—C45—C44 175.7 (5) 
C2—O1—C16—C17 -50.7 (4) C37—C36—C45—C46 176.9 (5) 
C2—O1—C16—C15 169.4 (4) C35—C36—C45—C46 -4.1 (6) 
C2—O1—C16—C4 56.5 (4) C32—O11—C46—C45 168.7 (4) 
C14—C15—C16—O1 72.2 (6) C32—O11—C46—C47 -53.0 (4) 
C6—C15—C16—O1 -97.9 (4) C32—O11—C46—C34 56.8 (4) 
C14—C15—C16—C17 -54.8 (8) C44—C45—C46—O11 88.7 (6) 
C6—C15—C16—C17 135.0 (5) C36—C45—C46—O11 -91.6 (5) 
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C14—C15—C16—C4 -177.4 (5) C44—C45—C46—C47 -37.8 (8) 
C6—C15—C16—C4 12.4 (5) C36—C45—C46—C47 141.9 (5) 
C3—C4—C16—O1 -31.1 (5) C44—C45—C46—C34 -160.8 (5) 
C5—C4—C16—O1 94.3 (4) C36—C45—C46—C34 18.9 (5) 
C3—C4—C16—C17 76.1 (4) C33—C34—C46—O11 -33.1 (4) 
C5—C4—C16—C17 -158.4 (4) C35—C34—C46—O11 91.6 (4) 
C3—C4—C16—C15 -146.8 (4) C33—C34—C46—C45 -150.6 (4) 
C5—C4—C16—C15 -21.3 (5) C35—C34—C46—C45 -26.0 (5) 
O1—C16—C17—O9 -162.2 (5) C33—C34—C46—C47 74.2 (4) 
C15—C16—C17—O9 -32.6 (8) C35—C34—C46—C47 -161.2 (4) 
C4—C16—C17—O9 91.3 (6) O11—C46—C47—O19 -158.9 (5) 
O1—C16—C17—C1 23.6 (4) C45—C46—C47—O19 -28.6 (8) 
C15—C16—C17—C1 153.2 (4) C34—C46—C47—O19 93.9 (6) 
C4—C16—C17—C1 -82.9 (4) O11—C46—C47—C31 27.3 (4) 
C31—C1—C17—O9 78.5 (6) C45—C46—C47—C31 157.7 (5) 
C2—C1—C17—O9 -164.0 (5) C34—C46—C47—C31 -79.8 (4) 
C31—C1—C17—C16 -107.1 (4) C32—C31—C47—O19 -166.7 (5) 
C2—C1—C17—C16 10.4 (5) C1—C31—C47—O19 70.8 (6) 
O1—C2—C18—C19 51.6 (6) C32—C31—C47—C46 7.1 (4) 
C1—C2—C18—C19 166.3 (5) C1—C31—C47—C46 -115.5 (4) 
C3—C2—C18—C19 -58.3 (6) O11—C32—C48—C49 56.0 (6) 
O2—S1—C20—C25 159.4 (5) C31—C32—C48—C49 171.5 (4) 
O3—S1—C20—C25 27.8 (6) C33—C32—C48—C49 -55.2 (6) 
C3—S1—C20—C25 -85.3 (5) O12—S2—C50—C55 -141.4 (4) 
O2—S1—C20—C21 -22.6 (6) O13—S2—C50—C55 -10.9 (5) 
O3—S1—C20—C21 -154.2 (5) C33—S2—C50—C55 105.3 (5) 
C3—S1—C20—C21 92.7 (5) O12—S2—C50—C51 38.9 (5) 
C25—C20—C21—C22 1.5 (9) O13—S2—C50—C51 169.4 (4) 
S1—C20—C21—C22 -176.5 (5) C33—S2—C50—C51 -74.3 (5) 
C20—C21—C22—C23 0.7 (9) C55—C50—C51—C52 -0.6 (8) 
C21—C22—C23—C24 -1.8 (10) S2—C50—C51—C52 179.1 (4) 
C22—C23—C24—C25 0.7 (10) C50—C51—C52—C53 2.6 (9) 
C21—C20—C25—C24 -2.5 (9) C51—C52—C53—C54 -2.9 (9) 
S1—C20—C25—C24 175.5 (5) C52—C53—C54—C55 1.3 (9) 
C23—C24—C25—C20 1.4 (9) C51—C50—C55—C54 -1.0 (8) 
C5—O4—C26—C27 -28.9 (6) S2—C50—C55—C54 179.3 (5) 
C5—O5—C27—C26 -26.8 (6) C53—C54—C55—C50 0.7 (9) 
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Table 1.2 (Continued) 
O4—C26—C27—O5 33.6 (6) C35—O14—C56—C57 -16.3 (11) 
C17—C1—C31—C32 -142.1 (4) O14—C56—C57—O15 20.9 (13) 
C2—C1—C31—C32 108.2 (5) C35—O15—C57—C56 -18.8 (12) 
C17—C1—C31—C47 -29.3 (6) C56—O14—C56B—C57B -89 (6) 
C2—C1—C31—C47 -138.9 (4) C35—O14—C56B—C57B 24 (3) 
C46—O11—C32—C48 -176.0 (4) C35—O15—C57B—C56B 13 (5) 
C46—O11—C32—C31 58.1 (4) C57—O15—C57B—C56B -21 (14) 
C46—O11—C32—C33 -55.9 (4) O14—C56B—C57B—O15 -23 (4) 
C1—C31—C32—O11 80.2 (5) C11S—C12S—C13S—C14S -177.5 (9) 
C47—C31—C32—O11 -39.8 (4) C12S—C13S—C14S—C15S 176.3 (9) 
C1—C31—C32—C48 -39.7 (6)   
 
Table 1.3 Hydrogen-bond parameters 
D—H···A D—H (Å) H···A (Å) D···A (Å) D—H···A (°) 
O6—H6O···O7 0.88 1.82 2.535 (5) 136.3 
O6—H6O···O9i 0.88 2.55 3.032 (5) 115.0 
O16—H16O···O17 0.88 1.78 2.496 (6) 137.1 
 
Symmetry code(s):  (i) -x+1, y+1/2, -z-1. 
 
Figure 1.1 Perspective views showing 50% probability for two independent molecules 
(disorder part and the H atoms that ride on the C atoms have been omitted). 
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Figure 1.2. Three-dimensional supramolecular architecture viewed along the b-axis 
direction (disorder part, the H atoms ride on C atoms and solvents have been omitted). 
Compound 5.17 
NOTE: The intensity of this data is too weak (#Sigma %<2s up to 92.3 at 0.94 Ang.), 
since the crystal is micro -size. This result is NOT for publication. 
Table 2.1 Experimental details 
 V-108 
Crystal data 
Chemical formula C50H52O15 
Mr 892.92 
Crystal system, space group Monoclinic, P21 
Temperature (K) 100 
a, b, c (Å) 14.4713 (7), 22.2295 (9), 19.9174 (8) 
b (°) 92.343 (2) 
V (Å3) 6401.9 (5) 
!"
#"
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Table 2.1 (Continued) 
Z 4 
Radiation type Mo Ka 
m (mm-1) 0.07 
Crystal size (mm) 0.24 ! 0.06 ! 0.04 
Data collection 
Diffractometer CCD area detector diffractometer 
Absorption correction Multi-scan  
SADABS (Sheldrick, 2009) 
 Tmin, Tmax 0.984, 0.997 
No. of measured, independent 
and observed [I > 2s(I)] 
reflections 
22193, 22193, 10735   
Rint 0.095 
Refinement 
R[F2 > 2s(F2)], wR(F2), S 0.141,  0.307,  1.08 
No. of reflections 22193 
No. of parameters 1050 
No. of restraints 1324 
H-atom treatment H-atom parameters constrained 
D#max, D#min (e Å-3) 1.01, -0.82 
Absolute structure Flack H D (1983), Acta Cryst. A39, 876-881 
Flack parameter -2 (2) 
 
  Computer programs: APEX2 v2009.3.0 (Bruker-AXS, 2009), SAINT 7.46A (Bruker-AXS, 2009), 
SHELXS97 (Sheldrick, 2008), SHELXL97 (Sheldrick, 2008), Bruker SHELXTL. 
       
 
Table 2.2 Geometric parameters (Å, º) 
O1—C2 1.581 (12) O22—C53 1.461 (11) 
O1—C16 1.633 (11) O23—C55 1.117 (10) 
O2—C3 1.458 (12) O24—C65 1.343 (13) 
O3—C5 1.116 (11) O24—C87 1.457 (9) 
O4—C8 1.355 (8) O25—C90 0.890 (15) 
O4—C37 1.442 (9) O25—C59 1.298 (13) 
O5—C12 1.358 (9) O26—C91B 1.38 (2) 
O5—C40 1.458 (15) O26—C91 1.393 (15) 
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Table 2.2 (Continued) 
O6—C9 1.420 (9) O26—C62 1.457 (13) 
O6—C41 1.434 (13) O27—C67 1.368 (13) 
O7—C42 1.442 (12) O27—C92 1.501 (13) 
O7—C17 1.553 (14) O28—C69 1.463 (12) 
O8—C33 1.434 (10) O28—C83 1.465 (13) 
O8—C19 1.486 (11) O29—C70 1.438 (11) 
O9—C20 1.471 (11) O30—C72 1.151 (12) 
O10—C22 1.145 (9) O31—C82 1.415 (10) 
O11—C32 1.379 (8) O31—C95 1.437 (9) 
O11—C45 1.422 (9) O32—C76 1.411 (9) 
O12—C48 1.428 (17) O32—C98 1.476 (9) 
O12—C26 1.432 (11) O33—C79 1.315 (8) 
O13—C29 1.270 (8) O33—C99 1.417 (12) 
O13—C49 1.619 (13) O34—C84 1.427 (13) 
O14—C34 1.435 (12) O34—C100 1.464 (14) 
O14—C50 1.536 (15) O35—C84 1.441 (12) 
O15—C17 1.184 (12) O35—C67 1.489 (12) 
O15—C34 1.347 (12) C51—C68 1.448 (13) 
C1—C18 1.421 (12) C51—C52 1.547 (15) 
C1—C2 1.494 (14) C51—C67 1.631 (14) 
C1—C17 1.774 (15) C52—C53 1.409 (14) 
C2—C35 1.462 (18) C52—C85 1.567 (15) 
C2—C3 1.488 (15) C53—C54 1.623 (13) 
C3—C4 1.517 (15) C54—C66 1.250 (14) 
C4—C5 1.425 (14) C54—C55 1.341 (14) 
C4—C16 1.462 (13) C55—C56 1.632 (10) 
C5—C7 1.630 (11) C59—C60 1.3900 
C9—C10 1.3900 C59—C64 1.3900 
C9—C14 1.3900 C60—C61 1.3900 
C10—C11 1.3900 C61—C62 1.3900 
C11—C12 1.3900 C62—C63 1.3900 
C12—C13 1.3900 C63—C64 1.3900 
C13—C14 1.3900 C63—C58 1.3900 
C13—C8 1.3900 C64—C65 1.3900 
C14—C15 1.3900 C65—C56 1.3900 
C15—C6 1.3900 C56—C57 1.3900 
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C6—C7 1.3900 C57—C58 1.3900 
C6—C16 1.494 (10) C57—C66 1.516 (13) 
C7—C8 1.3900 C66—C67 1.555 (15) 
C16—C17 1.448 (14) C68—C69 1.530 (14) 
C18—C34 1.466 (14) C68—C84 1.675 (14) 
C18—C19 1.471 (12) C69—C93 1.541 (16) 
C19—C20 1.452 (13) C69—C70 1.587 (14) 
C19—C43 1.516 (13) C70—C71 1.408 (15) 
C20—C21 1.571 (12) C71—C72 1.622 (16) 
C21—C22 1.509 (11) C71—C83 1.741 (16) 
C21—C33 1.542 (11) C72—C73 1.544 (10) 
C22—C23 1.547 (8) C76—C77 1.3900 
C26—C27 1.3900 C76—C81 1.3900 
C26—C31 1.3900 C77—C78 1.3900 
C27—C28 1.3900 C78—C79 1.3900 
C28—C29 1.3900 C79—C80 1.3900 
C29—C30 1.3900 C80—C81 1.3900 
C30—C31 1.3900 C80—C75 1.3900 
C30—C25 1.3900 C81—C82 1.3900 
C31—C32 1.3900 C82—C73 1.3900 
C32—C23 1.3900 C73—C74 1.3900 
C23—C24 1.3900 C74—C75 1.3900 
C24—C25 1.3900 C74—C83 1.543 (11) 
C24—C33 1.445 (9) C83—C84 1.321 (15) 
C33—C34 1.575 (13) C85—C86 1.518 (16) 
C35—C36 1.519 (9) C87—C88 1.548 (9) 
C37—C38 1.514 (9) C88—C89 1.344 (9) 
C38—C39 1.357 (9) C88—C97i 1.90 (2) 
C43—C44 1.551 (16) C93—C94 1.513 (17) 
C45—C46 1.546 (9) C95—C96 1.520 (9) 
C46—C47 1.333 (9) C96—C97 1.319 (10) 
O21—C52 1.464 (13) C97—C88ii 1.90 (2) 
O21—C66 1.602 (13)   
 
C2—O1—C16 90.9 (6) C91B—O26—C91 45.4 (18) 
C8—O4—C37 112.7 (9) C91B—O26—C62 125.3 (17) 
C12—O5—C40 121.2 (10) C91—O26—C62 164.8 (19) 
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C9—O6—C41 108.4 (7) C67—O27—C92 116.9 (8) 
C42—O7—C17 104.5 (7) C69—O28—C83 98.3 (8) 
C33—O8—C19 96.8 (6) C82—O31—C95 166.0 (12) 
C32—O11—C45 132.5 (9) C76—O32—C98 153.1 (11) 
C48—O12—C26 133.2 (12) C79—O33—C99 114.7 (6) 
C29—O13—C49 119.1 (7) C84—O34—C100 113.6 (9) 
C34—O14—C50 112.8 (9) C84—O35—C67 121.2 (8) 
C17—O15—C34 119.6 (9) C68—C51—C52 132.6 (9) 
C18—C1—C2 128.9 (9) C68—C51—C67 107.6 (8) 
C18—C1—C17 101.5 (8) C52—C51—C67 102.8 (8) 
C2—C1—C17 102.5 (8) C53—C52—O21 103.9 (9) 
C35—C2—C3 117.9 (11) C53—C52—C51 114.5 (10) 
C35—C2—C1 115.4 (10) O21—C52—C51 95.0 (8) 
C3—C2—C1 116.7 (9) C53—C52—C85 123.3 (9) 
C35—C2—O1 103.8 (10) O21—C52—C85 104.7 (9) 
C3—C2—O1 99.3 (8) C51—C52—C85 110.5 (9) 
C1—C2—O1 98.8 (7) C52—C53—O22 114.2 (9) 
O2—C3—C2 110.9 (8) C52—C53—C54 100.4 (8) 
O2—C3—C4 117.7 (9) O22—C53—C54 119.1 (7) 
C2—C3—C4 104.2 (9) C66—C54—C55 124.0 (11) 
C5—C4—C16 115.2 (9) C66—C54—C53 106.8 (9) 
C5—C4—C3 119.5 (9) C55—C54—C53 115.2 (8) 
C16—C4—C3 106.2 (9) O23—C55—C54 145.8 (10) 
O3—C5—C4 141.7 (11) O23—C55—C56 118.0 (9) 
O3—C5—C7 117.3 (9) C54—C55—C56 96.1 (7) 
C4—C5—C7 101.1 (7) O25—C59—C60 116.9 (7) 
C10—C9—C14 120.0 O25—C59—C64 122.1 (7) 
C10—C9—O6 126.8 (4) C60—C59—C64 120.0 
C14—C9—O6 113.1 (4) C61—C60—C59 120.0 
C11—C10—C9 120.0 C60—C61—C62 120.0 
C10—C11—C12 120.0 C63—C62—C61 120.0 
O5—C12—C13 118.3 (4) C63—C62—O26 115.2 (5) 
O5—C12—C11 120.9 (4) C61—C62—O26 124.7 (5) 
C13—C12—C11 120.0 C62—C63—C64 120.0 
C12—C13—C14 120.0 C62—C63—C58 120.0 
C12—C13—C8 120.0 C64—C63—C58 120.0 
C14—C13—C8 120.0 C65—C64—C63 120.0 
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C15—C14—C13 120.0 C65—C64—C59 120.0 
C15—C14—C9 120.0 C63—C64—C59 120.0 
C13—C14—C9 120.0 O24—C65—C56 119.2 (7) 
C6—C15—C14 120.0 O24—C65—C64 120.2 (7) 
C15—C6—C7 120.0 C56—C65—C64 120.0 
C15—C6—C16 128.3 (5) C65—C56—C57 120.0 
C7—C6—C16 111.6 (5) C65—C56—C55 131.1 (5) 
C8—C7—C6 120.0 C57—C56—C55 108.4 (5) 
C8—C7—C5 132.2 (5) C58—C57—C56 120.0 
C6—C7—C5 107.6 (5) C58—C57—C66 135.2 (6) 
O4—C8—C7 116.1 (4) C56—C57—C66 104.5 (6) 
O4—C8—C13 123.6 (4) C57—C58—C63 120.0 
C7—C8—C13 120.0 C54—C66—C57 106.1 (10) 
C17—C16—C4 125.7 (9) C54—C66—C67 123.2 (11) 
C17—C16—C6 122.5 (8) C57—C66—C67 123.9 (9) 
C4—C16—C6 104.0 (7) C54—C66—O21 99.0 (8) 
C17—C16—O1 98.8 (7) C57—C66—O21 103.1 (8) 
C4—C16—O1 97.7 (7) C67—C66—O21 94.4 (8) 
C6—C16—O1 101.5 (6) O27—C67—O35 115.1 (8) 
O15—C17—C16 132.7 (11) O27—C67—C66 113.5 (9) 
O15—C17—O7 112.0 (9) O35—C67—C66 111.6 (9) 
C16—C17—O7 107.1 (8) O27—C67—C51 116.9 (9) 
O15—C17—C1 101.9 (9) O35—C67—C51 97.1 (7) 
C16—C17—C1 97.3 (8) C66—C67—C51 100.7 (8) 
O7—C17—C1 98.6 (8) C51—C68—C69 124.5 (9) 
C1—C18—C34 104.8 (8) C51—C68—C84 107.4 (8) 
C1—C18—C19 123.5 (9) C69—C68—C84 98.0 (7) 
C34—C18—C19 105.4 (8) O28—C69—C68 100.5 (8) 
C20—C19—C18 117.4 (8) O28—C69—C93 112.5 (10) 
C20—C19—O8 100.8 (7) C68—C69—C93 115.2 (9) 
C18—C19—O8 98.1 (7) O28—C69—C70 101.4 (7) 
C20—C19—C43 110.9 (8) C68—C69—C70 110.4 (8) 
C18—C19—C43 119.1 (8) C93—C69—C70 115.0 (9) 
O8—C19—C43 107.3 (7) C71—C70—O29 105.9 (9) 
C19—C20—O9 115.4 (8) C71—C70—C69 103.2 (8) 
C19—C20—C21 102.6 (7) O29—C70—C69 112.4 (8) 
O9—C20—C21 109.0 (7) C70—C71—C72 116.0 (11) 
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C22—C21—C33 105.3 (7) C70—C71—C83 104.2 (9) 
C22—C21—C20 116.5 (7) C72—C71—C83 93.7 (8) 
C33—C21—C20 100.4 (7) O30—C72—C73 120.0 (9) 
O10—C22—C21 131.3 (8) O30—C72—C71 124.4 (10) 
O10—C22—C23 125.0 (7) C73—C72—C71 115.0 (8) 
C21—C22—C23 103.4 (6) C77—C76—C81 120.0 
C27—C26—C31 120.0 C77—C76—O32 117.2 (5) 
C27—C26—O12 113.6 (5) C81—C76—O32 122.7 (5) 
C31—C26—O12 126.1 (5) C76—C77—C78 120.0 
C26—C27—C28 120.0 C79—C78—C77 120.0 
C29—C28—C27 120.0 O33—C79—C78 125.2 (3) 
O13—C29—C30 113.4 (4) O33—C79—C80 114.8 (3) 
O13—C29—C28 126.6 (4) C78—C79—C80 120.0 
C30—C29—C28 120.0 C79—C80—C81 120.0 
C29—C30—C31 120.0 C79—C80—C75 120.0 
C29—C30—C25 120.0 C81—C80—C75 120.0 
C31—C30—C25 120.0 C82—C81—C80 120.0 
C32—C31—C30 120.0 C82—C81—C76 120.0 
C32—C31—C26 120.0 C80—C81—C76 120.0 
C30—C31—C26 120.0 C73—C82—C81 120.0 
O11—C32—C23 116.2 (4) C73—C82—O31 112.1 (5) 
O11—C32—C31 123.8 (4) C81—C82—O31 127.7 (5) 
C23—C32—C31 120.0 C82—C73—C74 120.0 
C24—C23—C32 120.0 C82—C73—C72 132.9 (5) 
C24—C23—C22 110.3 (4) C74—C73—C72 107.1 (5) 
C32—C23—C22 129.5 (4) C75—C74—C73 120.0 
C23—C24—C25 120.0 C75—C74—C83 126.7 (5) 
C23—C24—C33 110.0 (4) C73—C74—C83 113.3 (5) 
C25—C24—C33 129.1 (4) C74—C75—C80 120.0 
C24—C25—C30 120.0 C84—C83—O28 103.6 (9) 
O8—C33—C24 111.0 (7) C84—C83—C74 129.8 (9) 
O8—C33—C21 103.4 (6) O28—C83—C74 105.3 (8) 
C24—C33—C21 106.5 (6) C84—C83—C71 108.0 (10) 
O8—C33—C34 96.9 (7) O28—C83—C71 97.5 (8) 
C24—C33—C34 128.4 (7) C74—C83—C71 107.8 (7) 
C21—C33—C34 108.0 (7) C83—C84—O34 123.2 (10) 
O15—C34—O14 105.8 (8) C83—C84—O35 117.2 (10) 
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O15—C34—C18 110.9 (8) O34—C84—O35 105.1 (9) 
O14—C34—C18 112.2 (9) C83—C84—C68 103.7 (9) 
O15—C34—C33 111.6 (8) O34—C84—C68 105.7 (8) 
O14—C34—C33 114.6 (8) O35—C84—C68 98.3 (7) 
C18—C34—C33 101.9 (8) C86—C85—C52 109.3 (9) 
C2—C35—C36 108.3 (12) O24—C87—C88 152 (2) 
O4—C37—C38 104.7 (11) C89—C88—C87 113.4 (13) 
C39—C38—C37 112.1 (13) C89—C88—C97i 127.7 (14) 
C19—C43—C44 117.9 (10) C87—C88—C97i 118.8 (14) 
O11—C45—C46 107.1 (12) C94—C93—C69 106.9 (10) 
C47—C46—C45 113.3 (13) O31—C95—C96 160 (2) 
C52—O21—C66 95.0 (8) C97—C96—C95 116.2 (15) 
C65—O24—C87 110.2 (12) C96—C97—C88ii 143.3 (19) 
C90—O25—C59 165 (2)   
 
C18—C1—C2—C35 28.5 (16) C66—O21—C52—C85 -179.8 (8) 
C17—C1—C2—C35 144.7 (12) C68—C51—C52—C53 165.6 (10) 
C18—C1—C2—C3 173.5 (9) C67—C51—C52—C53 -65.4 (11) 
C17—C1—C2—C3 -70.3 (10) C68—C51—C52—O21 -86.6 (13) 
C18—C1—C2—O1 -81.4 (11) C67—C51—C52—O21 42.4 (9) 
C17—C1—C2—O1 34.8 (9) C68—C51—C52—C85 21.1 (16) 
C16—O1—C2—C35 179.7 (9) C67—C51—C52—C85 150.1 (9) 
C16—O1—C2—C3 57.8 (8) O21—C52—C53—O22 -156.1 (8) 
C16—O1—C2—C1 -61.3 (8) C51—C52—C53—O22 -53.9 (12) 
C35—C2—C3—O2 83.5 (13) C85—C52—C53—O22 85.6 (13) 
C1—C2—C3—O2 -60.6 (12) O21—C52—C53—C54 -27.4 (10) 
O1—C2—C3—O2 -165.4 (8) C51—C52—C53—C54 74.8 (10) 
C35—C2—C3—C4 -148.9 (11) C85—C52—C53—C54 -145.7 (11) 
C1—C2—C3—C4 67.0 (11) C52—C53—C54—C66 -12.1 (12) 
O1—C2—C3—C4 -37.8 (10) O22—C53—C54—C66 113.3 (10) 
O2—C3—C4—C5 -105.6 (12) C52—C53—C54—C55 129.8 (10) 
C2—C3—C4—C5 131.1 (10) O22—C53—C54—C55 -104.8 (10) 
O2—C3—C4—C16 122.0 (10) C66—C54—C55—O23 175.3 (16) 
C2—C3—C4—C16 -1.4 (11) C53—C54—C55—O23 41 (2) 
C16—C4—C5—O3 173.3 (14) C66—C54—C55—C56 -8.5 (12) 
C3—C4—C5—O3 45 (2) C53—C54—C55—C56 -143.1 (8) 
C16—C4—C5—C7 -6.9 (11) C90—O25—C59—C60 82 (9) 
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C3—C4—C5—C7 -135.3 (9) C90—O25—C59—C64 -110 (8) 
C41—O6—C9—C10 -6.8 (9) O25—C59—C60—C61 168.6 (8) 
C41—O6—C9—C14 176.0 (6) C64—C59—C60—C61 0.0 
C14—C9—C10—C11 0.0 C59—C60—C61—C62 0.0 
O6—C9—C10—C11 -177.0 (7) C60—C61—C62—C63 0.0 
C9—C10—C11—C12 0.0 C60—C61—C62—O26 -176.5 (9) 
C40—O5—C12—C13 -167.5 (9) C91B—O26—C62—C63 160 (2) 
C40—O5—C12—C11 2.0 (12) C91—O26—C62—C63 112 (7) 
C10—C11—C12—O5 -169.3 (6) C91B—O26—C62—C61 -24 (3) 
C10—C11—C12—C13 0.0 C91—O26—C62—C61 -71 (7) 
O5—C12—C13—C14 169.6 (6) C61—C62—C63—C64 0.0 
C11—C12—C13—C14 0.0 O26—C62—C63—C64 176.8 (8) 
O5—C12—C13—C8 -10.4 (6) C61—C62—C63—C58 180.0 
C11—C12—C13—C8 180.0 O26—C62—C63—C58 -3.2 (8) 
C12—C13—C14—C15 180.0 C62—C63—C64—C65 180.0 
C8—C13—C14—C15 0.0 C58—C63—C64—C65 0.0 
C12—C13—C14—C9 0.0 C62—C63—C64—C59 0.0 
C8—C13—C14—C9 180.0 C58—C63—C64—C59 180.0 
C10—C9—C14—C15 180.0 O25—C59—C64—C65 12.0 (9) 
O6—C9—C14—C15 -2.6 (6) C60—C59—C64—C65 180.0 
C10—C9—C14—C13 0.0 O25—C59—C64—C63 -168.0 (9) 
O6—C9—C14—C13 177.4 (6) C60—C59—C64—C63 0.0 
C13—C14—C15—C6 0.0 C87—O24—C65—C56 99.9 (13) 
C9—C14—C15—C6 180.0 C87—O24—C65—C64 -71.0 (15) 
C14—C15—C6—C7 0.0 C63—C64—C65—O24 170.8 (9) 
C14—C15—C6—C16 -175.5 (6) C59—C64—C65—O24 -9.2 (9) 
C15—C6—C7—C8 0.0 C63—C64—C65—C56 0.0 
C16—C6—C7—C8 176.2 (5) C59—C64—C65—C56 180.0 
C15—C6—C7—C5 -175.5 (5) O24—C65—C56—C57 -170.9 (9) 
C16—C6—C7—C5 0.7 (6) C64—C65—C56—C57 0.0 
O3—C5—C7—C8 8.7 (12) O24—C65—C56—C55 0.0 (9) 
C4—C5—C7—C8 -171.1 (5) C64—C65—C56—C55 170.9 (7) 
O3—C5—C7—C6 -176.6 (8) O23—C55—C56—C65 8.6 (12) 
C4—C5—C7—C6 3.6 (8) C54—C55—C56—C65 -169.0 (6) 
C37—O4—C8—C7 -95.6 (10) O23—C55—C56—C57 -179.7 (8) 
C37—O4—C8—C13 90.7 (10) C54—C55—C56—C57 2.7 (7) 
C6—C7—C8—O4 -173.9 (6) C65—C56—C57—C58 0.0 
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C5—C7—C8—O4 0.2 (7) C55—C56—C57—C58 -172.7 (5) 
C6—C7—C8—C13 0.0 C65—C56—C57—C66 174.8 (6) 
C5—C7—C8—C13 174.2 (6) C55—C56—C57—C66 2.1 (7) 
C12—C13—C8—O4 -6.6 (6) C56—C57—C58—C63 0.0 
C14—C13—C8—O4 173.4 (6) C66—C57—C58—C63 -172.9 (8) 
C12—C13—C8—C7 180.0 C62—C63—C58—C57 180.0 
C14—C13—C8—C7 0.0 C64—C63—C58—C57 0.0 
C5—C4—C16—C17 156.9 (10) C55—C54—C66—C57 10.5 (14) 
C3—C4—C16—C17 -68.4 (13) C53—C54—C66—C57 148.1 (8) 
C5—C4—C16—C6 7.5 (11) C55—C54—C66—C67 162.5 (10) 
C3—C4—C16—C6 142.3 (8) C53—C54—C66—C67 -59.8 (13) 
C5—C4—C16—O1 -96.4 (9) C55—C54—C66—O21 -96.1 (11) 
C3—C4—C16—O1 38.3 (9) C53—C54—C66—O21 41.6 (10) 
C15—C6—C16—C17 20.5 (11) C58—C57—C66—C54 167.0 (6) 
C7—C6—C16—C17 -155.3 (8) C56—C57—C66—C54 -6.6 (9) 
C15—C6—C16—C4 171.1 (5) C58—C57—C66—C67 15.2 (14) 
C7—C6—C16—C4 -4.7 (8) C56—C57—C66—C67 -158.4 (9) 
C15—C6—C16—O1 -87.8 (6) C58—C57—C66—O21 -89.4 (8) 
C7—C6—C16—O1 96.4 (5) C56—C57—C66—O21 97.0 (6) 
C2—O1—C16—C17 69.9 (8) C52—O21—C66—C54 -57.9 (10) 
C2—O1—C16—C4 -58.2 (8) C52—O21—C66—C57 -166.8 (8) 
C2—O1—C16—C6 -164.2 (6) C52—O21—C66—C67 66.8 (8) 
C34—O15—C17—C16 -110.4 (14) C92—O27—C67—O35 53.8 (12) 
C34—O15—C17—O7 105.9 (10) C92—O27—C67—C66 -76.6 (12) 
C34—O15—C17—C1 1.4 (12) C92—O27—C67—C51 166.8 (9) 
C4—C16—C17—O15 174.0 (11) C84—O35—C67—O27 103.1 (11) 
C6—C16—C17—O15 -42.0 (18) C84—O35—C67—C66 -125.5 (10) 
O1—C16—C17—O15 67.8 (15) C84—O35—C67—C51 -21.0 (11) 
C4—C16—C17—O7 -41.1 (13) C54—C66—C67—O27 -58.4 (14) 
C6—C16—C17—O7 102.9 (9) C57—C66—C67—O27 88.7 (12) 
O1—C16—C17—O7 -147.3 (7) O21—C66—C67—O27 -162.2 (8) 
C4—C16—C17—C1 60.3 (12) C54—C66—C67—O35 169.5 (10) 
C6—C16—C17—C1 -155.7 (7) C57—C66—C67—O35 -43.4 (13) 
O1—C16—C17—C1 -45.9 (8) O21—C66—C67—O35 65.7 (9) 
C42—O7—C17—O15 81.6 (10) C54—C66—C67—C51 67.4 (13) 
C42—O7—C17—C16 -71.3 (9) C57—C66—C67—C51 -145.5 (9) 
C42—O7—C17—C1 -171.7 (7) O21—C66—C67—C51 -36.5 (9) 
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C18—C1—C17—O15 6.0 (11) C68—C51—C67—O27 -94.5 (10) 
C2—C1—C17—O15 -128.5 (9) C52—C51—C67—O27 122.4 (10) 
C18—C1—C17—C16 142.6 (8) C68—C51—C67—O35 28.4 (10) 
C2—C1—C17—C16 8.0 (10) C52—C51—C67—O35 -114.7 (9) 
C18—C1—C17—O7 -108.8 (8) C68—C51—C67—C66 142.1 (9) 
C2—C1—C17—O7 116.7 (8) C52—C51—C67—C66 -1.0 (10) 
C2—C1—C18—C34 106.7 (11) C52—C51—C68—C69 -146.9 (11) 
C17—C1—C18—C34 -9.9 (10) C67—C51—C68—C69 85.8 (11) 
C2—C1—C18—C19 -133.0 (11) C52—C51—C68—C84 100.1 (12) 
C17—C1—C18—C19 110.4 (10) C67—C51—C68—C84 -27.3 (11) 
C1—C18—C19—C20 169.5 (9) C83—O28—C69—C68 -53.7 (8) 
C34—C18—C19—C20 -70.5 (11) C83—O28—C69—C93 -176.7 (9) 
C1—C18—C19—O8 -83.9 (11) C83—O28—C69—C70 59.9 (9) 
C34—C18—C19—O8 36.1 (9) C51—C68—C69—O28 -87.5 (11) 
C1—C18—C19—C43 31.1 (14) C84—C68—C69—O28 30.0 (9) 
C34—C18—C19—C43 151.1 (9) C51—C68—C69—C93 33.7 (14) 
C33—O8—C19—C20 59.5 (8) C84—C68—C69—C93 151.2 (9) 
C33—O8—C19—C18 -60.5 (7) C51—C68—C69—C70 166.1 (9) 
C33—O8—C19—C43 175.5 (7) C84—C68—C69—C70 -76.4 (9) 
C18—C19—C20—O9 -55.5 (11) O28—C69—C70—C71 -42.2 (10) 
O8—C19—C20—O9 -160.6 (7) C68—C69—C70—C71 63.7 (10) 
C43—C19—C20—O9 86.0 (10) C93—C69—C70—C71 -163.8 (10) 
C18—C19—C20—C21 62.9 (10) O28—C69—C70—O29 -155.8 (8) 
O8—C19—C20—C21 -42.2 (8) C68—C69—C70—O29 -50.0 (11) 
C43—C19—C20—C21 -155.6 (8) C93—C69—C70—O29 82.5 (12) 
C19—C20—C21—C22 123.5 (8) O29—C70—C71—C72 -131.2 (9) 
O9—C20—C21—C22 -113.7 (8) C69—C70—C71—C72 110.6 (10) 
C19—C20—C21—C33 10.4 (9) O29—C70—C71—C83 127.4 (8) 
O9—C20—C21—C33 133.2 (7) C69—C70—C71—C83 9.2 (11) 
C33—C21—C22—O10 168.6 (8) C70—C71—C72—O30 64.7 (16) 
C20—C21—C22—O10 58.3 (12) C83—C71—C72—O30 172.4 (11) 
C33—C21—C22—C23 -18.3 (7) C70—C71—C72—C73 -124.1 (10) 
C20—C21—C22—C23 -128.6 (7) C83—C71—C72—C73 -16.4 (11) 
C48—O12—C26—C27 -28.5 (17) C98—O32—C76—C77 -36 (2) 
C48—O12—C26—C31 158.2 (12) C98—O32—C76—C81 141.3 (19) 
C31—C26—C27—C28 0.0 C81—C76—C77—C78 0.0 
O12—C26—C27—C28 -173.8 (7) O32—C76—C77—C78 177.2 (7) 
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C26—C27—C28—C29 0.0 C76—C77—C78—C79 0.0 
C49—O13—C29—C30 169.1 (6) C99—O33—C79—C78 1.3 (8) 
C49—O13—C29—C28 -8.6 (9) C99—O33—C79—C80 -178.9 (5) 
C27—C28—C29—O13 177.6 (6) C77—C78—C79—O33 179.8 (6) 
C27—C28—C29—C30 0.0 C77—C78—C79—C80 0.0 
O13—C29—C30—C31 -177.9 (5) O33—C79—C80—C81 -179.8 (5) 
C28—C29—C30—C31 0.0 C78—C79—C80—C81 0.0 
O13—C29—C30—C25 2.1 (5) O33—C79—C80—C75 0.2 (5) 
C28—C29—C30—C25 180.0 C78—C79—C80—C75 180.0 
C29—C30—C31—C32 180.0 C79—C80—C81—C82 180.0 
C25—C30—C31—C32 0.0 C75—C80—C81—C82 0.0 
C29—C30—C31—C26 0.0 C79—C80—C81—C76 0.0 
C25—C30—C31—C26 180.0 C75—C80—C81—C76 180.0 
C27—C26—C31—C32 180.0 C77—C76—C81—C82 180.0 
O12—C26—C31—C32 -7.1 (8) O32—C76—C81—C82 2.9 (7) 
C27—C26—C31—C30 0.0 C77—C76—C81—C80 0.0 
O12—C26—C31—C30 172.9 (8) O32—C76—C81—C80 -177.1 (7) 
C45—O11—C32—C23 120.5 (16) C80—C81—C82—C73 0.0 
C45—O11—C32—C31 -59.3 (17) C76—C81—C82—C73 180.0 
C30—C31—C32—O11 179.8 (6) C80—C81—C82—O31 -175.2 (8) 
C26—C31—C32—O11 -0.2 (6) C76—C81—C82—O31 4.8 (8) 
C30—C31—C32—C23 0.0 C95—O31—C82—C73 -160 (6) 
C26—C31—C32—C23 180.0 C95—O31—C82—C81 15 (6) 
O11—C32—C23—C24 -179.8 (6) C81—C82—C73—C74 0.0 
C31—C32—C23—C24 0.0 O31—C82—C73—C74 175.9 (7) 
O11—C32—C23—C22 6.2 (6) C81—C82—C73—C72 177.3 (7) 
C31—C32—C23—C22 -173.9 (5) O31—C82—C73—C72 -6.8 (8) 
O10—C22—C23—C24 -177.0 (7) O30—C72—C73—C82 5.3 (14) 
C21—C22—C23—C24 9.3 (6) C71—C72—C73—C82 -166.3 (6) 
O10—C22—C23—C32 -2.6 (10) O30—C72—C73—C74 -177.1 (9) 
C21—C22—C23—C32 -176.3 (4) C71—C72—C73—C74 11.2 (9) 
C32—C23—C24—C25 0.0 C82—C73—C74—C75 0.0 
C22—C23—C24—C25 175.0 (4) C72—C73—C74—C75 -177.9 (5) 
C32—C23—C24—C33 -170.4 (5) C82—C73—C74—C83 179.4 (6) 
C22—C23—C24—C33 4.6 (5) C72—C73—C74—C83 1.5 (7) 
C23—C24—C25—C30 0.0 C73—C74—C75—C80 0.0 
C33—C24—C25—C30 168.4 (6) C83—C74—C75—C80 -179.3 (7) 
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Table 2.2 (Continued) 
C29—C30—C25—C24 180.0 C79—C80—C75—C74 180.0 
C31—C30—C25—C24 0.0 C81—C80—C75—C74 0.0 
C19—O8—C33—C24 -165.7 (6) C69—O28—C83—C84 60.3 (10) 
C19—O8—C33—C21 -51.9 (7) C69—O28—C83—C74 -161.2 (7) 
C19—O8—C33—C34 58.5 (7) C69—O28—C83—C71 -50.4 (8) 
C23—C24—C33—O8 95.4 (6) C75—C74—C83—C84 33.4 (15) 
C25—C24—C33—O8 -73.9 (7) C73—C74—C83—C84 -145.9 (11) 
C23—C24—C33—C21 -16.4 (7) C75—C74—C83—O28 -89.6 (7) 
C25—C24—C33—C21 174.3 (4) C73—C74—C83—O28 91.0 (7) 
C23—C24—C33—C34 -146.6 (8) C75—C74—C83—C71 167.1 (6) 
C25—C24—C33—C34 44.1 (10) C73—C74—C83—C71 -12.3 (9) 
C22—C21—C33—O8 -95.2 (7) C70—C71—C83—C84 -81.8 (12) 
C20—C21—C33—O8 26.2 (8) C72—C71—C83—C84 160.3 (9) 
C22—C21—C33—C24 21.8 (8) C70—C71—C83—O28 25.3 (11) 
C20—C21—C33—C24 143.2 (6) C72—C71—C83—O28 -92.7 (8) 
C22—C21—C33—C34 162.8 (7) C70—C71—C83—C74 134.0 (9) 
C20—C21—C33—C34 -75.8 (8) C72—C71—C83—C74 16.0 (10) 
C17—O15—C34—O14 113.3 (10) O28—C83—C84—O34 -157.8 (9) 
C17—O15—C34—C18 -8.5 (14) C74—C83—C84—O34 78.5 (16) 
C17—O15—C34—C33 -121.4 (10) C71—C83—C84—O34 -55.1 (13) 
C50—O14—C34—O15 62.3 (11) O28—C83—C84—O35 68.7 (11) 
C50—O14—C34—C18 -176.6 (9) C74—C83—C84—O35 -55.0 (16) 
C50—O14—C34—C33 -61.1 (11) C71—C83—C84—O35 171.5 (8) 
C1—C18—C34—O15 11.9 (11) O28—C83—C84—C68 -38.3 (10) 
C19—C18—C34—O15 -119.7 (9) C74—C83—C84—C68 -162.0 (10) 
C1—C18—C34—O14 -106.2 (9) C71—C83—C84—C68 64.5 (10) 
C19—C18—C34—O14 122.2 (8) C100—O34—C84—C83 -61.4 (14) 
C1—C18—C34—C33 130.8 (8) C100—O34—C84—O35 76.6 (11) 
C19—C18—C34—C33 -0.9 (10) C100—O34—C84—C68 179.9 (9) 
O8—C33—C34—O15 82.3 (9) C67—O35—C84—C83 -104.0 (12) 
C24—C33—C34—O15 -41.5 (13) C67—O35—C84—O34 115.0 (9) 
C21—C33—C34—O15 -171.1 (8) C67—O35—C84—C68 6.2 (11) 
O8—C33—C34—O14 -157.4 (8) C51—C68—C84—C83 134.9 (9) 
C24—C33—C34—O14 78.8 (11) C69—C68—C84—C83 4.9 (10) 
C21—C33—C34—O14 -50.8 (10) C51—C68—C84—O34 -94.2 (9) 
O8—C33—C34—C18 -36.1 (9) C69—C68—C84—O34 135.7 (8) 
C24—C33—C34—C18 -159.9 (8) C51—C68—C84—O35 14.2 (10) 
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Table 2.2 (Continued) 
C21—C33—C34—C18 70.5 (9) C69—C68—C84—O35 -115.9 (8) 
C3—C2—C35—C36 52.3 (18) C53—C52—C85—C86 -69.5 (14) 
C1—C2—C35—C36 -163.2 (12) O21—C52—C85—C86 172.5 (9) 
O1—C2—C35—C36 -56.3 (15) C51—C52—C85—C86 71.3 (11) 
C8—O4—C37—C38 177.0 (11) C65—O24—C87—C88 -124 (3) 
O4—C37—C38—C39 -64 (2) O24—C87—C88—C89 103 (3) 
C20—C19—C43—C44 -86.9 (12) O24—C87—C88—C97i -78 (4) 
C18—C19—C43—C44 54.0 (13) O28—C69—C93—C94 -62.2 (13) 
O8—C19—C43—C44 164.0 (9) C68—C69—C93—C94 -176.6 (10) 
C32—O11—C45—C46 -179.2 (10) C70—C69—C93—C94 53.2 (13) 
O11—C45—C46—C47 -135 (2) C82—O31—C95—C96 22 (10) 
C66—O21—C52—C53 49.7 (9) O31—C95—C96—C97 -146 (5) 
C66—O21—C52—C51 -67.0 (8) C95—C96—C97—C88ii -161 (2) 
 
Symmetry code(s):  (i) x, y, z-1; (ii) x, y, z+1. 
 
Table 2.3 Hydrogen-bond parameters 
D—H···A D—H (Å) H···A (Å) D···A (Å) D—H···A (°) 
O2—H2O···O30i 0.86 2.02 2.883 (11) 179.9 
O9—H9O···O23ii 0.86 1.90 2.757 (10) 180.0 
O22—H22O···O10iii 0.86 2.00 2.860 (9) 179.5 
O29—H29O···O3iv 0.86 2.13 2.992 (11) 179.9 
 
Symmetry code(s):  (i) x-1, y, z-1; (ii) x-1, y, z; (iii) x+1, y, z; (iv) x+1, y, z+1. 
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Figure 2.1a 
 
Figure 2.1b 
 
Figure 2.1. Perspective views showing 50% (The disorder part has been omitted). 
  Appendix 3 
 210!
Appendix 3 
 Selected 1H and 13C Spectra 
!
O
Et
SO2Ph
O
O
H
TBSO H
O O
Me Me
2.21
10.5 10.0 9.5 9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0 -0.5
210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 -10
Appendix 3
211
O Et
SO2Ph
MOMO
MOMO
HO
HO O
H
O
O
Me
Me
2.26
10.5 10.0 9.5 9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0 -0.5
210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 -10
Appendix 3
212
OMOMO
MOMO
O
O
Et
SO2PhH
O O
MeMe
O
NC
2.28
10.5 10.0 9.5 9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0 -0.5
210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 -10
Appendix 3
213
O
Et
SO2Ph
O H
TBSO H
OH
O
2.36
10.5 10.0 9.5 9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0 -0.5
200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 -10
Appendix 3
214
O
Et
SO2Ph
O H
TBSO H
OPiv
O
10.5 10.0 9.5 9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0 -0.5
210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 -10
Appendix 3
215
O
Et
SO2Ph
O H
HO H
OPiv
O
2.37
10.5 10.0 9.5 9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0 -0.5
210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 -10
Appendix 3
216
O
Et
SO2PhO H
OPiv
2.41
10.5 10.0 9.5 9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0 -0.5
210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 -10
Appendix 3
217
O
Et
SO2PhO H
OPiv
2.42
10.5 10.0 9.5 9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0 -0.5
210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 -10
Appendix 3
218
O Et
SO2Ph
MOMO
MOMO
O
O O
H
O
1.110
10.5 10.0 9.5 9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0 -0.5
210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 -10
Appendix 3
219
O Et
SO2Ph
MeO
MeO
HO
HO O
H
PivO
2.59
10.5 10.0 9.5 9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0 -0.5
210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 -10
Appendix 3
220
O Et
SO2Ph
MeO
MeO
HO
HO
O
O
H
PivO
2.60
10.5 10.0 9.5 9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0 -0.5
210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 -10
Appendix 3
221
O Et
SO2Ph
MeO
MeO
O
O
O
O
H
PivO
2.61
10.5 10.0 9.5 9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0 -0.5
210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 -10
Appendix 3
222
O Et
SO2Ph
MeO
MeO
O
O
O
O
H
O
2.62
10.5 10.0 9.5 9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0 -0.5
210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 -10
Appendix 3
223
O
Et
SO2PhTIPSO
O
H
3.3
10.5 10.0 9.5 9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0 -0.5
210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 -10
Appendix 3
224
O
Et
SO2Ph
O
TIPSO
O
Et
PhO2S
O
OTIPS
H
H
H
H
3.5
10.5 10.0 9.5 9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0 -0.5
210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 -10
Appendix 3
225
OO O
PhO2S
O
HO OH
SO2PhHH
Et Et
H HO
3.8
10.5 10.0 9.5 9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0 -0.5
210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 -10
Appendix 3
226
O Et
SO2Ph
MeO
MeO
MeO
MeO
O
O
H
O
4.10
10.5 10.0 9.5 9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0 -0.5
210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 -10
Appendix 3
227
MeO
MeO
O
OPh
S(O)Ph
4.27
10.5 10.0 9.5 9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0 -0.5
200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 -10
Appendix 3
228
O Et
SO2Ph
MeO
MeO
H
HO
PivO
O
H
4.28
10.5 10.0 9.5 9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0 -0.5
210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 -10
Appendix 3
229
O Et
SO2Ph
MeO
MeO HO
O
O
H
PivO
4.29
10.5 10.0 9.5 9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0 -0.5
160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 -10 -20 -30 -40 -50 -60
Appendix 3
230
MeO
MeO HO
O
PivO
O
H
Et
SO2Ph
O
O
OH
4.32
10.5 10.0 9.5 9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0 -0.5
210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 -10
Appendix 3
231
O Et
SO2Ph
MeO
MeO O
O
O
H
PivO
4.33
10.5 10.0 9.5 9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0 -0.5
160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 -10 -20 -30 -40 -50 -60
Appendix 3
232
O Et
SO2Ph
MeO
MeO O
O
O
H
O
4.13
10.5 10.0 9.5 9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0 -0.5
210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 -10
Appendix 3
233
MeO
O
OMe
O
MeOOMe
O O
Et EtPhO2S SO2Ph
O O
H
H O
OO
O
H H
4.12
10.5 10.0 9.5 9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0 -0.5
210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 -10
Appendix 3
234
OMeO
O
OMe
O
MeOOMe
O O
Et EtPhO2S SO2Ph
OHHO
H H
O O
HH
5.7
10.5 10.0 9.5 9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0 -0.5
210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 -10
Appendix 3
235
OMeO
O
OMe
O
MeOOMe
O O
Et EtPhO2S SO2Ph
OMeMeO
H H
O O
HH
5.16
10.5 10.0 9.5 9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0 -0.5
210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 -10
Appendix 3
236
OMeO
O
OMe
O
MeOOMe
O O
Et EtHO OH
OMeMeO
H H
O O
HH
5.17
10.5 10.0 9.5 9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0 -0.5
210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 -10
Appendix 3
237
OMeO
O
OMe
O
MeOOMe
O O
Et EtO O
OMeMeO
H H
O O
HH
5.22
10.5 10.0 9.5 9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0 -0.5
210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 -10
Appendix 3
238
OMeO
O
OMe
O
MeOOMe
O O
Et EtAcO OAc
OMeMeO
H H
HH
AcO OAc
5.47
10.5 10.0 9.5 9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0 -0.5
210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 -10
Appendix 3
239
OMeO
O
OMe
O
MeOOMe
O O
Et EtAcO OAc
OMeMeO
H H
HH
5.48
10.5 10.0 9.5 9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0 -0.5
210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 -10
Appendix 3
240
OMeO
O
OMe
O
MeOOMe
O O
Et Et
OMeMeO
H H
HH
O O
5.49
10.5 10.0 9.5 9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0 -0.5
210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 -10
Appendix 3
241
